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Abstract 
Cardiovascular diseases are responsible for approximately a third of all death worldwide, 
with hypertension being a major risk factor for many of those. Hypertension can lead to 
left ventricle hypertrophy and diastolic and systolic dysfunction. Myocardial deformation 
parameters have been shown to have high sensitivity at the early stage of contractile 
dysfunction. They can be derived from myocardial tagging, considered to be the gold-
standard method, or from routinely acquired cine images using feature tracking (FT) 
techniques. 
This work aimed to validate FT as a post processing technique. Three FT software 
packages were used to measure strain parameters in healthy subjects and hypertensive 
patients in order to assess agreement. Intra- and inter-observer reproducibility was also 
investigated. The CVI42 software was found to have the best reproducibility. Good 
agreement across the three software packages and both groups was also observed for 
circumferential strain calculated from mid-ventricle short axis and longitudinal strain 
parameters. CVI42 was also compared to the reference tagging analysis by applying both 
techniques to a healthy and hypertensive patient cohort. Although tagging could 
discriminate between the two populations (longitudinal strain), no statistically significant 
differences were found by CVI42. The final validation step was to generate simulation 
models mimicking simplified cardiac views to compare the experimental results against a 
true gold-standard for which strain values are known. Two commercial FT software 
packages were used to analyze the simulated cine images with increasing complexity 
levels. Both showed inaccurate tracking and high errors compared to analytical values. 
This indicated that more realistic and complex numerical models should be investigated.  
Although FT is a relatively new and promising technique, the results demonstrated that it 
still requires going through standardization to better understand inter-vendor variability. 
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Chapter 1: Thesis Overview 
1.1 Thesis objectives 
There is an increased understanding that myocardial deformation parameters have the 
capability of detecting early contractile dysfunction in a number of cardiovascular 
diseases (1)(2). Feature tracking (FT) is a promising post-processing technique introduced 
recently to derive myocardial deformation parameters (3). FT relies on the analysis of 
routinely acquired functional Cardiac Magnetic Resonance (CMR) images to calculate 
these regional deformation parameters. This technique is time effective and a number of 
commercial and research software packages are available, making it a potential clinical 
tool.  
An increasing numbers of studies using FT are published and the ability of deformation 
parameters to distinguish between healthy subjects and cardiovascular disease patients 
has been demonstrated (4)(5). However, high variability and low reproducibility has been 
reported for some deformation parameters when measured by different FT software 
(6)(7). 
To fully harvest the clinical potential of FT, it is necessary to ensure that software 
packages are reproducible in the measurements they produce and that inter-vendor 
variability is investigated. Ideally, the results should be compared to current clinical gold 
standards and/or ground truth numerical simulations. 
The aims of this PhD is to assess inter-vendor agreement and the quality of the 
measurement produced by commercially available and research FT software packages. 
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This is first achieved by comparing global and regional deformation parameters derived 
from the FT packages in healthy and patient populations. As Magnetic Resonance 
Imaging (MRI) tagging is an established method to obtain myocardial deformation 
parameters (8),  FT packages are compared to tagging in healthy and hypertensive 
patients. The final aim is to develop ground truth simulation models and compare FT 
packages using those models. 
1.2 Thesis plan 
This thesis contains a further seven chapters. The second chapter provides brief 
background information on cardiac anatomy and physiology and the necessary 
information to understand how the CMR images, used in the subsequent chapters, are 
acquired. The third chapter is an introduction to FT and a comprehensive review of 
articles using or validating FT published to date. It should give the reader a clear 
understanding of the key findings, the advantages, disadvantages and limitations of 
studies published in this field. The review focusses on applications of feature tracking to 
both healthy subjects and cardiovascular disease patients. It also includes comparative 
studies with tagging technique or echocardiography. This chapter clearly highlights the 
lack of validation studies, either using in-vivo data or computer simulation. Furthermore, 
it also demonstrates the need for standardization of the parameters if they are to be used 
as viable indices to guide clinical decisions. The fourth chapter describes the common 
methods used in comparing global and regional deformation parameters derived from 
different software packages as well as outlining in detail the approaches of different 
software package used in the remainder of the dissertation. Descriptive information 
regarding the type and choice of statistical tests used to assess the agreement and 
reproducibility of feature tracking software packages are exhaustively discussed. The next 
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three chapters are designed to address some of the validation issues highlighted by 
chapter 3. In chapter 5, three FT packages are compared using data from 26 hypertensive 
patients and 28 healthy subjects. Both global and regional deformation parameters are 
calculated from functional CMR images. Further to the software packages comparison, 
the reproducibility of the three FT software packages was also investigated by assessing 
the inter-observer and intra-observer variability. To extend the comparison to a healthy 
population, and compare FT against the established tagging method, data from the 
HAPPY London study (9), are analysed in chapter six. In addition, the correlation 
between deformation parameters with diastolic and systolic blood pressure is evaluated. 
The differences between global and regional deformation parameters relevant to gender 
and hypertension are also assessed. The clear differences between software found in both 
chapter 5 and 6 justified the need for a ground truth numerical phantom. In chapter 
seven, five short and long axis simulations models of increasing complexity are designed; 
uniform short and long axis models, radial short and long axis models and finally a 
checkerboard short axis model. The five models are analyzed using two commercial FT 
software packages and results compared to the known theoretical values that are 
calculable using theoretical motion and deformation equations. Finally, chapter eight 
summarises the major findings of the entire thesis, discusses its limitations and highlights 
possible areas of for further research. 
  
 
23 
Chapter 2: Cardiac Magnetic Resonance 
Imaging 
2.1 Introduction 
The feature tacking methodology studied in this thesis makes use of cardiac magnetic 
resonance (CMR) images. Consequently, this chapter provides the reader with 
background information on how such images are acquired. It is by no means a detailed 
account of cardiac MRI physics and the interested reader can find more details for 
example in references (10)(11)(12). 
Unlike most other organs that are “static”, cardiac imaging has first to deal with cardiac 
motion. This is most commonly achieved by using an ECG trigger. Consequently, the 
first part of this chapter introduces succinctly cardiac anatomy and physiology. Once 
again the interested reader can find more details in (13)(14). 
2.2 Cardiac Anatomy  
The heart is a muscular organ weighing about 300g with its size likened to a human fist, 
and it is located within the middle and left of the mediastinum. The human heart is 
surrounded and protected by a double-membraned sac known as the pericardium sac.  
The heart is cone-shaped and tilted forward to the left. The tip of the cone is called apex 
of the heart, at the bottom, the apex lies to the left of the midline of the heart. The top of 
the human heart is known as the base, where the great vessels enter the heart and lies 
posterior to the sternum as shown in (Figure 2.1). The human heart is divided into four 
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chambers namely, upper left and right atria; and lower left and right ventricle. The right 
atrium and ventricle are often grouped as the right heart while the left atrium and 
ventricle are also referred to left heart (14). The two smaller atria are located at the base 
of the heart, whereas, the two larger ventricles are located at the apex. Fibrous tissue 
separates the atria from the ventricles and within these tissues are the four cardiac valves 
are located. A muscular septum separates the right heart from the left heart. 
The heart is also composed of valves, which prevent back flow of blood through the 
chambers. Between the right atrium and ventricle is the tricuspid valve while the bicuspid 
valve is located between the left atrium and left ventricle. The wall of the heart contains 
three layers of muscle; the innermost endocardial tissue, which is the thick myocardial 
layer, and outer pericardium, that covered in fibrous layer, to the pericardium. The 
innermost layer of the endocardium has a lining of endothelial cells which represents the 
thin endocardial layer. The outer epicardial surface contains the major coronary blood 
vessels and is separated from the pericardium by a thin layer of fluid (15). 
 
Figure 2.1: Anterior view of the heart showing the anatomical features (16). 
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2.3 Cardiac Cycle  
The cardiac motion is a periodic contraction and relaxation of the cardiac muscles to 
pump blood out of the ventricles into the circulatory system (13). The cardiac cycle is 
composed of systole (contraction and ejection) and diastolic (relaxation and filling) 
phases and since the human heart is comprised of four chambers, the cycle consists of 
atrial systole, atrial diastole, ventricular systole and ventricular diastole (17).  
 
Figure 2.2: Relationship between the cardiac cycle and ECG: At first there is atria and 
ventricular relaxation (diastole). Atria contraction (systole) immediately follows 
depolarisation of the atruim as represented by the P-wave in the ECG and continues until 
the QRS- complex starts, with the atrium now undergoing relaxation. The QRS-complex 
represents ventricular depolaristaion closely followed by ventricular contraction 
(systole). Repolarisation of the ventricles marks the start of ventricular relaxation and is 
represented by the T-wave in the ECG. 
 
Atrial Systole and Diastole: This phase involves the atrial muscles contraction and 
pressure rise within the atria leading to the pumping of blood into the ventricles through 
the open tricuspid and bicuspid valves. Atrial systole ends prior to ventricular systole, as 
the atrial muscle returns to diastole. 
Ventricular Systole: In this phase, there is rapid ventricle contraction also known as 
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(ventricular systole). At first ventricular blood pressure increases as the muscles within 
the ventricle contracts leading to rise in the blood pressure within the chamber, the blood 
pressure quickly builds up above the atria which are undergoing relaxation in the diastolic 
phase at that time. This increase in blood pressure results in backward flow of blood 
towards the atria, causing the tricuspid and mitral valves to close. The ventricular systole 
begins to increase pressure within the ventricle to a threshold required to open the 
semilunar valves. This leads to pumping of blood from the ventricles of the heart into 
systemic circulation by pushing open the pulmonary and aortic semilunar valves. 
(15)(18).  
Ventricular Diastole: In this phase, the muscles of the ventricles undergo relaxation, 
pressure within the remaining blood in the chamber begins to drop. A fall in ventricular 
pressure below the pressure in both pulmonary trunk and aorta leads to back flow of 
blood towards the heart leading to closure of the semilunar valves and prevents blood 
from going into system circulation. Following ventricular muscle relaxation, blood 
pressure within the ventricles drop even further. It gets to a point where it drops below the 
atrial pressure leading flow of blood from atria into the ventricles pushing open the mitral 
and tricuspid valve. Further drop in pressure within the ventricle leads to flow of blood 
from the major veins into the relaxed atria and subsequently into the ventricles. At this 
stage when both chambers are in diastole, the atrioventricular valves are open and the 
semilunar valves are closed marks the complete phase of the cardiac cycle (15). 
Different cardiac views in this thesis were used including three short axis views (basal, 
mid-ventricle, apical) as well as two-chamber and four chamber views as shown in Figure 
2.3. 
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Figure 2.3: Typical SSFP images for mid-ventricle short axis view (a), two-chamber long 
axis view (b) and four-chamber long axis view (c). 
2.3 Hypertension 
Hypertension is a major growing public health concern since it affects more than 1 billion 
people worldwide every year (19). Hypertension is an important risk factor for numerous 
cardiac diseases and the consequences of hypertension includes myocardial infarction, 
strokes, heart failure and coronary heart disease (19)(20). Hypertension accounts for 
increase incidents of global death (21). The relationship between blood pressure and its 
resultant complications is linear over a wide range of blood pressure, and there seems to 
be no clear threshold for the increased risk (22). The risk of complications in healthy 
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subjects as a result of high blood pressures require both researchers and clinicians to lay 
more emphasis on how to prevent or manage hypertensive conditions, hence early 
detection, treatment, and control of this condition should be prioritised  (20). 
Hypertension is defined as over 140/90 mmHg as the systolic blood pressure is >140 
mmHg or the diastolic blood pressure is > 90 mmHg (23). Spiking blood pressure 
consistently increase the risk of developing hypertensive cardiovascular diseases 
however, hypertension occurs when the blood pressure in the arteries is persistently 
raised.  
2.3.1 Effects on heart structure (remodelling): 
The structure of the heart is easily influenced by pressure and volume loads (21). 
Clinically diagnosed hypertensive heart disease are often characterised by changes in 
myocardial structure such as the more common left ventricular hypertrophy. At the onset 
of hypertension, the heart tries to overcome the increased afterload by the left ventricle 
induced by neurohormornal activation (24). This initially will lead to compensation 
(myocardial wall stress and enlargement) to deal with the pressure. However, persistent 
afterload and more neurohormonal activation eventually lead to progressive loss of 
cardiac muscle (adverse remodelling). At this stage patients present with heart failure 
symptoms in situations where it is too late to reverse the remodelling that has already 
occurred. The raised pressure load, as experienced in hypertension, is mainly caused by 
the increased peripheral blood vessel resistance and reduced atrial compliance (21).  
2.3.2 Effects on cardiac Function: 
Hypertension leads to physiological disorders such as diastolic dysfunction. The onset 
and progression of left ventricle hypertrophy (LVH) is affected mainly by blood pressure, 
however, there are other contributing factors such as obesity, salt intake and age (20). 
LVH has been reported to be a strong independent risk factor of mortality for patients 
 
29 
diagnosed with hypertensive heart disease (21). 
LV concentric hypertrophy often result in decrease in LV diastolic filling and compliance 
(21). Moreover, systolic function changes which occurs during hypertensive condition are 
defined by lower left ventricle ejection fractions. 
The irreversible remodelling during LV hypertrophy leads to heart failure which can 
disrupt fluid and electrolyte balance within the extracellular fluid which causes either 
pulmonary or pedal edema depending on the severity. 
2.4 Basic general MRI physics  
2.4.1 Origin of Spin  
Magnetic resonance imaging is based on the nuclear magnetic resonance principle 
observed in atoms that possess an overall spin. Although, different atoms can be imaged, 
hydrogen (1H) is the one used in almost all clinical applications due to its natural 
abundance in the human body in the form of water and lipid molecules. A hydrogen 
nucleus consists of a single proton that can be thought of as spinning on its own axis. 
Protons are positively charged resulting in a magnetic dipole moment and the proton to 
act like a tiny magnet.  
When placed a static magnetic field (B0) the proton dipoles align almost parallel or 
almost anti-parallel with the field (Figure 2.4), this is referred to as “spin up” or “spin 
down” (25).  
In quantum mechanical terms, the spins toward the external magnetic field are in low 
energy state, while protons which spins against the external magnetic field are in high 
energy state. There is a slight excess of spins in the spin-up state resulting in a small net 
magnetisation (M0) in the direction of the magnetic field (z-axis) (26), known as the 
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longitudinal magnetisation. As the protons precess out of phase with each other thus 
resulting in a zero net magnetisation in the transverse (xy) plane (transverse 
magnetisation). 
 
 
Figure 2.4: Atoms orientated randomly in the absence of magnetic field (on left-hand 
side). Atoms spin up and spin down alignment of the protons in the presence of strong 
magnetic field (on right-hand side). 
As the magnetic moment is not aligned exactly with the magnetic field, it experiences a 
torque which causes it to precess around the axis of the main magnetic field. The 
frequency of precession is called the Larmor frequency (equation 1) (26).  
w0= .Bo (1) 
where . is the gyromagnetic ratio and equal to 42.57 rad MHz T-1 for 1H. 
2.4.2 Excitation 
The equilibrium longitudinal net magnetisation is extremely small when compared with 
the static magnetic field. In order to be able to measure the NMR signal and create an 
image, the net magnetisation is first tipped away from the longitudinal axis by applying a 
radiofrequency (RF) pulse perpendicular to B0 and oscillating at a frequency equal to the 
resonance Larmor frequency. This is known as the excitation pulse or B1 field. The flip 
angle is the angle through which the net magnetisation is tipped.  
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Figure 2.5: NMR signal or free induction decay observed in the transverse plane. 
 
For example, a 90o RF pulse tips the net magnetisation vector into the transverse plane 
where it precesses around the axis of the static field and induces a signal in a receiver 
coil. This signal is known as the free induction decay (Figure 2.5): following the 
excitation pulse the transverse magnetisation (Mxy) and therefore, signal amplitude, 
rapidly decreases to zero as the protons dephase. The longitudinal component of the net 
magnetisation (Mz) increases exponentially back to its equilibrium value. This process is 
known as relaxation. 
 
2.4.3 Relaxation 
The mechanisms by which the magnetization regain its equilibrium state are collectively 
known as relaxation. Relaxation starts occurring as soon as RF pulse is stopped. There are 
two main relaxation processes; transverse and longitudinal relaxation. 
Spin-spin relaxation is the decay of the magnetisation in the transverse plane (Mxy) due to 
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the interaction between the spins, or magnetic moments, of neighbouring protons. Note 
that spin-spin relaxation can lead to complete dephasing in the transverse plane with no 
corresponding recovery of magnetization in the longitudinal axis, nor a net loss of energy. 
T2 is the spin-spin relaxation time, defined as the time taken for transverse magnetization 
to decay to 37% of its initial value (Figure 2.6). As well as spin-spin interactions, 
transverse magnetisation is also lost through interaction with magnetic field 
inhomogeneities; T2* is a modified value of T2 which takes these extra effects into 
account, and is thus always smaller than T2. T2* is of particular relevance in 
cardiovascular imaging as it can be used to measure iron load. 
 
Figure 2.6: Transverse and longitudinal relaxation curves. The transverse relaxation 
(black) decays with a relaxation time T2 equals to 37% of its initial value while the 
longitudinal relaxation recovers with a relaxation time T1, or the time it takes for the 
magnetisation to reach 63% of the equilibrium value. 
Spin-lattice relaxation is the recovery of the magnetization along the z-direction (Mz), the 
longitudinal direction, caused by interactions between the magnetic moment of the 
protons and the surrounding tissue, or lattice. T1, the spin-lattice relaxation time, is the 
time taken for longitudinal magnetization to recover to 63% of its equilibrium size. 
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Figure 6 shows T1 and T2 relaxation curves. In human tissue, T2 is always shorter than T1.  
2.5 Basic Sequences 
In order to create an image, the NMR signal needs to be spatially encoded; this is done 
using a series of time varying magnetic field gradients (often just referred to as gradients). 
The arrangement of RF pulses and gradients are known as a pulse sequence. As it takes 
time for spatial to occur, the data collection does not occur during the FID, instead an 
“echo” is generated during which the data is collected. The way the echo is generated 
leads to two family of sequences, spin echo in which a second RF pulse is used and 
gradient echo in which the reversal of one of the gradient is used to generate the echo. 
Basic spin and gradient spin echo sequences are displayed in Figure 2.7. 
 
Figure 2.7: Basic spin (left) and gradient (right) pulse sequences. In a gradient echo 
sequence, a flip angle smaller than 90° is typically used. 
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The time between the RF excitation pulse and the echo is known as the echo time (TE). 
For each echo, data is acquired and the raw data is placed in a matrix known as k-space. 
A line of k-space is acquired per excitation and consequently, the sequence need to be 
repeated a number of time to acquire sufficient data to create an image. The phase 
encoding gradient is incremented for each experiment and the time between each 
successive excitation is known as the repetition time (TR). In a gradient echo sequence, 
field inhomogeneities are not refocussed and consequently the echo is T2* dependent. In 
most anatomical imaging, the way the image look is directly dependent on the choice of 
acquisition parameter in particular TE, TR and the flip angle in a gradient echo sequence. 
2.6 Cardiac imaging 
 
Figure 2.8: Typical Black Blood Spin Echo (A-B) and Bright Blood Gradient Echo (C-D) 
CMR images. 
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Cardiac MRI, often called CMR, is routinely used to investigate the anatomy and function 
of the cardiovascular system. Unlike conventional MRI, it usually relies on the use of an 
ECG or a vector ECG (VCG) to synchronise the data acquisition to the cardiac motion in 
order to acquire data in specific phases of the cardiac cycle. Furthermore, unlike most 
other body part the way the image looks is primarily dictated by blood flow. On one 
hand, spin echo sequences produce dark blood images as the blood excited by the 90° 
typically flows out of the slice by the time the 180° pulse is applied to produce the echo, 
hence generating a signal void is produced (Figure 2.8 A-B). Black blood images are 
primarily used to look at the anatomy of the heart and the vessels, and the signal from the 
blood is usually further suppressed by the application of preparation pulses (27). On the 
other hand, blood appears bright on gradient echo sequences (Figure 2.8 C-D). This is 
because those sequences use short TR and consequently, static tissues are exposed to 
numerous RF pulses and their signal gets saturated, or in other words does not recover 
fully between TR. They are said to be “beaten down” meanwhile fresh blood that hasn’t 
been exposed to RF pulses flows into the slice and therefore appears brighter (27). Bright 
blood are typically used to evaluate cardiac function (27). These types of images are used 
in chapter 5 and 6 to compare different FT software packages. 
The assessment of global and regional contractile functionality of the heart can be 
achieved by using cine (gradient echo) sequence synchronised to the patient’s ECG. A 
cine scan provide a series of dynamic images throughout the cardiac cycle, that can be 
used to visualise cardiac motion abnormality and assess cardiac function (28)(29)(30). In 
routine CMR imaging, the data are acquired over multiple heartbeats and the acquisition 
synchronised to the patient’s ECG to overcome the motion and artefacts resulting from 
cardiac motion (10). The methods to synchronise data acquisition are detailed below. 
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2.6.1 Prospectively ECG gating 
For prospective ECG gating (in Figure 2.9 -top), the pulse sequence is triggered on the R-
wave. The signal acquisition of the first cardiac phase starts after a short trigger delay 
(normally used to initiate acquisition of data after the QRS complex) and the number of 
cardiac phases is chosen by the user but limited by the heart rate. The acquisition of data 
must be stopped before the end of the cardiac cycle in order to allow for detection of the 
next R-wave thereby missing the last part of the cardiac cycle (10). This technique 
requires an estimation of the average R-R interval for each patient being examined which 
can manually be inputted by the MR operator or automatically captured from the ECG 
trace within the MR system (10). The estimated R-R interval is then used to estimate the 
length of the cardiac cycle over which data can be captured as well as to determine the 
maximum number of cardiac phases that can be acquired.  
2.6.2 Retrospectively ECG gating 
For retrospective gating (Figure 2.9 -bottom) data is continuously acquired and 
retrospectively matched to ECG. Data acquisition continues until enough k-space is filled 
for the defined number of cardiac phases thereby promoting accurate matching of the data 
to the whole of the cardiac cycle without missing any part from being imaged (10). 
2.6.3. Cardiac function 
The assessment of functional cardiac can be achieved by several global measures. The 
Left Ventricular End-Diastolic Volume (LVEDV) and Left Ventricular End-Systolic 
Volume (LVESV) can both be measured by using CMR or echocardiography. Compared 
to echocardiography, CMR provides more accurate and reproducible volumetric 
measurements and is considered the gold standard for LV functional assessment (31). 
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Figure 2.9: Prospective triggering (above) and retrospective gating (bottom) as used in 
cardiac MR imaging. Image adapted from (10). 
CMR calculates the left ventricle cavity volumes from as set of true short axis cine slices 
that provide a complete coverage of the left ventricle and does not suffer for the 
limitations of echochardiography (suboptimal acoustic windows and view planning).  
The end-systolic volume (ESV) is the volume of blood left in a ventricle at the end of 
contraction. The difference between End Diastolic Volume (EDV) and End Systolic 
Volume (ESV) is called the Stroke Volume (SV) and it describes a volumetric 
measurement of blood ejected from the right and left ventricle with each heartbeat:  /0 = 230 − 2/0 (2) 
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The Ejection Fraction (EF) is defined as the volumetric fraction of blood pumped out of 
the left ventricle with each cardiac cycle. This fraction can be measured for both the left 
and right ventricles. EF is expressed in % and calculated as the stroke volume SV divided 
by end-diastolic volume EDV: 
25 % = /0230×100 (3) 
The acquisition of cine images of the heart can be achieved by acquiring data throughout 
the cardiac cycle  over several heart beats as shown in Figure 2.10 (32). For each slice 
location multiple time points covering the entire cardiac cycle are acquired images to 
allow function analysis. This technique requires sampling of a number of cardiac phases 
(usually between 20 and 30 phases, also referred to as ‘’frames’’) to achieve the desired 
temporal resolution depending on the heart rate of the patient being imaged (32). These 
images are then analysed semi-automatically to calculate the different parameters as 
shown in Figure 2.10.  
 
Figure 2.10: The cardiac phases and their images within one cardiac cycle (top). Short 
axis endocardial and epicardial contours (bottom-left-hand side) are drawn to calculate 
LV volume metrics. The corresponding left ventricle volume time curve for a short axis 
cine stack is shown (bottom-right-hand side). 
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2.7 CMR sequences used for myocardial motion analysis 
2.7.1 Fast Gradient Echo sequences 
Gradient-echo (GRE) sequences are by nature very fast  as they use very short TR and 
consequently form the backbone of cardiac examination; they are used for function, 
tagging, perfusion, etc (33). 
For a very short TR, the magnetisation does not have time to fully recover between each 
excitation; this forces the signal to reach a “steady-state” where it stays more or less 
constant. This happens to both the transverse and the longitudinal magnetisation, see 
Figure 2.11. 
 
Figure 2.11: Steady state. In fast gradient echo sequences, the signal does not have to 
fully recover between excitations and consequently, after a number of RF pulses, it will 
reach a steady state in both the longitudinal and transverse magnetisations. 
 
There are two basic types of fast sequences; for the first type both the transverse and 
longitudinal magnetisations, this is the balanced or coherent steady-state sequence 
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(balance steady state free precession or bSFFP, TrueFISP or FIESTA depending on the 
scanner manufacturer (34). For the second type, the remaining transverse magnetisation is 
destroyed before each new excitation, those sequences are incoherent or spoiled gradient 
echo. Pulse sequence diagrams of those two types of sequences are shown in Figure 2.12.  
Typically, balanced steady states have a high contrast ratio between the myocardium and 
the blood and have a high signal-to-noise (SNR) ratio. However, they are hard to optimise 
and are prone to artefacts in particular banding. Spoiled sequences have a lower SNR but 
tend to be more reliant to artefacts. Typical images are given in Figure 2.13. 
 
Figure 2.12: The diagram for steady state free precession (on left-hand side), Spoiled 
gradient echo sequence (on right-hand side) (33). 
 
 
 
Figure 2.13: Typical cardiac images acquired with balanced (a), and spoiled gradient 
echo sequences (b). 
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Cardiac images used in Chapter 5 and 6 for FT analysis were acquired using balanced 
SSFP sequences. In chapter 6, tagging images were acquired using spatial modulation of 
magnetisation (CSPAMM) sequence, which is discussed below. 
2.7.2 Tagging 
The tagging technique was invented in the eighties (35), and quickly improved on (36). 
This improved methodology still forms the basis of the technique used today this 
technique and is called “spatial modulation of magnetisation” or SPAMM. The pulse 
sequence is divided into two phases; a preparation phase where the tag lines are created 
and an imaging phase which consists of a fast gradient echo sequence (Figure 2.14). 
 
 
Figure 2.14: The SPAMM technique based on the principle that a slice-selective 
magnetisation saturated planes are created perpendicular to the imaging slice following 
the application of the tag pulses which disturbs the longitudinal magnetisation. (a) Pulse 
sequence showing the tagging preparation stage: tagging a plane requires slice-selective 
RF pulses to modulate the longitudinal magnetisation (RO = readout, PE = phase 
encoding, SS = slice selection). (b) Image acquisition stage after tagging showing the 
acquired slice and the tagged  lines perpendicular to it (37). 
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Figure 2.15: Typical SPAMM images at end-diastole (a) and end-systole (b). CPAMM 
images at end-diastole (c) and end-systole (d). Fading of the tagged lines (reduced 
contrast) in the systolic phase can be clearly observed for SPAMM (b), while this effect is 
greatly reduced in CSPAM (persistent tag lines contrast) (d). 
 
Myocardial tissue tagging can be generated through the conventional SPAMM sequence 
(Figure 2.14). Tag preparation requires the application of slice selective radiofrequency 
pulses perpendicular to the imaging plane in order to disturb the longitudinal 
magnetisation at the point of intersection between the imaging plane and the selected slice 
without affecting other regions within the slices (37). The application of the first RF pulse 
brings all spins in phase by tipping the magnetisation into the transverse plane followed 
immediately by the application of a gradient pulse along the desired tagging direction. 
The applied gradient pulse modulates the transverse magnetisation in a sinusoidal pattern 
along the direction of the gradient by increasing the phase shift of the spins along this 
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direction. The modulated transverse magnetisation then returns to the longitudinal plane 
following the application of the second RF pulse. Finally, a spoiling gradient is applied to 
remove any residual transverse magnetization prior to image acquisition.  
The CSPAMM (complementary SPAMM) tagging technique was introduced to resolve 
the problem associated with fading of tagging contrast through the cardiac cycle due to 
longitudinal relaxation commonly encountered in the SPAMM sequence (36) (see Figure 
2.15). This fading phenomenon makes tracking of tagged lines extremely difficult and 
results in incomplete analysis of myocardial deformation in the diastolic cardiac phases. 
To reduce this effect, CSPAMM uses two SPAMM tagging sequences where the polarity 
of one of the RF pulses is inverted in the second tagging sequence. The final tagged 
images are then produced by subtracting the pair of SPAMM images. This results in: i) 
the removal of the static (DC) component; and ii) an enhancement of the amplitude of the 
tagged magnetisation, enabling it to last for longer compared to SPAMM (Figure 2.15 b 
and d). 
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Chapter 3: Myocardial Deformation 
Assessment Using Cardiovascular 
Magnetic Resonance Feature Tracking  
3.1 Introduction 
There is a growing recognition that early detection of cardiac abnormalities could 
improve patient quality of life and reduce both morbidity and mortality (38)(39)(40). 
Extensive improvements and developments in CMR sequences and post-processing 
techniques have been introduced to facilitate their use in clinical settings in order to 
improve the diagnostic accuracy of CVD in its onset stage (41)(42)(43). 
Recent research has proven that global measures, such as ejection 
 fraction, are only an indicator of global heart function and cannot be used to infer 
regional function, nor to detect any ventricle dysfunction at the very early stages of 
established diseases (44). Contrary to visual myocardial wall-deformation analysis, 
indices including strain, strain rate and torsion can be sensitive indicators of underlying 
myocardial contractile dysfunctions. Those indices can be also derived from CMR-
tagging images (45). Tagging sequences use spatially selective saturation pulses to create 
dark lines on the myocardial tissue at the end diastole, with those lines persisting 
throughout part of or all the cardiac cycle (35). These techniques have since undergone 
extensive development and improvement for both imaging sequences (46)(47)(41), and 
post-processing methods (43)(42). CMR-tagging is now considered to be the gold 
standard for myocardial regional function assessment (48)(49).  
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This chapter first explains the principles of FT and the measurements that can be 
calculated using the method. Second, it reviews the expanding field of feature tracking 
with a particular emphasis on clinical and multimodality comparative studies.   
3.2 Feature tracking Principles and Derived Cardiac 
Motion Parameters  
3.2.1 Feature Tracking 
CMR feature tracking has been introduced in 2010, as a quantitative post-processing 
technique for cine SSFP sequences that are acquired as part of routine clinical cardiac 
examinations (50).  The fundamental principle of the feature tracking method is based on 
optical flow to extract spatiotemporal image features, such as varying image signal 
intensities, local textures and patterns from the cine images. The technique can then track 
anatomical features, such as epicardial and endocardial borders and myocardial tissue, in 
consecutive cine image frames by searching for the most comparable features in a local 
neighbourhood (defining a local voxel search window).  
Current FT software packages are semi-automated and rely on an operator to manually 
delineate the initial endocardial and epicardial contours, usually on the end-diastolic 
cardiac phase. This frame then serves as the initial time point from which all motion 
parameters are calculated. Myocardial deformation parameters such as displacement, 
velocity, strain and strain rates can be computed at local and global levels.  Further details 
on the operation of the FT software used in this thesis can be found in chapter 4. FT was 
initially developed for 2D cine images but can easily be extended to 3D cine images 
based on the same principles. The details of how tracking is implemented in different FT-
software packages are not always known and this might affect the quality and accuracy of 
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the tracking and of the derived strain measurements. Furthermore, results are also 
affected by CMR imaging sequence parameters, such as temporal and spatial resolutions, 
and image quality, in particular signal-to-noise ratio (3) (51)(39). 
3.2.2. Parameters 
Quantitative regional assessments can add incremental information in early stage of 
cardiac diseases that can improve the quality of life for many cardiac patients. The 
regional assessment of cardiac function includes displacement, velocity strain and strain 
rate. A schematic of the different parameters measured by FT are given in Figure 3.1. 
 
 
Figure 3.1: Myocardial deformation contains three strain components, circumferential, 
radial and longitudinal of the left ventricle: longitudinal (A), radial and circumferential 
(B). The direction of the deformation in diastole is shown as a dashed line and in systole 
shown as a solid line. The myocardial fibres shorten and lengthen in the three spatial 
directions: longitudinal, radial and circumferential. The strain can be calculated as the 
difference between myocardial fibre length (radial, circumferential and longitudinal) at 
end-diastole and at end-systole divided by the length at end-diastole, and expressed as 
percentage (%) (52).  
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The principal measurements can be defined as follows: 
Displacement: It is the distance covered by a moving object over time. The object does 
not undergo deformation when all parts move with the same velocity. However, if 
different parts of the object move with different velocities, the object will be undergoing 
deformation (53). 
Strain: Strain is a dimensionless quantity of myocardial deformation (54). It is 
mathematically defined as the change of myocardial fiber length during stress at end-
systole (l) compared to its original length in a relaxed state at end-diastole (l0):  
/,!"$' = (% − %;)%;  (1) 
Strain is usually expressed as a percentage (%). 
Negative strain indicates fiber shortening or myocardial thinning, whereas a positive 
value describes lengthening or thickening (54). Put simply, strain measures the magnitude 
of myocardial fiber contraction and relaxation. 
Strain Rate: The change of strain per unit of time is referred to as strain rate (SR). It is 
usually expressed as (%/s). 
Longitudinal, radial and circumferential measurements: Cardiac function can be 
further assessed by more detailed measurements. This is achieved by calculating the 
deformation in particular segments and in specific directions. There are three main 
components of contraction deformation: radial, longitudinal, and circumferential (54). 
• Longitudinal contraction represents motion from the base to the apex, which represent 
lengthening and shortening in the longitudinal direction (Figure 1.A). 
• Radial contraction in the short axis is perpendicular to both long axis and the 
myocardial wall (see Figure 1.B). Thus, radial strain represents myocardial thickening 
and thinning. 
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• Circumferential strain is defined as the in plane myocardial circumferential motion 
(rotational motion) (see Figure 1.B). 
Longitudinal deformation is assessed using longitudinal cardiac views (horizontal long 
axis, vertical long axis) while short axis views are used to assess in-plane circumferential 
and radial deformations. 
3.3 Review of FT literature published to date 
3.3.1 Feature Tracking (CMR-FT) studies 
Cardiovascular Magnetic Resonance feature tracking (CMR-FT) is a quantitative post-
processing technique that tracks myocardial tissue motion on SSFP cine images, the most 
commonly used sequence in clinical cardiac function assessment. The first software 
package based on FT techniques was introduced by TomTec Imaging Systems GMbH 
(Munich, Germany) and has been used in most clinical studies published to date (51)(50) 
(55). More recent studies used a different FT software package: a tissue tracking module 
within the CVI42 software (Circle Cardiovascular Imaging Inc. Calgary, Canada) (56); A 
summary of studies using CMR-FT is given in Table 3.1. 
Some clinical studies were dedicated to assessing the reproducibility of FT by evaluating 
inter- and intra-observer variability, whereas others applied FT to both healthy subjects 
and patients to quantify the difference in cardiac deformation parameters between those 
groups (55)(4). Feature tracking can be applied to evaluate the function and the 
mechanics of all heart chambers: right ventricle (RV), left ventricle (LV) and atrial 
deformations. 
CMR-FT was applied to detect quantitative motion changes at rest and stress in the LV, 
(51)(7) as left ventricular motion abnormalities detected by CMR post-processing 
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techniques could be an early and sensitive tool for any contractile dysfunction. The 
quantitative wall parameters derived from cine images were assessed at rest and during 
dobutamine stress in healthy volunteers (7) and in patients with ischaemic 
cardiomyopathy (51). CMR-FT demonstrated its ability to detect wall motion changes 
between rest and stress, where circumferential and radial strains increased significantly 
with dobutamine in both studies. However, there was no response to dobutamine in 
dysfunctional segments with scar in patients with ischaemic cardiomyopathy compared to 
non-dysfunctional segments. In stress studies, the more reproducible myocardial 
deformation parameter for inter- and intra-observer was circumferential strain (51)(7). 
CMR-FT can then be used to assess strain measures at rest and stress and could provide a 
potential method for assessing wall contraction changes. 
Heart failure and cardiomyopathies have also been evaluated using CMR-FT in particular 
hypertrophic cardiomyopathy (4).  The ability of CMR-FT to differentiate between 
patients and healthy controls was evaluated in two studies. (50)(4) In hypertrophic 
cardiomyopathy and heart failure patients, both left atrium longitudinal strain (22.1% and 
16.3 %) and strain rate (0.9 s-1 and 0.8 s-1) were lower than in healthy subjects (strain 
29.1% and strain rate 1.1 s-1).(4) Scarred segments showed lower contractile function, 
radial displacement, radial velocity, radial strain and longitudinal strain values compared 
to non-scar segments. Radial strain was shown to be the best parameter to discriminate 
between scarred segments from non-scarred ones (50). 
Diseases of the aorta have also been given a great deal of attention in clinical research, in 
particular coarctation of the aorta (COA) (55) (57). Repaired COA patients were assessed 
using CMR-FT compared to normal subjects (55). Global radial and global longitudinal 
strains were decreased in patients, while global circumferential strain was preserved 
compared to normal subjects. In the presence of hypertrophy, global longitudinal strain 
was significantly reduced, which could be used as an indicator of early LV dysfunction. 
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A study carried out by Maret et al. assessed the ability of the CMR-FT technique to detect 
scar defined with gadolinium-enhanced CMR of LV(50). Scarred segments showed lower 
functional measurements than distant segments. Myocardial function can also be 
measured by FT-motion parameters, such as velocity and displacement of a specific 
myocardial point or segment. Myocardial wall contractility will be reduced in the 
presence of scar and as a consequence of reduced myocardial blood flow. 
CMR-FT applications were not limited to cardiovascular disease patients, but included 
healthy subjects to assess inter-study reproducibility at global and segmental levels. 
Circumferential strain was found to be the most reproducible component, as its 
coefficient of variation (CV) is 20.3%, whereas reproducibility for radial strain was poor 
(CV= 27.2%). (6) In another study, inter- and intra-observer variability at rest was best 
for circumferential strain and the observer-variability did not significantly increase with 
stress (7).  
To evaluate whether inter-study reproducibility is affected by physiological variations, 
sixteen healthy volunteers underwent CMR examinations 3 times on the same day: the 
first scan was conducted after fasting, the second scan immediately after the first scan, 
and the last examination was a non-fasting scan in the afternoon. No diurnal variation was 
observed (6). Global measures showed no significant difference among the three repeated 
scans, as opposed to segmental measures, which were significant for radial strain. 
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Table 3.1: Comparison between studies using CMR-FT technique. 
C= Circumferential, R= Radial, L= Longitudinal, CS= Circumferential strain, RS= Radial strain, LS= Longitudinal strain, CSR= Circumferential strain rate, GRS= Global radial 
strain, GLS= Global longitudinal strain, GCS= Global circumferential strain, LV= Left ventricle, RV= Right ventricle, LA= Left atria 
l. 
Study Strain parameters Software Healthy Subjects 
Subjects 
Disease studied 
Main findings 
Limitations 
Positive Negative 
Schuster et 
al., 2011 (7) 
RV & LV 
C, R, L 
Segmental, Global 
Tomtec 10  - 
- During dobutamine stress, CS & 
RS increased significantly. 
- CS, best observer variability of 
LV.  
- Worse observer variability 
of RV- LS. - Small sample size. 
Schuster et 
al., 2013 (51)  
LV 
C, R 
Segmental 
Tomtec - 
15  
Ischaemic 
cardiomyopathy 
- No response to dobutamine in 
dysfunctional segments with scar in 
all C & R strain parameters. 
 
- Small sample size. 
- No Follow up post-
revascularization data. 
- No functional recovery data. 
Kowallick et 
al., 2014 (4)  
LA 
L 
Global and 
segmental 
Tomtec 10  
20  
Hypertrophic 
cardiomyopathy (10) 
Heart failure (10) 
- Excellent inter- & intra-observer 
variability for all strain and SR. 
- LS discrimination between patients 
and healthy controls. 
 - Small sample size. 
Taylor et al., 
2014  (5) 
LV 
C, R 
Segmental 
Tomtec 55  108 Cardiomyopathy 
- Lower CS & RS in patients than 
healthy controls.  
- Heterogeneous age and 
gender groups. 
Maret et al., 
2009 (50)  
LV 
R, L 
Global and 
segmental 
Tomtec - 30  Presence of LV scar 
- Lower functional measures in 
scarred segments than distant 
segments. 
 
- Heterogeneous (gender). 
- large number of infarctions 
with subendocardial 
distribution is needed to be 
tested by the FT-technique. 
- Low accuracy of ejection 
fraction. 
Morton et al., 
2012 (6)  
LV 
R, L 
Global and 
segmental 
Tomtec 16  - 
 
- More reproducible for global 
measurements than segmental ones.  
 
- CS most reproducible measure of 
LV. 
- Variable inter-study 
reproducibility. 
- L measures least 
reproducible segmental 
measure of RV 
measurements. 
RS least reproducible 
global measurement.  
- Small sample size. 
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3.3.2 Comparison between CMR-FT and CMR-tagging 
There are currently two main CMR post-processing techniques that have been applied in 
order to quantify regional myocardial function: analysis of CMR tagging, and CMR-FT 
using functional cine images (4)(5)(58). Regional myocardial deformation strain is a 
sensitive measure for detecting onset stages of myocardial dysfunctions and can be 
derived from CMR-FT and CMR-tagging techniques. CMR-FT and CMR-tagging 
techniques can help in early identification of myocardial dysfunctions. These techniques 
could prove important for clinical risk management, starting treatment and helping in 
therapy decision-making (45)(59). CMR-FT is increasingly being used in studies to 
assess its potential in routine clinical evaluation, as CMR-FT analysis computes strain 
from routinely performed SSFP cine images without the need to acquire any additional 
CMR sequences. However, CMR-FT requires standardisation of MRI acquisition and 
post-processing protocols to reduce any possible discrepancies between studies beside 
inherent natural physiological variability between healthy subjects (8). As for CMR-
tagging, tagged lines fade out towards the end of the cardiac cycle making them difficult 
to track using post-processing techniques (60). Few studies have compared CMR-FT to 
CMR-tagging in healthy subjects or patients to diagnose subtle myocardial motion 
abnormalities. The number of subjects in each study needs to be taken into account when 
comparisons are being made with other studies. A summary is given in Table 3.2. 
Muscular dystrophies such as Duchenne Muscular Dystrophy were the subject of regional 
myocardial function assessment using both FT and tagging techniques (8). The study 
included healthy volunteers and a large population of Duchenne Muscular Dystrophy 
patients of different age groups and severity; when strain values from the mid-left 
ventricular short-axis slice were compared between the two techniques, the mean 
circumferential strain was highly correlated. This study showed that the two techniques 
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were comparable. 
Comparison between the two techniques was also carried out in cardiomyopathies 
(1)(45)(61). One study compared the techniques in both healthy subjects and hypertrophic 
cardiomyopathy patients (1). The results showed a closer agreement in time-to-peak 
circumferential strain than in the magnitude of strain peak between both techniques. A 
second study compared the techniques in healthy volunteers, patients with left bundle 
branch block and hypertrophic cardiomyopathy (61). The segmental peak and time-to-
peak for systolic circumferential strains were assessed, and both the intra- and inter-
observer reproducibility were evaluated. This study demonstrated that absolute values of 
peak systolic circumferential strain are higher with CMR-FT than with tissue tagging. 
There was also a significant difference in mean peak systolic circumferential strain values 
between the populations studied. The inter- and intra-observer agreements were both 
lower with CMR-FT than with tagging. 
While most studies (1)(8) focused solely on systolic deformation parameters, a study by 
Moody et al. (45) compared both techniques in short and long axis views, both in systole 
and diastole, in healthy subjects and patients with dilated cardiomyopathy. The study 
showed a good agreement between CMR-FT and CMR-tagging techniques for systolic 
global circumferential strain (-22.7 ±6.2% vs. -22.5 ±6.9%, bias= 0.2 ±4%, p=0.8) 
respectively and early diastolic global circumferential strain rate (1.21 ±0.44 s-1 vs. 1.07 
±0.3 s-1, bias= -0.14 ±0.34 s-1). There was an acceptable agreement for systolic global 
longitudinal strain (-18.1 ±5 % vs. -16.7 ±4.8 %, bias=1.3 ±3.8%, p=0.03) in healthy 
subjects. In dilated cardiomyopathy patients, the difference between both techniques was 
not significant (-9.7 ±4.5% vs. -8.8 ±3.9%, p=0.44), whereas the agreement for early 
diastolic global longitudinal strain rate was poor, and the difference between both 
techniques was significant (p < 0.001) in healthy subjects. Overall, there was an 
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acceptable agreement between systolic and diastolic strains for some parameters 
measured by both techniques in both groups. However, the study only included 35 
healthy subjects and 10 dilated cardiomyopathy patients; this could have had an impact 
on the statistical results, and should be considered when comparing this study to other 
studies with larger population sizes. 
A different study was carried out to compare the two techniques for diastolic and systolic 
strain measurements in patients with aortic stenosis (62). In this study, the strain 
parameters were consistently higher with FT than with tagging. Furthermore, the 
interstudy reproducibility for circumferential peak systolic strain was excellent with FT 
and good with tagging, whereas the reproducibility for circumferential peak end diastolic 
strain rate was good only with basal and mid-slices. 
Finally, FT and tagging were compared in healthy adults (30). For global measurement of 
strain, there was a good agreement between both techniques with circumferential strain, 
but this was not the case with radial and longitudinal strains. Reproducibility showed the 
same trends with reasonable inter-observer variability for circumferential measures. The 
study showed some variation in strain with gender: longitudinal strain values were higher 
in females, whereas radial values were higher in males. 
There are obvious limitations in comparison studies that could explain the published 
disparities and disagreements in results. CMR-FT studies have been published by 
numerous centres using heterogeneous equipment (including field strength) and sequence 
acquisition parameters (temporal resolution, spatial resolution, slice orientation etc.). All 
these differences can affect the reported results and unfortunately, few studies include 
detailed limitations and reproducibility data. Although MRI acquisition parameters 
(temporal resolution, spatial resolution, slice orientation etc.) could be made as close as 
possible for both tagging and SSFP sequences, they are not identical (61)(63). There were 
also differences in external parameters such as population demographics (64).  
 Table 3.2: Comparison between studies using CMR-FT and tagging techniques. 
C= Circumferential, R= Radial, L= Longitudinal, CS= Circumferential strain, RS= Radial strain, LS= Longitudinal strain, SCS= Systolic circumferential strain, T2P-SCS= Time-to-peak-systolic 
circumferential strain, LV= Left ventricle. Tomtec= MR FT analysis (TomTec Imaging Systems, Munich, Germany). Tagging analysis: HARP= (Diagnosoft, Palo Alto, California). CIMTag2D= 
(CIMTag2D v.7, Auckland MRI Research Group, New Zealand). InTag= (Creatis, Lyon, France) and MASS= (Medis, Leiden, The Netherlands). 
Study Strain parameters Software 
Healthy 
subjects 
Subjects 
Disease studied 
Main findings 
Limitations 
Positive Negative 
Hor et al., 2010 
(8) 
LV 
C 
Global and 
segmental 
TomTec 
HARP 42 
191 
Duchenne 
Muscular 
Dystrophy 
(DMD) 
- CS derived by FT highly correlated with tagging 
technique. 
- Low intra-observer and inter-observer bias and 
variability for FT. 
 
- Analysis only performed on a mid-left 
ventricular short axis slice. 
- Only average strain was calculated, 
regional measures were not included in the 
study. 
Harrild, D.M et 
al. 2009 (1) 
LV 
C MATLAB 
13 
 
11 
Hypertrophic 
cardiomyopathy 
- Close agreement between both techniques. 
- Better agreement for time to peak strain than peak 
strain magnitude. 
 
- Small sample size. 
- Endocardial circumferential strain from 
mid-left ventricle was the only examined 
parameter. 
- Further study needed to examine radial 
and longitudinal strains as well as 
epicardial strain. 
Augustine et al. 
2013 (30) 
C, R, L 
Global and 
segmental 
TomTec 
CIMTag2D 
145 
 - 
- Good agreement between both techniques for CS. 
- Acceptable global inter-observer variability for 
circumferential measures. 
- Some variation in strain with gender: longitudinal 
strain higher and radial lower in females. 
- Poor agreement between FT and tagging for R 
and LS. 
 
- Poor inter-observer reproducibility for R and 
LS for both techniques. 
- Healthy subjects were heterogeneous 
related to gender. 
Singh et al., 2014 
(62) 
C, L 
Global and 
segmental 
TomTec 
InTag - 
18 
aortic stenosis 
(AS) 
- Excellent inter study reproducibility for 
circumferential peak systolic strain with FT and 
good with tagging. 
- Good reproducibility for circumferential peak end 
diastolic strain rate for basal and mid slices only. 
- Strain parameters consistently higher with FT. - Small sample size. 
Wu et al., 2014 
(61) 
LV 
C 
Segmental 
TomTec 
MASS 10 
20 
left bundle 
branch block (10) 
hypertrophic 
cardiomyopathy 
(10) 
 
- Intra and inter-observer agreement of 
segmental peak SCS and T2P-SCS substantially 
lower with FT compared with tagging. 
- Significant differences in mean peak SCS 
values between FT and tagging. 
- Higher absolute values of peak SCS with FT 
compared with tagging. 
- Significant difference in mean peak SCS 
values. 
- Small sample size. 
- Similar but not identical slice level used 
for CMR-FT and CMR-tagging. 
 
Moody et al., 
2014 (45) 
LV 
C, L 
Global 
TomTec 
CIMTag2D 35 
10 
dilated 
cardiomyopathy 
- Good agreement between both techniques at peak 
global systolic circumferential strain and early 
global diastolic circumferential strain rate. 
- Acceptable agreement at peak systolic global 
longitudinal strain. 
- Poor agreement for early diastolic global 
longitudinal strain. 
- Small sample size. 
- As a result of tag fading, late diastolic 
strain measures not possible. 
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3.3.3 Comparison between CMR-FT and Echocardiography 
The calculation of strain and strain rate always depends on image quality; this can have 
an effect on the reliability and reproducibility of deformation parameters derived from 
echocardiographic images. Echocardiography is limited by acquisition angle and operator 
dependence (60)(65). CMR is increasingly the method of choice because of its wide field-
of-view, better image quality and reproducibility (66) . A few clinical studies have 
compared echocardiography and CMR-FT in patients and healthy subjects to evaluate the 
clinical usefulness of the latter in assessing myocardial deformation parameters (67)(2). A 
summary of studies comparing CMR-FT to echocardiography is given in Table 3.3. 
Most comparative studies have focussed on adult congenital heart disease, in particular 
Tetralogy of Fallot (TOF) (67)(68). A study was carried out in adult TOF patients and 
healthy subjects comparing CMR-FT to speckle tracking echocardiography (STE) (68). 
There was a close agreement between global longitudinal and circumferential LV strains 
measured by CMR-FT and STE techniques, but the agreement was poor for global radial 
LV strain. There was also a good agreement between both techniques for global 
longitudinal RV strain. Inter-observer agreement for both techniques was similar for LV 
global longitudinal strain; however, CMR-FT showed better inter-observer 
reproducibility for LV circumferential and radial strains and RV global longitudinal 
strain. There was no significant difference between TOF patients and healthy subjects in 
LV circumferential strain (-23.5 ±6 vs. -22 ±3.9%, p=0.28) with CMR-FT, while LV 
longitudinal strain (-19.2 ±4 vs. -21.3 ±3.3%, p=0.048) and LV radial strain (22 ±8.9 vs. 
28 ±11.3%, p=0.2) were found to be lower in patients. Furthermore, RV longitudinal 
strain was lower in patients compared to healthy subjects (18.3 ±4.3 vs. 24.1 ±4%, 
p=0.0001) (68).  
The agreement between CMR-FT and STE techniques were also assessed for LV and RV 
 global longitudinal, radial and circumferential strains in TOF patients. (67) LV global 
circumferential and longitudinal strains had the best inter-modality agreement, whereas 
poorer inter-modalities and inter-observer variability were found for global radial strain, 
contrary to what was observed for radial strain in a previous study (68). When comparing 
TOF patients to healthy subjects, LV global circumferential, radial and longitudinal 
strains and RV global longitudinal strain were lower in patients compared to healthy 
subjects; this is in line with previously reported data (68).  
The feasibility of CMR-FT technique was assessed in patients with dyssynchrony (2). 
There was a reasonable agreement in radial dyssynchrony in patients with more marked 
dyssynchrony between CMR-FT and STE. The results showed a significant increase in 
radial myocardial contraction and circumferential strain after stent implantation. The 
feasibility of CMR-FT technique compared to echocardiography was also assessed in 
healthy subjects and patients with left ventricle hypertrophy cardiomyopathy (66). CMR-
FT-derived strain and strain rate correlated well with echocardiography, and consequently 
could become an alternative to echocardiography for assessing myocardial deformation 
parameters in clinical settings in the future. 
3.4 Discussion 
FT was used to assess regional cardiac function by calculating myocardial deformation 
parameters and their variation with age, gender and different cardiac dysfunction 
pathologies. An increasing number of research studies are using feature tracking and 
comparing it to tagging techniques or echocardiography in both patients and healthy 
subjects. Some studies have proved the usefulness of feature tracking for evaluating 
myocardial deformation indices and differentiating between healthy and disease states.  
 
 Table 3.3: Comparison between studies using CMR-FT and echocardiography 
C= Circumferential, R= Radial, L= Longitudinal, CS= Circumferential strain, RS= Radial strain, LS= Longitudinal strain, CSR= Circumferential strain rate, GRS= Global 
radial strain, GLS= Global longitudinal strain, GCS=Global circumferential strain, LV= Left ventricle, RV= Right ventricle. Tomtec= MR feature tracking analysis. 
Echocardiography FT: Tomtec (2DE) = 2D Echocardiography analysis. Tomtec (STE)= Speckle Tracking analysis. (TomTec Imaging Systems, Munich, Germany) 
Study Strain parameters Software 
Healthy 
subjects 
Subjects 
Disease 
studied 
Main findings 
Limitations 
Positive Negative 
Kempny et 
al., 
2012 (68)  
 
RV & LV 
C, R, L 
Global and 
segmental 
TomTec 
 
Tomtec 
(STE) 
25   
 
28  
Tetralogy of 
Fallot 
 
 
- Close agreement between 
global LV and global RV 
strain measurements. 
- Similar inter-observer 
agreement for both modalities 
for LV GLS. 
- Better inter-observer 
reproducibility for LV CS or 
RS and RV GLS measured by 
FT. 
- Reproducibility for 
regional strain using FT 
technique was poor. 
- No TOF patients with different severity 
of pulmonary regurgitation data, for the 
association between the severity of 
pulmonary regurgitation and strain 
measurements. 
 
Padiyath et 
al.,2013 
(67)  
 
RV & LV 
C, R, L 
Global and 
segmental 
TomTec 
 
Tomtec 
(2DE) 
20  
 
20 
Tetralogy of 
Fallot 
- Best intermodality agreement 
for GCS followed by GLS. 
- Acceptable inter-observer 
agreement for GLS and GCS 
of LV and RV with both 
modalities. 
 
- Inter-modality and 
inter-observer 
agreements were poor for 
GRS. 
- Small sample size. 
 
- Heterogeneous related to age and 
gender in both groups. 
- No Right ventricle out flow assessment 
by FT technique. 
Onishi et 
al., 
2013 (2)  
 
R 
Segmental 
TomTec 
 
Tomtec 
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Dyssynchrony 
 
- Reasonable agreement 
between both modalities for 
the patients with more marked 
dyssynchrony. 
 
 - No available long term follow up data. 
Orwat et 
al., 2014 
(66)  
L, C 
Global 
TomTec 
 
Tomtec 
20  
20 
patients with 
left ventricular 
hypertrophy 
cardiomyopathy 
(HCM) 
- Good agreement between 
both modalities for LV GLS 
for healthy and patients. 
- Poor agreement for CS 
and all SR 
measurements. 
- Higher LV and RV 
strain, inter-observer 
reproducibility compared 
to SR. 
- Small sample size. 
- Heterogeneous related to age in both 
group. 
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However, as summarised in Tables 3.1 to 3.3, the number of subjects varies between 
studies which has a subsequent impact on statistical results (68). The detection of motion 
abnormalities in the early stage of CVD is of great importance for an accurate diagnosis. 
Feature tracking provides a quantitative assessment of left ventricular motion (51)(7), and 
can therefore be a sensitive tool to detect contractile dysfunction. Significant changes 
between rest and dobutamine stress were detected by FT technique in ischaemic 
cardiomyopathy, with no response to dobutamine in dysfunctional parts with scar (51). 
FT can distinguish scarred segments from distant ones as scarred segments showed lower 
functional measures (50).  
Global strain measures proved to be more reproducible than regional results (4)(6)(67). 
The potential benefit of global myocardial strain assessment has been shown to be a 
sensitive indicator of RV function in TOF patients (67). In another study that assessed 
inter-observer reproducibility in TOF patients, a close agreement was found between 
global left (LV) and right ventricular (RV) global strain measures (68). The most 
consistently reproducible strain components were global longitudinal and global 
circumferential strain, whereas large variations were observed in global radial strain 
(51)(7). 
Despite the increasing number of published studies in feature tracking, there is still an 
obvious lack of comparison, standardisation and validation studies. Therefore, results of 
these studies have highlighted discrepancies between the different FT software packages 
available. Unlike speckle tracking echocardiography (69)(70), CMR-FT has not gone 
through standardisation and validation in physical or numerical phantom and/or animal 
models in order to validate it as a routine clinical tool. It is of paramount importance to 
understand the origin of these discrepancies in CMR-FT results. Consequently, in order to 
validate and compare the different FT software packages, it would be ideal to develop a 
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“ground truth” numerical phantom. Such a phantom would also allow for the optimisation 
of clinical applications. Feature tracking software providers should aim to reach a 
consensus for the validation and standardisation of reliable deformation parameters and 
MRI acquisitions and analysis of post-processing methods.  
3.5 Conclusion 
The current review chapter summarised the main results, reproducibility, and clinical 
applications of FT studies, as well as their limitations, while also suggesting important 
possible avenues for future work. 
Research studies in healthy volunteers and/or patients either applied CMR-feature 
tracking alone to assess myocardial motion or compared it to either established CMR-
tagging techniques or to speckle tracking echocardiography. These studies assessed the 
feasibility and reliability of calculating or determining global and regional myocardial 
deformation strain parameters. Regional deformation parameters are reviewed and 
compared. Better reproducibility for global deformation perameters was observed 
compared to segmental parameters. Overall, studies demonstrated that circumferential 
strain was the most reproducible parameter, usually followed by longitudinal strain; in 
contrast, radial strain showed high variability. 
Based on the high variability and low reproducibility for some deformation strain 
parameters derived from feature tracking technique noted in various research studies, 
there was a clear need to compare feature tracking software and establish inter and intra-
observer variability in clearly defined populations. Consequently, chapter 5 focusses on 
the comparison of three FT software packages in 26 hypertensive patients and 28 healthy 
subjects. Moreover, it is obvious that FT also need to be compared to the current MRI 
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gold standard that is Tagging. This is the aim of chapter 6 where a large cohort of 28 
healthy subjects and 62 hypertensive patients is analysed to compare FT and CMR-
tagging. 
Although comparative studies with tagging and echocardiography are a necessary step in 
validating CMR-FT, only numerical phantoms could give an absolute answer when 
evaluating different algorithms. Ideally, synthetic images mimicking known LV motions 
should be used to validate and compare the different FT software solutions. This is the 
main aim of chapter 7 in this thesis.  
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Chapter 4: Methodology 
The aim of this chapter is to describe the common methods used to investigate global and 
regional myocardial functional parameters calculated from feature tracking and cardiac 
tagging in the remainder of this thesis. The chapter also details the analysis process for 
the different CMR software packages. Different software packages were applied to 
healthy subjects and hypertensive patients; the derived results from the same population 
were compared, in order to ascertain whether the results from different software packages 
were comparable in accuracy and precision. The various statistical tests used in the 
experimental chapters are also discussed. The focus of chapter 5 is to compare the three 
most commonly available feature tracking software packages: Tomtec (Tomtec MR FT 
analysis, TomTec Imaging Systems, Munich, Germany), CVI42 (Circle Cardiovascular 
Imaging Inc. Calgary, Canada) and CIM-FT (CIM-FT, Auckland MRI Research Group, 
New Zealand). This was carried out on a patient population (26 hypertensive patients) 
and healthy subjects (28). The comparison includes both inter- and intra-observer 
variability. 
Chapter 6 is a comparative study of FT and tagging techniques. This study includes a 
larger hypertensive population (62) and the same healthy subjects (28) that was applied in 
chapter 5, both groups were carried out using two commercially available software were 
used; one for FT analysis (CVI42) and one for tagging (CIMTag2D).  
Image acquisition parameters for both studies are also discussed in this chapter. 
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4.1 Cardiac magnetic resonance (CMR) 
4.1.1 CMR cine acquisition protocol 
All CMR examinations were acquired using the recommended CMR protocol as defined 
by the cardiovascular magnetic resonance CMR guidelines paper for cine imaging and 
tagging sequences including recommended scan parameters for spatial resolution and 
temporal resolution, coverage, slice thickness and inter-slice gap (71). The 26 
hypertensive patient population analysed in chapter 5 was imaged using a 1.5T scanner 
(Avanto, Siemens Medical Imaging, Germany), in conjunction with 32-channel cardiac 
receiver coil was used. LV function was assessed with a retrospective ECG-gated SSFP 
cine sequence during short breath-holding in the following planes: two-chamber or four-
chamber, and three short axis slices (basal, mid, and apical levels). The SSFP acquisition 
parameters were: echo time (TE) 2.48 ms, repetition time (TR) 1.24 ms, flip angle 70°, 
typical field of view 292×360 mm2, slice thickness 7 mm, acquisition matrix size 
208×256, and reconstructed pixel size 1.25×1.25 mm2.  
The healthy population analysed in chapter 5 and 6, and the hypertensive population of 
chapter 6 were all enrolled in the HAPPY London study. All CMR images were acquired 
using a 1.5T scanner (Achieva, Philips Medical Systems, Best, the Netherlands) and a 
dedicated 32-channel cardiac receiver coil. Cine image acquisitions were retrospectively 
ECG-gated. All images were acquired during short breath-holding in the following 
planes: vertical long axis (VLA or two-chamber), horizontal long axis (HLA or four-
chamber), and short axis slices (basal, mid, and apical levels). Left ventricular apical, 
mid, and basal short-axes cine-images (SSFP) were acquired for all subjects.  
The SSFP sequence parameters were: TE 1.44 ms, TR 2.9 ms, field-of-view 205×380 
mm², acquisition matrix 108×186, slice thickness 8 mm with a 2 mm gap between slices, 
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30 reconstructed frames per cardiac cycle (typical temporal resolution of 46 ms for a 
heart-rate of 60 beats per minute), and a flip angle of 60°; typical images are as shown in 
Figure 4.1.  
 
Figure 4.1: Typical SSFP images; (a) apical short axis, (b) mid ventricle short axis, (c) 
basal short axis, (d) two chamber long axis, (e) four chamber long axis acquired for the 
study. 
4.1.2 CMR-tagging acquisition protocol 
In chapter 6, short axis apical, mid and basal two-chamber and four-chamber tagged 
images matched to the SSFP images were obtained using CSPAMM. Prospectively gated 
tagged images were acquired as follows; three short axis-tagged images of the LV (base, 
mid, and apex) four-chamber and two-chamber images were acquired using prospective 
ECG-gating. A uniform tag grid was created on the images using a CSPAMM sequence, 
with a tag separation of 7.5 mm, TR 25 ms, TE 10.28 ms, flip angle 25°, tag grid angle 
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90°, slice thickness 8 mm, and temporal resolution 25 ms; typical images are shown in 
Figure 4.2. 
4.1.3 HAPPY London study 
 
All participants gave written informed consent. The study was approved by the National 
Research Ethics Committee London-Central on February 21, 2013 (13LO/0094) and was 
conducted in accordance with the principles of the declaration of Helsinki to be used for 
subsequent analysis. HAPPY London study data was provided by Dr. Mohammed Khanji 
(9). 
 The primary objective of HAPPY London study was to assess the clinical effectiveness 
of personalised, continuous e-coaching to support a healthier lifestyle as a primary 
prevention tool in reducing future CV risk and improving quality of life in asymptomatic 
individuals with high predicted 10-year CVD risk. However, the aim of using HAPPY 
London data in my thesis was to compare the feature tracking analysis across the different 
FT software packages (Chapter 5) and to compare these against the tagging technique 
(Chapter 6).” 
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Figure 4.2: Typical CSPAMM images; (a) apical short axis, (b) mid ventricle short axis, 
(c) basal short axis, (d) 2-chamber long axis, (e) 4- chamber long axis acquired for the 
study. 
4.2 CMR feature-tracking for the assessment of 
deformation parameters 
Feature tracking is a post-processing technique that can be used to analyse cine CMR 
images.  
The endocardial and epicardial borders of the left ventricle are manually traced at the end 
diastolic phase. Then, the software algorithms track the anatomical features such as 
epicardial and endocardial borders and myocardial tissue as well as the edges between the 
tissue-blood pool cavities over time by searching the maximum likelihood displacement 
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of those features over a local neighbourhood in the successive frames (3). 
The motion of those features will be tracked throughout the cardiac cycle. The derived 
deformation and motion parameters obtained from left ventricular myocardium are: 
displacement, velocity, strain and strain rate for each software used in this thesis are 
shown in Table 4.1. These parameters can be measured for both the epicardial and 
endocardial contours at a global level for the whole LV, measured at the basal, mid, and 
apical short axes, and 2 chamber and 4 chamber long axes, or they can be measured at the 
regional level (myocardial segments).  
4.2.1 Tomtec 
Tomtec (Tomtec MR FT analysis, Version 4.6, Build 4.6.2.12, TomTec Imaging Systems, 
Munich, Germany) was the first software available for CMR feature tracking and has thus 
been used in a majority of research studies published to date. The first published study 
applied Tomtec feature tracing analysis to a population of 191 Duchenne muscular 
dystrophy patients (8). In this thesis, Tomtec was used to analyse the short axis (basal, 
mid and apical levels), two-chamber and four-chamber long axes images in chapter 5.  
The software is relatively easy to use; following the labelling of the view or orientation of 
the cine images, contour points need to be placed on the endocardial and epicardial 
borders of the initial frame corresponding to the end diastolic phase. These points 
manually delineate the endocardial and epicardial borders. It is also important to mark the 
upper septal insertion point between the left ventricle and right ventricle short axis to 
allow for accurate segmentation; segmental results based on a 16-segment or 17-segment 
model may be selected (3).  
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Table 4.1: Deformation parameters that can be derived from each feature tracking and tagging 
software package. Radial parameters can be calculated for both short and long axis, whereas 
circumferential only applies to short axis and longitudinal to long axis views. 
 
T
om
tec 
C
V
I42 
C
IM
-FT
 
C
IM
T
ag2D
 
 
Parameters Comment 
Displacement 
(mm) 
 
Global 
Radial  ü    
Distance between 
instantaneous and 
initial (often at the 
end diastole) position 
of a myocardial 
segment (72) 
 
Circumferential  ü    
Longitudinal  ü    
Endo 
Radial ü  ü    
Circumferential ü  ü    
Longitudinal ü  ü    
Epi 
Radial ü  ü    
Circumferential ü  ü    
Longitudinal ü  ü    
Velocity 
(mm.s-1) 
Global 
Radial  ü    
Accuracy is highly 
frame-rate dependent. 
Circumferential  ü    
Longitudinal  ü    
Endo 
Radial ü  ü    
Circumferential ü  ü    
Longitudinal ü  ü    
Epi 
Radial ü  ü    
Circumferential ü  ü    
Longitudinal ü  ü    
Strain 
(%) 
Global 
Radial ü  ü  ü  ü  Change in the length 
of myocardial fibre 
within a specific 
direction relative to 
its initial length 
(often at the end 
diastole) 
Accuracy is highly 
frame-rate dependent. 
Circumferential  ü  ü  ü  
Longitudinal  ü  ü  ü  
Endo 
Radial  ü  ü  ü  
Circumferential ü  ü  ü  ü  
Longitudinal ü  ü  ü  ü  
Epi 
Radial  ü  ü  ü  
Circumferential ü  ü  ü  ü  
Longitudinal ü  ü  ü  ü  
Strain rate 
(s-1) 
Global 
Radial ü  ü  ü  ü  
 
Circumferential  ü  ü  ü  
Longitudinal  ü  ü  ü  
Endo 
Radial  ü  ü  ü  
Circumferential ü  ü  ü  ü 
Longitudinal ü  ü  ü  ü  
Epi 
Radial  ü  ü  ü  
Circumferential ü  ü  ü  ü  
Longitudinal ü  ü  ü  ü  
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Figure 4.3: Example of FT analysis using Tomtec. Endocardial and epicardial contours of 
the LV are drawn on one frame and propagated throughout the cardiac cycle. (a) A short 
axis slice with endocardial and epicardial contours (left-hand side), and the corresponding 
radial (upper right-hand side) and circumferential strains (lower right-hand side). (b) A 2-
chamber view with endocardial and epicardial contours (left-hand side), with 
corresponding radial (upper right-hand side) and longitudinal strains (lower right-hand 
side). (c) A 4-chamber view with endocardial and epicardial contours (left-hand side), and 
the corresponding radial (upper right-hand side) and longitudinal strains (lower right-hand 
side). Other deformation parameters such as velocity, displacement and strain rates can be 
calculated. 
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Figure 4.4: Example of CVI42 FT analysis. The software semi-automatically defines the 
endocardial (red contour) and epicardial (green contour) LV contours throughout the 
cardiac cycle. (a) A short axis slice with delineated endocardial and epicardial contours 
(left-hand side) and the corresponding radial (middle) and circumferential strains (right-
hand side). (b) A 2-chamber long axis slice with delineated endocardial and epicardial 
contours (left-hand side) and the corresponding radial (middle) and longitudinal strains 
(right hand side). (c) A 4-chamber long axis slice with delineated endocardial and 
epicardial contours (left hand side) and the corresponding radial (middle) and 
longitudinal strains (right hand side). Additional calculated parameters include velocity, 
displacement and strain rates.  
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The initial contours are automatically tracked across the following time frames by the 
software, which then allows the myocardial deformation parameters to be computed. The 
contours can be visually checked in all cardiac phases, and in case of incorrectly tracked 
contours, the initial frame can be manually adjusted and re-propagated when necessary; 
an example is shown in Figure 4.3. 
4.2.2 CVI42 
CVI42 (release 5.1.1, Circle Cardiovascular Imaging Inc. Calgary, Canada) tissue 
tracking software was used in the first study published comparing Tomtec to another 
clinical software (73). 
This software can use cine CMR images in the (apical, mid and basal level) short axis, 
two-chamber and four-chamber long axis to calculate strain parameters.  
In order to obtain an accurate segmentation, reference points need to be positioned at the 
superior and inferior insertion points of the right ventricle on the short-axis images. The 
LV endocardial and epicardial contours are traced by placing a series of points on the 
endocardial and epicardial borders; these contours are delineated on the end-diastolic 
cardiac phase, usually the initial frame of the short axis and long axis cine images. Those 
points are then tracked by the software using the tissue tracking module over the entire 
cardiac cycle. Deformation parameters for both short and long axes can be computed and 
all cardiac motion and strain parameters can be exported as a text file or as an XML file 
format. Figure 4.4 illustrates part of the analysis process using CVI42. 
4.2.3 CIM-FT 
The software CIM-FT (version v.8.1.2, CIM-FT, Auckland MRI Research Group, New 
Zealand) is a non-commercial software that requires a research agreement with the 
providing institution.  
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Before analysis, each cine series has to be labelled as either a short-axis (mid, basal or 
apical slices) or as a long axis cardiac view. First, contours for short axis or long axis 
have to be drawn on the first frame, typically corresponding to the end diastolic phase. 
Guide points can be used to achieve the best possible fit of the initial epicardial and 
endocardial contours to the myocardial borders. Then, the right ventricle superior and 
inferior insertion points have to be identified and positioned on each short axis slice. It is 
best to do this on the end-systolic phase, when the blood pool is at its minimum and 
myocardial tissue is at its maximum thickness. The feature tracking mode is then selected 
and the epicardial and endocardial borders are tracked automatically. The resulting 
tracked contours are displayed for all cardiac phases, and the user in able to make manual 
contour adjustments in all of subsequent frames when needed in order to obtain the best 
possible tracking results. Finally, cardiac motion parameters are computed throughout the 
cardiac cycle; an example is displayed in Figure 4.5. 
4.3 Analysis of CMR-tagging for the assessment of 
deformation parameters using CIMTag2D 
The CMR-tagged images can be used to quantify myocardial regional deformation 
parameters by tracking non-invasive markers that are created in the myocardium tissue, 
referred to as ‘tags’. Tags are created within myocardial tissue via spatially selective 
radiofrequency saturation to generate regions of low signal intensity, which appear as 
dark lines in the acquired images (see chapter 2 section 2.7.2).  
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Figure 4.5: Example of CIM-FT analysis. Endocardial and epicardial contours of the LV 
are drawn on one frame and propagated throughout the cardiac cycle. (a) A short axis 
slice with delineated endocardial and epicardial contours (left hand side), and (right 
hand side) the corresponding radial, circumferential strain and shear. (b) A 2-chamber 
slice with delineated endocardial and epicardial contours (left hand side) and with 
corresponding radial, longitudinal strain and shear (right hand side). (c) A 4-chamber 
slice with delineated endocardial and epicardial contours (left hand side) and with 
corresponding radial, longitudinal strain and shear (right hand side). 
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Figure 4.6: Example of tagging analysis-using CIMTag2D. Endocardial and epicardial 
contours of the LV are drawn on one frame and propagated throughout the cardiac cycle. 
(a) A short axis slice with the deformation tagging grid (left hand side), and (right hand 
side) the corresponding radial, circumferential strain and shear. (b) A 2-chamber view 
with the deformation tagging grid (left hand side), with corresponding radial, 
longitudinal strain and shear (right hand side). (c) A 4-chamber view with the 
deformation tagging grid (left hand side), with corresponding radial, longitudinal strain 
and shear (right hand side). 
a 
b 
c 
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These created lines deform with cardiac contraction and therefore, by tracking their 
deformation throughout the cardiac cycle, the myocardial deformation parameters can be 
computed. In chapter 6, tagged images were analysed using CIMTag2D software (version 
8.1.5, Cardiac Image Modelling, University of Auckland, Auckland, New Zealand). 
CIMTag2D was used as an established or reference method (8) and has been previously 
be used for comparative studies with feature tracking (30)(45). In CIMTag2D, the short 
and long axes of the CMR-tagged images first need to be specified. Then, the grid model 
geometry requires to be initialised on the first frame, usually the end diastolic phase for 
the short- and long axes cine images. The step thereafter is achieved by using guide-
points, where the model grid is aligned manually to the myocardial tagging grid; these 
grid points can be adjusted by the user throughout consecutive frames.  
The left ventricular endocardial and epicardial contours can be adjusted using the guide 
points when necessary. The right ventricular superior and inferior points also need to be 
defined. Additionally, the software requires the end-systolic phase to be identified when 
the blood pool is at its minimal area, and myocardial tissue is at its maximal thickness. 
The software motion tracking mode can then be selected to follow the deformation of the 
grid tags throughout the cardiac cycle. Afterwards, adjustments to the tracked grid control 
points can be made in all cardiac frames when needed to improve the quality of the 
tracking; an example of analysis with CIMTag2D is shown on Figure 4.6. 
4.4 FT Software optimisation and standardization 
“All the software used in the thesis are available to our group (Cardiovascular Imaging, 
Barts Health/QMUL) and are subject to constant analysis optimisation and 
standardization (see section 4.4).  
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4.4.1 Personal Work 
In order to gain sufficient experience, I first practised using each software package on 
available data. I compared the strain values in the extracted text file every time I repeated 
the analysis, until I gained full confidence in the analysis process and my results showed 
little to no variability. I also compared my results with other users. As part of the studies 
in chapter 5 and 6, my analysis was compared against the most experienced user in our 
group. 
Each software has its standard operating procedure (SOP), which was provided by the 
company or research group. This allowed us to follow a clear step by step process on how 
to draw the endocardial and epicardial contours and extract the strain results as applied to 
all software packages: Tomtec, CVI42, CIM-FT and CIMTag2D. Those SOPs are 
updated and adapted by the group (see next section). 
CIM-FT and CIMTag2D software packages were provided by Auckland MRI Research 
Group. To start with, CIM-FT showed high sensitivity to contour drawing, and as a result, 
the peak strain values could jump from 30-40% to 2000%. Consequently, I raised this 
issue with the Auckland group that developed the software. As a result, they changed 
their SOP and advised to only modify the contours on the diastolic phase (first frame) and 
systolic phase without modifying the contours on the rest of the frame. 
As part of the study in chapter 5, I also tried to analyse the tagged SPAMM data for the 
26 hypertensive patients. However, the fading of the tagging grids in the systolic phases 
did not allow for reliable analysis and consequently, I did not analyse the full data set and 
did not include those results. As the HAPPY London data included CSPAMM imaging, 
with no fading of tagged lines through the cardiac cycle, the analysis was easier and more 
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reproducible and consequently the analysis forms part of Chapter 6.  
 4.4.2 Group Standardisation  
As part of the group effort to standardise analysis and minimise intra and inter-observer 
variabilities, local SOPs have been put in place for the different software. The most 
commonly used software in the group is CVI42 and the standardisation of analysis has 
been mainly based on the experience using this software. The standardisation has been 
applied to short axis, 2-chamber and 4-chamber views. For short axis left ventricular 
function, only slices where 50% of the myocardium tissue is displayed are included; 
CVI42 allows for open and closed contours.  
Contours are always drawn on the first frame (end-diastolic frame when the volume is at 
its maximum), and the systolic frame. Those frames are first identified by going through 
all frames to look for the minimum and maximum left ventricle volumes. 
It was also decided not to include the papillary muscle in short axis, 2-chamber and 4-
chamber long axes to allow calculating the strain for myocardial tissue and to allow 
comparison across our groups.” 
4.5 General statistical analysis  
Statistical analysis was performed using IBM SPSS Statistics version 23. All deformation 
parameters measured by all software packages were first assessed by the Shapiro-Wilk 
test to check for normality of the distribution, the criterion for significance was p < 0.05. 
Non-normally distributed variables were tested using non-parametric methods 
(Friedman), but the intra-class correlation (ICC) which requires a normal distribution was 
not calculated for these variables.  The difference between distributions when using two 
or more methods for the same observation can be assessed using the Friedman test (74). 
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The Friedman test was used as it does not make any assumption about the distribution, so 
it can be applied to all variables including non-normally distributed variables. Friedman 
test is not applied to the measurements themselves, but ranks the methods from the lowest 
to highest value in each row (each observation) and compares the total ranks for those 
variables across the methods. As the Friedman test was applied to a large number of 
variables, Bonferroni adjustment was used as a multiple test procedure (75). The 
significance level was adjusted according to Bonferroni with p<0.05 divided by n, where 
n is the total number of comparisons made. 
Intra-observer variability was assessed when the same observer repeats the same 
measurements by using the same technique on the same subjects after a short period of 
time. Inter-observer variability can be assessed when two different observers measure the 
same parameters by using the same technique on the same subject. The two observers 
who did the measurements on the same population are Haifa Almutairi, the author of the 
thesis, and José Miguel Paiva, a radiographer with 2.5 years’ experience (analysing 
>5000 cases). Each observer made strain measurements using Tomtec, CVI42, CIM-FT 
and CIMT2D at different time points.  
Bland-Altman statistics, with a calculation of 95% limits of agreement were applied to 
assess the agreement between two software packages’ results, and to assess the agreement 
for inter- and intra-observer measurements (76). It is a method to visualise the data 
graphically in order to evaluate the range within which it is expected discrepancies 
between the methods to lie as well as any bias between the methods as shown by a mean 
difference between both measurements that differs from zero. The difference between the 
means of two measurements shows the bias from zero, and the limits of agreement are 
calculated as mean ± 1.96 SD. SD is the standard deviation of differences which 
represents the distribution of how far the observations differ from the mean. Paired t-tests 
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were used to test whether the bias in the results generated from the software packages and 
between and within observers was significantly different from zero.  
Agreement between methods or raters can also be assessed using the ICC as a measure of 
reliability (77). However, ICC can only be applied for variables that are normally 
distributed and so this method has not been used for the non-normally distributed 
variables derived from all software packages. The intra-class correlation coefficient 
(consistency and absolute agreement) was assessed. Absolute agreement evaluated 
whether the three software types provided the same results; ICC (absolute agreement) 
will be low if there is low correlation between the software results or if there are relevant 
differences in means between the strain measures derived from different software 
packages i.e. if one software gives consistently higher results than another. Consistency 
ICC considers whether the software packages rank the values consistently. If the 
consistency ICC is higher than the absolute ICC this suggests that the methods may give 
good agreement if the bias between means could be adjusted for (77).  
Box plots were used for visual comparison between global and regional deformation 
parameters across all software packages in healthy subjects and hypertensive patients as 
well as between male and female, and between healthy subjects and hypertensive 
patients. Comparisons allow commenting on the distribution, median, range (between the 
maximum and minimum values) and the interquartile range (IQR), which is the box width 
for the measurements. The independent sample t-test is a test to compare means between 
two unrelated groups for the same dependent continuous variable and was used to test for 
differences between males and females, hypertensive and non-hypertensive subjects and 
non-diabetic and diabetic subjects. To compare two continuous variables Spearman’s 
correlation coefficient was used. It ranks the order of the measurements for n 
observations, and measures the strength and direction of the correlation between the 
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ranks. Spearman correlation can be used for both normal and non-normally distributed 
variables and was used to test the association of systolic and diastolic blood pressure with 
the deformation parameters. The statistician Jackie Cooper who provided me with 
statistics advise on all the analysis that I run.  
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Chapter 5: Comparison of feature 
tracking software packages in 
hypertensive patients and healthy 
subjects 
5.1 Introduction 
CMR-feature tracking allows the assessment of global and regional deformation 
parameters of the left ventricle, thus potentially offering useful clinical information (3). 
Myocardial deformation parameters have been used to detect early left ventricular 
contractile dysfunction in some CVD (51)(55). Previous studies have applied FT to 
normal subjects and reported reference strain values that can be used when comparing 
healthy and CVD strain results. Despite the potential of the technique in early diagnosis 
of cardiac pathology, it is yet to be implemented in routine clinical CMR, due to high 
variability in reported results when compared to other modalities such as CMR-tagging 
and echocardiography.  
In this chapter, three FT software packages were used to analyse SSFP cine CMR images 
both of healthy subjects and hypertensive patients in order to assess the agreement in 
global and regional cardiac deformation parameters between the three software packages. 
The chapter also evaluated the inter- and intra-observer variability of those three FT 
software packages. All the data that was included in chapter 5 are pre-existing data at our 
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unit, which was run by other colleagues, 26 hypertensive patients (in Chapter 5) from The 
Heart Hospital, while 28 healthy subjects from HAPPY London study (9). Finally, the 
results for health subjects and hypertensive patients were compared for each software. 
Both datasets were acquired at different imaging centers using different MRI scanners, 
acquisition parameters and spatial and temporal resolutions, which is expected to have an 
impact on the derived results. 
5.2 Methods 
Twenty-eight (28) healthy subjects and twenty-six (26) hypertensive patients underwent 
different standardised CMR scan at different centers (71). The CMR cine acquisition 
protocol for SSFP for healthy subjects and hypertensive patients are presented in chapter 
4 (4.1.1). 
LV systolic deformation parameters were obtained by analysing cine CMR images using 
three different FT software packages: Tomtec = MR FT analysis (TomTec Imaging 
Systems, Munich, Germany), CVI42 (Circle Cardiovascular Imaging Inc. Calgary, 
Canada), and CIM-FT (CIM-FT, Auckland MRI Research Group, New Zealand) (see 
section 4). Inter- and intra-observer variability were assessed in ten healthy subjects; 
CMR images were re-analysed by the author of this dissertation for intra-observer 
variability and analysed by an experienced second observer, José Miguel Paiva, a 
radiographer with 2.5 years’ experience (analysing >5000 cases), to evaluate inter-
observer variability. 
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5.2.1 Study Population 
All 28 healthy subjects that were recruited in the HAPPY London study had no previous 
angina or myocardial infarction, no history of stroke or transient ischaemic attack (TIA), 
or any Cardiac sounding chest pain requiring further investigations. Other than vascular 
disease, healthy subjects had no medical history of diabetes, were not on hypertension 
treatment and had no history of overt cardiac disease(9). The 26 hypertensive patients 
were prospectively recruited from a tertiary hypertension clinic and enrolled to undergo 
CMR examinations. Table 5.1 illustrates the demographic variables for the healthy 
subjects and hypertensive patients. Both groups were not matched for gender and age.  
Diastolic and systolic BP and the ejection fraction were also not matched as those 
parameters are affected by hypertension.  
5.2.2 Statistical analysis 
IBM SPSS Statistics version 23 was used for conducting statistical tests. All LV 
deformation parameters are presented as mean ± standard deviation (SD). Differences in 
the distribution of variables between software packages were tested using a paired non-
parametric method, Friedman test, that can be applied to normal and non-normal 
distributed variables. A Bonferroni adjustment was applied to take multiple testing into 
account; 20 comparisons in Table 5.2 and 5.3, therefore p=0.05/20 thus, a p<0.003 was 
considered to highlight a statistically significant difference (75).  
The inter- and intra-observer variability for deformation parameters (global, endocardial 
and epicardial strains) were assessed using the Bland-Altman approach, with a calculation 
of the 95% limits of agreement (76). The p-value for inter- and intra-observers were 
calculated for all deformation parameters to examine any significant bias between inter- 
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and intra-measurements. The significance level after Bonferroni adjustment was taken as 
p<0.002 (30 comparisons, p<0.05/30) for CVI42 and CIM-FT and p<0.003, (20 
comparisons, p<0.05/20) for Tomtec. 
 
Table 5.1: Demographic details for healthy subjects and hypertensive patients. Red cell = 
significant difference (p<0.05). 
Parameters Healthy subjects Hypertensive Patients 
Female / Male 8 / 20 11 / 15 
Age (years) 66.2 ± 5.3 53.5± 15.6 
Height (m) 1.74 ± 0.10 1.69± 0.11 
Weight (kg) 80.8 ± 11.4 81.6± 14.9 
BMI (kg/m2) 26.8 ± 3.1 28.2± 4.3 
BSA (m2) 1.97 ± 0.18 1.96± 0.22 
Systolic BP (mmHg) 125.9 ± 8.6 150.6± 17.8 
Diastolic BP (mmHg) 77.1 ± 6.5 88.2± 8.9 
LV ejection fraction (%) 62.1 ± 6.0 71.8± 7.5 
BMI=body mass index, BSA = Body surface area, BP=blood pressure, LV-EF= Left Ventricle ejection 
fraction. 
 
Normality for all variables measured by FT software packages was determined using the 
Shapiro-Wilk test. All derived deformation parameters were normally distributed, except 
for the radial strain derived from the short axis and long axis using CIM-FT software. 
Intra-class correlation coefficient (ICC), the two-way mixed model for absolute 
agreement and consistency was computed for all derived variables with normal 
distributions to assess agreement as shown in Table 5.4. Absolute agreement evaluated 
whether the three software provided the same results; ICC (absolute agreement) is low for 
a high bias between mean differences. In this instance, consistency considers whether the 
software packages rank the values consistently but is not affected by differences in 
means. Based on ICC, the results were categorised for agreement and consistency as 
follows: ICC≤0.4, poor; 0.4<ICC≤0.6, fair; 0.6<ICC≤0.75, good; ICC>0.75, excellent 
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(78)(77). Box plots were used to compare between deformation parameters across the 
three FT software packages in healthy subjects and hypertensive patients. 
5.3 Results 
5.3.1 Comparison between software packages 
The global, endocardial and epicardial circumferential, radial and longitudinal strain 
means are given in Tables 5.2 (healthy) and 5.3 (hypertensive). The Friedman test 
showed significant differences in most parameters across the three FT software packages 
in healthy subjects as shown in Table 5.2. However, there were agreements for six 
parameters: global and endocardial circumferential strain for apical short axis, global 
circumferential strain for mid ventricle short axis, global radial strain for 2-chamber and 
4-chamber and for endocardial longitudinal strain for 2-chamber. The Friedman test also 
demonstrated significant differences across all FT software packages in hypertensive 
patients as shown in Table 5.3. However, there were also agreements for nine parameters: 
endocardial circumferential strain for apical, mid and basal ventricle short axes, as well as 
global circumferential strain for apical short axis.  Global and endocardial longitudinal 
strain for 2-chamber as well as global, endocardial and epicardial longitudinal strain for 
4-chamber.  
All circumferential and longitudinal strains showed low standard deviations (narrow 
distribution) across all software packages in healthy and hypertensive patients, indicating 
low variation between observations (Tables 5.2 and 5.3). While global, endocardial and 
epicardial radial strains, in particular in short axis views, showed larger standard 
deviation in particular for CIM-FT in hypertensive patients (Table 5.3).  
ICC results were calculated for normal distributed parameters derived from all FT 
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software packages in healthy subjects and patients (Table 5.4). Overall, software 
performed slightly better in patients than in volunteers.  Consistency was good or 
excellent in 10/17 parameters in healthy subjects and 15/17 in patients. The most 
consistent parameters across the two populations were circumferential strains from mid-
short axis (excellent) followed by circumferential strains from apical short axis and 
longitudinal strain from 2-chamber long axis, both good. Circumferential strain from the 
basal short axis were both excellent in the hypertensive population but only poor to fair in 
the healthy population. Radial strain, especially from the mid-short axis slice was the 
worst performer across the two populations. 
 
 Table 5.2: Summary of the strain values (mean ± standard deviation) in the healthy population calculated by the different software. Tomtec only calculate 
global radial strain values. Red cell = significant difference (p<0.003) between the three software. 
Strain 
(%) 
Tomtec CVI42 CIM-FT Friedman test 
Global Endo Epi Global Endo Epi Global Endo Epi Global Endo Epi 
C
ir
cu
m
fe
re
nt
ia
l Basal-
SAX 
-15.42 
±3.01 
-19.79 
±3.44 
-11.12 
±3.09 
-24.44 
±3.63 
-26.33 
±3.85 
-22.15 
±3.18 
-16.85 
±2.41 
-19.27 
±2.55 
-14.57 
±2.56 0.000 0.000 0.000 
Mid-
SAX 
-13.77 
±2.69 
-17.86 
±3.29 
-9.78 
±2.57 
-19.40 
±2.63 
-20.82 
±2.72 
-18.03 
±2.67 
14.96 
±2.26 
-17.30 
±2.44 
-12.69 
±2.22 0.06 0.000 0.000 
Apical-
SAX 
-17.01 
±4.07 
-20.88 
±4.23 
-13.25 
±4.42 
-19.49 
±3.20 
-21.18 
±3.36 
-17.87 
±3.32 
-18.48 
±4.87 
-21.57 
±5.06 
-15.59 
±4.85 
0.12 0.78 0.000 
R
ad
ia
l  
Basal-
SAX 
36.14 
±7.43 NA NA 
52.19 
±19.37 
60.87 
±23.46 
41.77 
±11.27 
49.34 
±13.75 
50.18 
±14.14 
48.49 
±13.66 0.000 NA NA 
Mid-
SAX 
38.43 
±12.67 NA NA 
33.88 
±7.87 
38.21 
±8.82 
30.03 
±7.34 
52.20 
±15.39 
53.76 
±15.04 
51.06 
±15.97 0.000 NA NA 
Apical-
SAX 
31.14 
±10.55 NA NA 
38.49 
±10.80 
44.84 
±13.27 
33.35 
±9.64 
52.73 
±15.74 
57.48 
±16.05 
49.21 
±15.99 0.000 NA NA 
2ch-
LAX 
39.07 
±13.91 NA NA 
33.58 
±8.84 
33.93 
±10.05 
33.82 
±8.32 
40.72 
±13.43 
41.16 
±14.22 
40.15 
±13.25 0.04 
NA NA 
4ch-
LAX 
31.39 
±6.35 NA NA 
35.95 
±7.63 
37.09 
±8.74 
37.41 
±8.80 
36.02 
±14.02 
36.84 
±14.43 
34.86 
±13.15 0.13 NA NA 
L
on
gi
tu
di
na
l  
 
2ch-
LAX 
-15.51 
±3.22 
-18.48 
±3.87 
-12.59 
±3.49 
-18.12 
±2.38 
-18.17 
±2.44 
-18.38 
±2.44 
-16.98 
±2.43 
-17.25 
±2.46 
-16.63 
±2.46 0.000 0.01 0.000 
4ch-
LAX 
-16.80 
±3.49 
-19.52 
±4.19 
-14.2 
3±3.69 
-18.55 
±2.22 
-18.74 
±2.34 
-19.23 
±2.54 
-15.65 
±1.73 
-15.9 
7±1.93 
-15.25 
±1.63 0.000 0.000 0.000 
Endo = endocardial, Epi= epicardial, SAX = short axis, LAX = long axis, 2ch = 2 chamber, 4ch =4 chamber, NA = not available. 
  
 Table 5.3: Summary of the strain values (mean ± standard deviation) in the hypertensive population calculated by the different software. Tomtec only 
calculate global radial strain values. Red cell = significant difference (p<0.003) between the three software. 
Strain (%) Tomtec CVI42 CIM-FT Friedman p-value Global Endo Epi Global Endo Epi Global Endo Epi Global Endo Epi 
C
ir
cu
m
fe
re
nt
ia
l  Basal 
SAX 
-19.53 
±4.26 
-25.25 
±4.84 
-13.82 
±4.30 
-25.82 
±4.45 
-28.43 
±4.76 
-22.89 
±3.89 
-18.82 
±3.03 
-23.86 
±3.87 
-14.09 
±2.69 0.000 0.011 0.000 
Mid 
SAX 
-18.33 
±4.23 
-23.5 
7±5.67 
-13.12 
±3.59 
-20.66 
±4.24 
-22.92 
±4.60 
-18.43 
±3.96 
-17.13 
±2.91 
-22.87 
±4.02 
-11.51 
±2.35 0.000 0.30 0.000 
Apical 
SAX 
-20.20 
±4.43 
-25.24 
±5.83 
-15.19 
±5.83 
-19.96 
±3.56 
-22.19 
±4.02 
-17.66 
±3.15 
-19.61 
±4.28 
-26.06 
±5.29 
-13.60 
±3.56 0.45 0.01 0.000 
R
ad
ia
l 
Basal 
SAX 
36.66 
±8.42 NA NA 
59.65 
±20.09 
73.6 
3±26.55 
44.81 
±12.48 
69.40 
±27.57 
79.41 
±37.88 
68.12 
±32.91 0.000 NA NA 
Mid 
SAX 
36.13 
±14.59 NA NA 
39.00 
±13.32 
47.28 
±17.42 
31.77 
±10.35 
94.90 
±38.30 
119.98 
±73.72 
85.34 
±36.16 0.000 NA NA 
Apical 
SAX 
26.13 
±14.24 NA NA 
40.44 
±10.89 
49.49 
±14.22 
33.01 
±8.15 
92.84 
±45.59 
115.54 
±65.05 
86.19 
±44.21 0.000 NA NA 
2ch 
LAX 
36.01 
±11.01 NA NA 
33.81 
±6.91 
34.24 
±7.05 
33.49 
±7.48 
63.13 
±21.84 
66.66 
±22.66 
59.19 
±20.67 0.000 NA NA 
4ch 
LAX 
27.92 
±8.09 NA NA 
37.28 
±10.59 
38.63 
±11.02 
38.06 
±11.42 
55.89 
±24.41 
59.35 
±26.98 
51.76 
±21.68 0.000 NA NA 
L
on
gi
tu
di
na
l 2ch 
LAX 
-16.73 
±4.64 
-19.38 
±5.07 
-14.15 
±4.42 
-18.97 
±2.25 
-19.13 
±2.35 
-18.86 
±2.39 
-18.83 
±3.46 
-19.86 
±3.44 
-17.69 
±3.66 0.01 0.96 0.000 
4ch 
LAX 
-19.19 
±5.17 
-20.43 
±5.56 
-18.01 
±4.95 
-19.07 
±3.33 
-19.54 
±3.31 
-19.03 
±3.49 
-17.89 
±2.89 
-18.76 
±2.73 
-16.89 
±3.35 0.05 0.11 0.04 
Endo = endocardial, Epi= epicardial, SAX = short axis, LAX = long axis, 2ch = 2 chamber, 4ch =4 chamber, NA = not available. 
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Table 5.4: Intra-class correlation coefficient (ICC) results for consistency and absolute 
agreement for normal distributed variables derived by Tomtec, CVI42 and CIM-FT, in healthy 
subjects and hypertensive patients. 
Strain (%) 
Consistency Absolute agreement 
Healthy Hypertensive Healthy Hypertensive 
C
ir
cu
m
fe
re
nt
ia
l  
Apical 
SAX 
Global 0.64 0.70 0.61 0.71 
Endo 0.63 0.67 0.69 0.62 
Epi 0.61 0.75 0.53 0.65 
Mid 
SAX 
Global 0.82 0.93 0.51 0.86 
Endo 0.76 0.93 0.63 0.93 
Epi 0.82 0.88 0.36 0.59 
Basal 
SAX 
Global 0.45 0.84 0.16 0.59 
Endo 0.36 0.83 0.18 0.75 
Epi 0.55 0.79 0.17 0.41 
R
ad
ia
l Apical SAX Global 0.68 0.33 0.48 0.15 
Mid 
SAX 
Global 0.49 0.55 0.36 0.26 
L
on
gi
tu
di
na
l  2ch 
LAX 
Global 0.73 0.72 0.65 0.68 
Endo 0.69 0.71 0.68 0.71 
Epi 0.63 0.67 0.39 0.53 
4ch 
LAX 
Global 0.54 0.82 0.45 0.82 
Endo 0.52 0.79 0.42 0.78 
Epi 0.42 0.81 0.26 0.79 
Endo = endocardial, Epi= epicardial, SAX = short axis, LAX = long axis, 2ch = 2 chamber, 4ch =4 
chamber. 
 
Absolute agreement was not as good as consistency for the two populations, with only 
5/17 parameters rated good in the healthy population and 11/17 good or excellent in the 
hypertensive population. For global parameters, circumferential strain from the apical 
short axis slice and longitudinal from the 2-chamber long axis were the most consistent 
across populations (good), while circumferential strain from the basal short axis slice and 
radial strains were the worst (poor to fair). Notably, the absolute agreements for 
circumferential strain from the mid-short axis slice and longitudinal strain from the 4-
chamber view were excellent in the patient population while it was only fair in the 
healthy population. 
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The three FT software packages were also compared against each other in both healthy 
subjects and hypertensive patients. In healthy subjects and hypertensive patients, global 
circumferential strain calculated from mid ventricle and basal short axis by CVI42 were 
lower than the value obtained by Tomtec and CIM-FT, see also in Figure 5.1 B-C. There 
were statistically significant differences for mid and basal short axis across the three 
software packages in both groups. However, there was no statistically significant 
difference for apical short axis in hypertensive patients, while its statistically significant 
in healthy subjects across the three software packages (see also Figure 5.1 A).  
Global longitudinal strain results for 4-chamber did not differ significantly between the 
software packages for hypertensive patients, while they differ significantly for healthy 
subjects. Tomtec software results for 2-chamber and 4-chamber longitudinal strain results 
were higher in both healthy subjects and hypertensive patients compare to CVI42 and 
CIM-FT results, see also Figure 5.2 A-B. Finally, measurements derived by Tomtec 
showed higher variability than CVI42 and CIM-FT in healthy subjects (Figure 5.2 A-B).  
The global radial strain parameters derived from the three FT software packages showed 
statistically significant differences in both groups for apical, mid and basal short axis as 
well as 2-chamber and 4-chamber, however the only parameter that not differ 
significantly between the software packages in healthy subjects is global radial strain for 
4-chamber (P =0.13) (Figure 5.5 A-E). 
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Figure 5.1: Box plots for global circumferential strains by Tomtec, CVI42 and CIM-FT in 
healthy subjects (black) and hypertensive patients (red) calculated from (A) apical, (B) 
mid and (C) basal short axis for the three software. The blue p-value (P<0.05 considered 
as significant) shows any significant difference between healthy subjects and hypertensive 
patients for Tomtec, CVI42 and CIM-FT software packages. The black p-value (P<0.05 
considered as significant) shows any significant difference between Tomtec, CVI42 and 
CIM-FT software packages for healthy subjects. The red p-value (P<0.05 considered as 
significant) shows any significant difference between Tomtec, CVI42 and CIM-FT 
software packages for hypertensive patients. The significance level is unadjusted for 
multiple comparison. 
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Figure 5.2: Box plots for global longitudinal strains by Tomtec, CVI42 and CIM-FT in 
healthy subjects (black) and hypertensive patients (red) calculated from (A) 2-chamber, 
(B) 4-chamber long axis for the three software. The blue p-value (P<0.05 considered as 
significant) shows any significant difference between healthy subjects and hypertensive 
patients for Tomtec, CVI42 and CIM-FT software packages. The black p-value (P<0.05 
considered as significant) shows any significant difference between Tomtec, CVI42 and 
CIM-FT software packages for healthy subjects. The red p-value (P<0.05 considered as 
significant) shows any significant difference between Tomtec, CVI42 and CIM-FT 
software packages for hypertensive patients. The significance level is unadjusted for 
multiple comparison. 
5.3.2 Inter and Intra-observer variability 
Inter-observer variability was evaluated in all three FT software packages; results for the 
three software packages are shown in Table 5.5 and Bland-Altman for the global strains 
calculated with all three FT software packages are shown in Figure 5.3. Overall, inter-
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observer variability was very good with all global strains in agreement for all software 
and a single parameter displaying significant statistical difference across the three 
software (Tomtec: endocardial circumferential strain calculated from the apical short axis 
slice). When considering all global measurement, CVI42 had the lowest bias (1.20 ± 2.95 
%), followed by Tomtec (3.33 ± 7.33 %), with CIM-FT exhibiting the worse agreement 
(5.73 ± 15.03%). For the three software packages, global circumferential and longitudinal 
strain exhibited good agreement (better than 2%) whereas the agreement for radial strain 
was more variable. Across all parameters and software, the lowest bias and lowest 
standard deviation results were observed for circumferential and longitudinal strain 
parameters for Tomtec. For this software, the lowest bias for a global measurement was   
-0.04% (SD=±1.62) for 4-chamber longitudinal strain. For CVI42, the majority of global 
measurements (6/10) had a bias lower than 1%, with only one measurement being slightly 
worse than 3% (basal short axis radial strain). For CIM-FT, the agreement global 
circumferential and mid-short axis radial strains were good (<2%), however, the 
agreement for the other global radial measurements was poor especially for the basal 
short axis (over 20%) and the 2 long axis measurements (c.a. 13%). 
Intra-observer variability results for the three software packages are given in Table 5.6 
and Bland-Altman graphs for the global parameters for all three FT software packages are 
displayed in Figure 5.4. Overall, intra-observer variability was good but two parameters 
showed statistically significant differences; endocardial circumferential strain calculated 
from the apical short axis slice and the 2-chamber global longitudinal strain. When 
considering all global measurements, intra-observer displayed the same trend as inter-
observer variability; CVI42 had the lowest bias (1.64 ± 3.67 %), followed by Tomtec 
(2.87 ± 7.81 %), with CIM-FT exhibiting the worse agreement (7.62 ± 12.84%). Across 
all parameters and software, the lowest bias and lowest standard deviation results were 
observed for longitudinal strain parameters for CVI42. For this software, the lowest bias 
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for a global measurement was 0.01 ± 1.89% for 4-chamber longitudinal strain closely 
followed by the 2-chamber longitudinal strain (0.16 ± 1.40%). CVI42 also performed 
really for global circumferential strains (all biases <2%) and for radial strain derived from 
apical and mid-short axis. Radial strain from long axis view was also acceptable (<3%) 
but poorer for the basal short axis. 
 Table 5.5: Bland-Altman statistics for inter-observer variability across all the measured strain parameters in healthy volunteers. Red cell = significant difference. 
Strain (%) 
Tomtec CVI42 CIM-FT 
Bias SD Limits of agreement Bias SD Limits of agreement Bias SD Limits of agreement 
C
ir
cu
m
fe
re
nt
ia
l 
Apical 
SAX 
Global -1.12 1.05 -3.17 0.94 0.28 0.89 -1.47 2.03 0.49 2.03 -3.49 4.49 
Endo -2.31 1.58 -5.40 0.79 0.45 0.89 -1.28 2.19 0.72 2.93 -5.03 6.46 
Epi 0.11 1.44 -2.71 2.92 0.30 1.27 -2.18 2.78 0.24 1.70 -3.09 3.58 
Mid 
SAX 
Global -0.83 1.17 -3.13 1.47 0.26 0.49 -0.71 1.22 0.62 2.79 -4.87 6.09 
Endo -1.06 1.57 -4.14 2.01 0.63 0.91 -1.15 2.42 1.41 3.18 -4.82 7.64 
Epi -0.59 1.27 -3.08 1.89 0.25 0.69 -1.09 1.59 -0.26 2.74 -5.65 5.12 
Basal 
SAX 
Global -1.61 1.53 -4.62 1.39 0.84 0.92 -0.96 2.64 1.07 2.52 -3.87 6.02 
Endo -2.67 2.53 -7.63 2.28 1.17 1.09 -0.97 3.31 2.74 3.09 -3.32 8.79 
Epi -0.54 0.97 -2.44 1.37 0.61 1.04 -1.42 2.64 -0.58 2.40 -5.30 4.14 
R
ad
ia
l 
Apical 
SAX 
Global 1.19 7.61 -13.73 16.12 -0.31 1.76 -3.75 3.14 6.49 22.23 -37.08 50.07 
Endo - - - - -1.30 2.84 -6.84 4.23 39.31 76.03 -109.70 188.32 
Epi - - - - -0.03 2.20 -4.33 4.27 -18.95 24.14 -66.25 28.35 
Mid 
SAX 
Global -5.45 6.34 -17.88 6.99 0.18 1.74 -3.21 3.58 0.68 33.28 -64.54 65.90 
Endo - - - - -0.51 1.93 -4.27 3.25 36.59 62.01 -84.94 158.12 
Epi - - - - 0.48 1.55 -2.54 3.51 -16.39 28.62 -72.47 39.69 
Basal 
SAX 
Global -2.66 4.70 -11.88 6.56 -3.14 3.71 -10.37 4.08 -21.59 35.31 -90.80 47.61 
Endo - - - - -4.82 5.33 -15.21 5.57 9.62 39.89 -68.58 87.81 
Epi - - - - -1.79 3.18 -7.99 4.40 -45.40 49.51 -142.43 51.63 
2ch 
LAX 
Global -5.11 10.00 -24.72 14.49 -2.54 7.19 -16.58 11.49 13.17 28.34 -42.38 68.72 
Endo - - - - -2.58 8.56 -19.28 14.12 12.98 30.34 -46.49 72.46 
Epi - - - - -2.34 7.03 -16.05 11.37 12.75 26.09 -38.39 63.891 
4ch 
LAX 
Global -14.70 36.74 -86.71 57.31 1.92 7.34 -12.39 16.24 -12.61 22.38 -56.47 31.26 
Endo - - - - 0.99 5.89 -10.49 12.48 -14.81 22.81 -59.52 29.901 
Epi - - - - 2.81 8.64 -14.03 19.66 -10.54 21.98 -53.61 32.54 
L
on
gi
tu
di
na
l 2ch 
LAX 
Global 0.58 2.59 -4.51 5.66 1.42 1.91 -2.29 5.14 -1.57 1.57 -4.64 1.49 
Endo 0.83 3.92 -6.86 8.512 1.53 2.15 -2.66 5.72 -1.64 2.72 -6.96 3.69 
Epi 0.29 1.69 -3.02 3.61 1.13 2.19 -3.15 5.40 -1.61 1.66 -4.87 1.65 
4ch 
LAX 
Global -0.04 1.62 -3.23 3.15 0.75 2.11 -3.36 4.86 -1.47 2.41 -6.19 3.245 
Endo -0.001 1.64 -3.21 3.21 0.94 1.87 -2.70 4.59 -1.09 2.86 -6.69 4.512 
Epi -0.11 1.91 -3.86 3.64 0.49 2.25 -3.89 4.87 -1.89 2.164 -6.13 2.35 
Endo = endocardial, Epi= epicardial, SAX = short axis, LAX = long axis, 2ch = 2 chamber, 4ch = 4 chamber.  
 Table 5.6: Bland-Altman statistics for intra-observer variability across all the measured strain parameters in healthy volunteers. Red cell = significant difference. 
Strain (%) Tomtec CVI42 CIM-FT Bias SD Limits of agreement Bias SD Limits of agreement Bias SD Limits of agreement 
C
ir
cu
m
fe
re
nt
ia
l 
Apical 
SAX 
Global -1.14 1.03 -3.156 0.87 0.39 0.98 -1.52 2.32 -1.37 1.96 -5.20 2.46 
Endo -0.55 1.98 -4.43 3.33 0.28 0.89 -1.47 2.03 -3.79 2.523 -8.75 1.16 
Epi -1.65 1.66 -4.89 1.61 0.75 1.45 -2.08 3.58 0.88 2.167 -3.367 5.12 
Mid 
SAX 
Global 0.18 0.87 -1.53 1.89 0.76 0.85 -0.90 2.42 -0.71 1.478 -3.601 2.19 
Endo 0.57 0.96 -1.31 2.46 0.96 1.14 -1.26 3.19 -1.94 2.46 -6.77 2.89 
Epi -0.25 0.87 -1.97 1.46 0.89 1.10 -1.25 3.05 0.45 1.09 -1.678 2.578 
Basal 
SAX 
Global -0.90 0.88 -2.62 0.82 1.58 1.21 -0.77 3.93 -0.75 1.98 -4.63 3.13 
Endo -1.04 1.79 -4.55 2.48 1.58 1.34 -1.04 4.19 -2.28 2.33 -6.85 2.28 
Epi -0.77 0.65 -2.05 0.51 1.52 1.41 -1.22 4.27 0.66 2.52 -4.27 5.59 
R
ad
ia
l 
Apical 
SAX 
Global 1.11 10.19 -18.87 21.09 -1.15 2.50 -6.03 3.73 21.02 24.31 -26.63 68.67 
Endo - - - - -0.94 2.95 -6.70 4.82 43.68 77.69 -108.60 195.96 
Epi - - - - -1.62 3.48 -8.40 5.16 9.88 20.75 -30.79 50.55 
Mid 
SAX 
Global -0.51 5.62 -11.51 10.50 -0.89 2.61 -5.99 4.19 13.24 27.36 -40.38 66.86 
Endo - - - - -1.28 2.67 -6.50 3.92 52.76 48.29 -41.88 147.41 
Epi - - - - -0.93 2.73 -6.25 4.39 -4.32 28.44 -60.056 51.41 
Basal 
SAX 
Global -1.35 7.90 -16.84 14.14 -6.32 5.84 -17.71 5.08 10.15 21.57 -32.12 52.42 
Endo - - - - -7.41 7.96 -22.94 8.12 32.39 38.82 -43.70 108.47 
Epi - - - - -5.09 5.19 -15.23 5.05 -0.19 23.09 -45.44 45.07 
2ch 
LAX 
Global -5.56 11.03 -27.18 16.06 -2.67 7.50 -17.29 11.96 20.448 25.81 -30.13 71.03 
Endo - - - - -3.36 9.37 -21.63 14.92 21.69 27.25 -31.72 75.12 
Epi - - - - -2.62 7.96 -18.15 12.90 19.11 24.21 -28.34 66.56 
4ch 
LAX 
Global -16.68 36.29 -87.81 54.44 2.49 11.90 -20.71 25.69 4.97 20.77 -35.73 45.68 
Endo - - - - 1.62 12.06 -21.90 25.14 5.27 21.50 -36.87 47.42 
Epi - - - - 1.99 14.63 -26.54 30.53 5.07 19.41 -32.96 43.11 
L
on
gi
tu
di
na
l 2ch 
LAX 
Global 0.41 2.25 -4.00 4.81 0.16 1.40 -2.57 2.89 -1.79 1.46 -4.66 1.06 
Endo 0.31 2.71 -5.00 5.63 0.41 1.95 -3.39 4.22 -2.70 1.49 -5.63 0.23 
Epi 0.50 3.32 -5.99 7.00 0.12 1.56 -2.92 3.16 -0.79 1.73 -4.19 2.61 
4ch 
LAX 
Global 0.82 2.02 -3.14 4.79 0.01 1.89 -3.68 3.70 -1.74 1.72 -5.11 1.63 
Endo -0.62 1.68 -3.91 2.67 0.09 2.09 -3.99 4.19 -1.86 2.17 -6.03 2.31 
Epi 2.20 3.23 -4.14 8.55 0.43 2.52 -4.47 5.34 -1.51 1.75 -4.94 1.92 
Endo = endocardial, Epi= epicardial, SAX = short axis, LAX = long axis, 2ch = 2 chamber, 4ch = 4 chamber.  
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Figure 5.3: Bland-Altman plots for inter-observer variability for global strain parameters 
for all software. Top row (A-C) circumferential strain, second row (DE) longitudinal 
strain and bottom 2 rows (F-J) radial strain.  
Tomtec did perform well for circumferential, longitudinal and short axis radial strains (all 
biases <2%) but the results were poor for radial strain for 2-chamber (-5.56 ± 11.03 %) 
and 4-chamber (-16.68 ± 36.29 %). 
Once more CIM-FT was the poorest performer. Although the results were good for 
circumferential and longitudinal strains (<2%), they were poor from all radial strains with 
bias ranging from 5 to 21%. 
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Figure 5.4: Bland-Altman plots for intra-observer variability for global strain parameters 
and all software. Top row (A-C) circumferential strain, second row (DE) longitudinal 
strain and bottom 2 rows (F-J) radial strain.  
5.3.3 Comparison between populations 
When comparing healthy subjects and hypertensive population, all three software 
packages returned slightly higher absolute global circumferential and global longitudinal 
strain values for the patient population (see Tables 5.2 and 5.3, Figures 5.1 and 5.2). 
However, the picture was mixed for global radial strain as the values measured for 
hypertensive patients were lower for Tomtec, slightly higher for CVI42 and significantly  
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higher for CIM-FT (Figure 5.5).  
Table 5.7: Acquisition parameters for Steady State Free Precession (SSFP) sequence. 
 
In fact, there were significant differences in most parameter derived by CIM-FT between 
healthy subjects and hypertensive patients. Global, endocardial and epicardial radial 
strain for apical and mid ventricle short axis as well as for 2-chamber and 4-chamber 
were significantly lower in healthy subjects when compared to hypertensive patients. 
Furthermore, endocardial circumferential strain for basal and mid ventricle short axis as 
well as endocardial longitudinal strain for 4-chamber were statistically significantly lower 
in healthy subject results compared to hypertensive patients results derived by CIM-FT. 
However, epicardial circumferential strain for apical, mid ventricle and basal short axis 
by CIM-FT showed to be lower in hypertensive patients. 
 
Parameters 
Siemens MRI 1.5 scanner 
(26 hypertensive patients) 
Philips MRI 1.5 scanner 
(28 healthy subjects) 
TR (ms) 2.5  2.9 
TE (ms) 1.24 1.44 
Matrix 208 × 256 108 × 186 
Field of view (mm2) 292 ×360 205 × 380 
Acquired pixel size 
(mm2) 
1.4 × 1.4  1.89 × 2.1  
Temporal resolution 
(ms) 
35  46  
Slice thickness 
(mm) 
7  8  
Flip Angle (º) 70 60 
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Figure 5.5: Global radial strains in healthy volunteers (black) and hypertensive patients 
(red) calculated from short axis (A-C), 2 chamber (D) and 4 chamber views (E) for the 
three software. Box plots for global radial strains by Tomtec, CVI42 and CIM-FT in 
healthy subjects (black) and hypertensive patients (red) calculated from (A) apical, (B) 
mid, (C) basal short axis for the three software. The blue p-value (P<0.05 considered as 
significant) shows any significant difference between healthy subjects and hypertensive 
patients for Tomtec, CVI42 and CIM-FT software packages. The black p-value (P<0.05 
considered as significant) shows any significant difference between Tomtec, CVI42 and 
CIM-FT software packages for healthy subjects. The red p-value (P<0.05 considered as 
significant) shows any significant difference between Tomtec, CVI42 and CIM-FT 
software packages for hypertensive patients. The significance level is unadjusted for 
multiple comparison. 
There were no significant differences between healthy subject’s results and hypertensive 
patients’ results derived by CVI42. While epicardial longitudinal strain for 4-chamber 
and epicardial circumferential strain for apical short axis as well as epicardial radial strain 
for apical short axis and for 2-chamber by CVI42 showed to be lower in hypertensive 
patients.  
The endocardial circumferential strain for basal short axis by Tomtec was statistically 
lower in healthy subjects compared to hypertensive patients. Global, endocardial and 
epicardial circumferential strain for mid ventricle short axis was also statistically lower in 
 101 
healthy subjects than hypertensive patients. However, global radial strain for apical and 
mid ventricle short axis, 2-chamber and 4-chamber by Tomtec showed to be lower in 
hypertensive patient than healthy subjects.  
It is important to highlight that images for the healthy subjects and hypertensive patients 
CMR images were acquired at different centers using different scanners and with slightly 
different imaging parameters (Table 5.7) but at the same field strength. This was a 
pragmatic choice, as this hypertensive patient study did not include comparative healthy 
volunteer data but I had access to the healthy volunteer data from the HAPPY London 
Study (9). The main differences were a higher spatial and temporal resolutions for the 
hypertensive patients. This could potentially have an effect on the results of all three FT 
software packages and can be considered a potential confounding factor in this chapter. 
As explained in chapter 3 of this thesis, FT analysis relies on features (image signal 
intensities, local texture or patterns, boundaries edges) that can be tracked at pixel level in 
consecutive frames (3). The FT software packages define those features at the first frame 
in the area of interest identified by contours drawn on the endocardial and epicardial 
boundaries in the short axis or long axis view. After defining those features in the area of 
interest the FT software searches for the best comparable features in the following frames 
(3). Assuming comparable image quality, higher spatial and temporal resolutions would 
be expected to improve tracking accuracy (better ability to resolve finer in-plane and 
through time pixel motion) (39)(79). All healthy subjects and hypertensive patients’ CMR 
images used for the analysis had no artefacts that could affect the FT tracking quality. 
Hence, it was possible to analyse all images without having to exclude any subjects in 
either groups. 
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5.4 Discussion 
In this chapter, most absolute strain results were higher in hypertensive patients than 
healthy subjects for most global and regional parameters derived by the three FT software 
packages, which is not in line with previous studies (80)(81)(82). The only notable 
exception was for radial strains derived by Tomtec that were slightly lower in 
hypertensive patients. There were significant differences between healthy subjects and 
hypertensive patients strain results derived by Tomtec and CIM-FT, whereas differences 
calculated by CVI42 were not statistically significant. The significant differences between 
both groups were observed by the three software packages. It is important to highlight 
that both groups are not match in age and gender, and they use different CMR images 
acquisition parameters, particularly spatial and temporal resolutions. These limitations 
could be confounding factors and could affect the results.  
In order to further investigate these findings, a similar analysis needs to be applied to a 
larger cohort matched in terms of age, gender and other demographic variables to 
eliminate any uncertainties.”  
Across the two groups and the three software, the most reliable and consistent parameters 
were circumferential strain for mid ventricle short axis followed by longitudinal strain 
results. The reproducibility was very high for those deformation strain parameters derived 
by CVI42 followed by Tomtec. CIM-FT exhibited the poorest results. 
Although FT technique showed to be a promising tool to discriminate between healthy 
subjects and CVD patients (4)(50), the significant differences across the three FT 
software packages in both groups, can have a bad influence on the FT implementation in 
clinical practice today. The high variability makes it difficult to drive a reliable cut-off for 
healthy subjects and hypertensive patients in this chapter. The high variability observed in 
this chapter is consistent with several studies which previously observed variabilities in 
 103 
FT technique (83)(7)(6)(73). As observed by previous studies, several other factors could 
have an impact on our results, which may have introduced variabilities in the measured 
parameters such as inherent natural physiological variability between subjects including 
gender, age, race (63). The CMR acquisition protocol parameters vary from vendor to 
vendor. The temporal and spatial resolution depends on the acquisition protocol and 
hence when they vary, this can affect image quality and impact on the analysed results. In 
this chapter, there were inherent variabilities between the two different populations, 
scanner types and CMR acquisition parameters, so possible discrepancies between groups 
can be expected. It is important to note that this is the first study conducted to compare 
three different FT software packages for circumferential, radial and longitudinal strain in 
hypertensive patients and healthy subjects. In terms of different scanners and different 
CMR image parameters, hypertensive patients showed agreement in more global and 
regional parameters compared to healthy results between the three FT software packages. 
This could be in part due to the higher spatial and temporal image resolutions resulting in 
a better tracking quality and therefore, better agreement between software approaches as 
shown in data using Friedman test in Table 5.2, Table 5.3 and ICC in Table 5.4 (39)(79). 
The most recent study compared four FT software packages (Tomtec, CVI42, Medis and 
MTT) in 110 subjects, including preclinical and overt arrhythmogenic right ventricle 
dysplasia patients and control group, to assess any agreement of right ventricle global and 
regional longitudinal strain measurements derived from four chamber acquisitions (83). 
In general, the results for the right ventricular longitudinal strain showed significant 
variability between the four FT software packages, which is consistent with the variability 
of the global longitudinal strain observed in this chapter across the three FT software and 
both groups. The ICC for absolute agreement for global longitudinal strain was 0.44 for 
the right ventricle (83), whereas in this chapter, the ICC was 0.45 for the left ventricle in 
healthy subjects, which was similar and two of those FT-software packages in their 
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research were also Tomtec and CVI42, which was similar to the ones used in our study 
(83). Also in their study, Tomtec had the highest longitudinal strain for 4-chamber 
compared to other FT software packages followed by CVI42 (83), while in our current 
study, Tomtec had  the highest longitudinal strain in both groups followed by CVI42 as 
shown in Figure 5.2. Findings from this chapter are also in line with the observation of 
previous studies, which used multiple software packages for analysis of speckle tracking 
by echocardiography. In one study, it was reported that even previous versions of the 
same software yielded a wide range of global longitudinal strain with significant bias in 
healthy subjects (84) and hence, only the global longitudinal strain was compared since it 
was the most stable used parameter, and thus included as a quantification parameter in 
strain echocardiography examination guidelines (85). Similarly, another study 
investigating speckle tracking echocardiography applied seven different analysis 
approaches from different vendors to compare global longitudinal strain to healthy 
volunteers (69), the variation was small but significant. 
Another related study, which used Tomtec and CVI42 for comparisons, noted reasonable 
inter- and intra-vendors’ agreement for circumferential strain, high variability for radial 
strain of left ventricle. These findings are consistent with the results from this chapter, 
which showed that the most consistent parameter in both group was circumferential 
strain. Their study also ranked the degree of agreement according to software used for 
each parameter and reported more variability for circumferential strain measured by 
CVI42 and more variability for radial strain by Tomtec (73). In this chapter, CVI42 
showed less variability for all parameters and best inter- and intra- agreement followed by 
Tomtec software. 
Feature tracking technique offers the possibility to assess LV myocardial strain 
parameters from cine images, which is a more time-effective approach compared to the 
tagging technique, which requires separate acquisition of tagged images and more time-
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consuming post-processing (61), which make FT attractive to use. There is increase 
demand on the FT technique after the first software (Tomtec) (8), and more recently, 
CVI42 and CIM-FT were introduced. However, it is important to note that all FT 
software packages used in this chapter required initial derivation of endocardial and 
epicardial delineation contours by the user and making correction to the tracking when 
necessary, which could also contribute to the observed variability. It is crucial that FT 
software variabilities are kept to a minimum with a high reproducibly to allow 
widespread clinical use (73). 
Circumferential strain parameters for mid ventricle short axis images showed to be the 
most consistent parameter across the three software packages in both group in healthy 
subjects and hypertensive patients. Furthermore, the reproducible of circumferential strain 
is superior followed by longitudinal in comparison to radial strain parameters (67). The 
global circumferential strain showed the best agreement between Tomtec and CVI42 FT 
software packages in healthy subjects (73). Circumferential strain for mid ventricle is 
preferable in several studies (8) for its high reproducibility this could be a result of the 
mid-wall layer, with circumferentially oriented fibres (8)(86). 
The reproducibility for inter- and intra-observer for the three FT software packages 
showed the best agreement with lowest bias and lowest standard deviation for 
circumferential and longitudinal strain parameters contrary to radial strain results. This 
finding is in line with previously published reviews in healthy subjects (87)(6)(73) which 
reported acceptable inter-observer agreement for global longitudinal strain and global 
circumferential strain of LV and RV using both CMR FT and echocardiography, poor 
inter-observer agreement for global radial strain in tetralogy of Fallot patients (67). These 
results are consistent with this chapter findings. Global deformation parameters were 
better for inter-observer than intra-observer across FT software packages as well as global 
measurements showed higher reproducibility compared to regional measurements, this is 
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in line with previous studies (6)(72).  
5.5 Conclusion  
This chapter compared the results of three FT software in hypertensive and healthy 
populations. The results might not be fully generalizable as the two populations were not 
matched and the images acquired on different scanners with different scan parameters. 
However, some interesting observations were made. 
Firstly, most global and regional deformation parameters were significantly higher in 
hypertensive patients than in healthy subjects for all the three FT software packages but 
this may have been partly due to the confounding factors including different acquisitions 
parameters in particular temporal and spatial resolutions and both populations are not 
matched for age and gender. 
Secondly, circumferential strain parameters for mid ventricle short axis images showed to 
be the most consistent parameter by ICC agreement in both groups. 
Finally, when investigating the inter- and intra- observer variability, CVI42 showed a 
better reproducibility followed by Tomtec software. However, it is important to highlight 
that these results cannot be generalised to all other versions of these software packages as 
vendors constantly update and try to improve their tracking algorithms.  
The circumferential and longitudinal strain parameters showed lowest bias and standard 
deviation as well as narrowest limits of agreement. Radial strain in general showed higher 
variations, wider limit of agreement, in particular when using the CIM-FT software 
package. Overall, the most consistent parameters across the three software by ICC 
agreement were circumferential strain for mid-ventricle short axis and to a lesser extend 
longitudinal strain.  
Consequently, it might be advisable to use circumferential and longitudinal strains in 
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clinical analysis, especially when comparing results across centres/software. Conversely, 
radial strain showed high variation between the three software packages, and thus, it 
might be better to avoid using this parameter in isolation when comparing different 
studies.  
In order to avoid some of the limitations, a larger cohort of hypertensive patients was 
studied in the next chapter. For chapter 6, both groups were recruited as part of the 
HAPPY London study. Consequently, the images were acquired with the same protocol 
on the same scanner. The main aim of the next chapter was to compare FT to the current 
MRI gold-standard for deformation, tagging. As CVI42, demonstrated the best 
reproducibility of the three software, only this one was used for the FT analysis.  
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Chapter 6: Comparison of feature 
tracking and tagging analysis in healthy 
subjects and hypertensive patients 
6.1 Introduction 
Although FT has seen improvements since its creation (87) and commercial software are 
now available, its abilities to highlight several cardiac health pathologies (83)(88) will 
only be truly harvested when the technique will be fully validated. Different studies, 
including chapter 5, have highlighted the high variability between different software. 
Another step, that needs to be taken to validate FT is to compare it to established 
techniques, echocardiography speckle tracking and CMR tagging that can be considered 
the “gold standard” for this modality. 
This chapter aimed to compare the results from FT (CVI42) and tagging (CIMTag2D) in 
healthy subjects and hypertensive patients from the HAPPY London study (9). Since 
CVI42 software demonstrated the best reproducibility of the three software (Tomtec, 
CVI42 and CIM-FT) in chapter 5, hence only CVI42  was used for the FT analysis in this 
chapter. Compared to chapter 5, this chapter includes a larger cohort of hypertensive 
patients. Furthermore, both patients and controlled populations were recruited as part of 
the HAPPY London study. Consequently, the MRI scanner and the image acquisition 
parameters used are identical for both populations hence removing some of the 
limitations discussed in chapter 5. It is important to highlight that the healthy population 
used in this chapter is identical to the one used in chapter 5. The primary objective of this 
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chapter was to examine whether there was any agreement in global and regional cardiac 
deformation results between FT and tagging software packages in healthy participants 
and hypertensive patients. The secondary objectives were to examine whether 
hypertension could affect strain values when compared with a healthy population and to 
investigate if any deformation parameters displayed significant differences with regards 
to gender. 
6.2 Methods 
Twenty-eight (28) healthy subjects and sixty-two (62) hypertensive patients underwent 
the same standardised CMR scan (71). Left ventricular systolic strain deformation 
parameters results were derived by using FT and tagging software packages (CVI42 and 
CIMTag2D) to analyse cine SSFP and tagging images. The CMR cine acquisition 
protocol for SSFP and CSPAMM are presented in Chapter 4 (sections 4.1.1 and 4.1.2). 
The endocardial and epicardial borders of the mid ventricle short axis, as well as in the 
two and 4-chamber long axes of the left ventricle, were analysed as presented in the 
method chapter (sections 4.2.2 and 4.3). 
6.2.1 Study Population 
The population (Table 6.1) consisted of ninety (90) subjects including 62 hypertensive 
patients, 18 (29%) of whom had diabetes. All participants were aged 50 or over. Forty-
nine (49%) of the hypertensive patients were on antihypertensive medications. All 28 
healthy subjects that were recruited for the HAPPY London study had no previous angina 
or myocardial infarction, no history of stroke or transient ischaemic attack (TIA), or any 
cardiac sounding chest pain requiring further investigations. Other than vascular disease, 
healthy subjects had no medical history of diabetes, were not on hypertension treatment 
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and had no history of overt cardiac disease (9).  
Table 6.1: Demographic variables for healthy subjects and hypertensive patients. Red cell = 
significant difference (p<0.05).  
Parameters Healthy Subjects Hypertensive Patients 
Number of participants 28 62 
Female / Male 8 / 20 30 / 32  
Age (years) 66.2 ± 5.3 65.1 ± 5.5 
Height (m) 1.74 ± 0.10 1.69 ± 0.09 
Weight (kg) 80.8 ± 11.4 81.5 ± 16.5 
BMI (kg.m-2) 26.8 ± 3.1 28.2 ± 4.6 
BSA (m2) 1.97 ± 0.18 1.95 ± 0.24 
Systolic-BP (mmHg) 125.9 ± 8.6 138.7 ± 13.6 
Diastolic-BP (mmHg) 77.1 ± 6.5 80.8 ± 10.3 
Heart Rate (beats/minute) 59± 8 64 ± 12 
LV Ejection Fraction (%) 62.1 ± 6.0 66.8 ± 6.8 
BMI=body mass index, BSA=body surface area, BP=blood pressure, LV=left ventricle. 
Population groups were not matched in term of size and gender, but were matched for 
age. The diastolic and systolic BP and the ejection fraction as well as heart rate show 
significant differences as those parameters are affected by hypertension. Both datasets 
were from the HAPPY London project previously described in section 4.1.3 p 63.(9). 
Healthy subjects that are included in this chapter are the same healthy subjects included 
in the previous chapter. Details by sex for the healthy subjects are given in Table 6.2. 
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Table 6.2: Demographic variables by sex for healthy subjects, red cells indicate statistical 
difference (p<0.05). 
Parameters Male Female 
Number 20 8 
Age (years) 65.4±5.2 68.6±4.7 
Systolic-BP (mmHg) 126.6±6.7 124.3±13.4 
Diastolic-BP (mmHg) 78.1±6.9 74.4±4.3 
Heart rate (beats/min) 58±8 63±7 
BMI (kg/ m2) 26.4±3.4 27.8±2.2 
BSA (m2) 2.02±0.2 1.80±0.1 
LV EF (%) 60.8±5.5 65.9±6.3 
BMI=body mass index, BSA=body surface area, BP=blood pressure, LV=left ventricle. 
6.2.2 Statistical analysis 
Statistical analysis was performed using IBM SPSS Statistics version 23. The 
demographic variables for healthy subjects and hypertensive patients were presented as 
the mean ± standard deviation (SD) in Tables 6.1 and 6.2. Continuous data for 
deformation parameters derived from CVI42 and CIMTag2D were presented as mean ± 
standard deviation (SD), in the healthy and hypertensive patients’ results as shown in 
Table 6.3. The maximum and minimum values for each deformation parameter were 
identified in healthy subjects and hypertensive patients for CVI42 and CIMTag2D as 
shown in Table 6.4. Paired t-tests were carried out to determine any significant 
differences between CVI42 and CIMTag2D software packages; results as shown in Table 
6.3. A significant difference for the paired t-test results in Table 6.3, after Bonferroni 
adjustment, was considered to be p<0.003 (p<0.05 divided by 18, the number of 
comparisons) (75). The inter- and intra-observer reproducibility of global and regional 
deformation parameters derived from CIMTag2D were evaluated by the Bland-Altman 
method, with a calculation of the 95% limits of agreement as shown in Table 6.5 (76). 
The p-value for inter- and intra-observer assessment were computed by paired t-test to 
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examine any significant bias between inter- and intra-measurements and the significance 
level after Bonferroni adjustment considered to be p<0.003 for inter-observer (p<0.05 
divided by 18 comparisons) and p<0.002 for intra-observer (p< 0.05 divided by 30 
comparisons). An independent sample t-test was used to compare strain values derived 
from CVI42 and CIMTag2D between healthy male and female subjects in Table 6.6 and 
between healthy subjects and hypertensive patient in Table 6.7. Box plots were used to 
compare between male and female strain results as well as between healthy subjects and 
hypertensive patients strain results. Bonferroni correction was not applied to the results in 
table 6.6 and 6.7 as the power was low for these comparisons and in order to avoid type II 
error for these associations. Principal components analysis (PCA) was performed to 
reduce the number of variables to aid interpretation (89). All subjects were included in the 
principal components analysis. A large number of derived variables (72) measured by 
CVI42 needed to be reduced. PCA reduced the number of the variables to a smaller 
number that retained 72% of the variance observed in the original data. CVI42 variables 
reduced to 9 variables loaded on four principal components as shown in Table 6.8. 
Spearman’s correlation coefficient was applied to investigate the correlation between 
systolic and diastolic blood pressure and the components PC1, PC2, PC3 and PC4 that 
resulted from PCA results as shown in Table 6.9. The results for independent samples 
tests between demographic categorical variables (gender, hypertension, hypertension 
treatment, diabetes) with principal component analysis: PC1, PC2, PC3, and PC4 are 
shown in Table 6.10. The discrimination between hypertension and healthy subjects was 
evaluated using the area under the Receiver Operating Characteristic (ROC)) curve. For 
the area under the curve (ROC), a value of [0.90–1.0] was considered excellent, [0.80–
0.90] good, [0.60–0.80] moderate and <0.60 poor (83)(90). 
 Table 6.3: A summary of CVI42 and CIMTag2D strain parameters. Data are presented as the mean ± standard deviation (SD) in healthy subjects and hypertensive 
patients. Red cell = significant difference (p<0.003). 
Strain (%) 
Healthy Subjects Hypertensive Patients 
Global Endo Epi Global Endo Epi 
FT Tag FT Tag FT Tag FT Tag FT Tag FT Tag 
Circumferential Mid SAX 
-19.40 
±2.63 
-19.77 
±2.43 
-20.82 
±2.72 
-24.69 
±3.15 
-18.03 
±2.67 
-14.92 
±2.13 
-20.23 
±2.94 
-19.25 
±2.68 
-21.78 
±3.15 
-24.04 
±3.16 
-18.64 
±2.69 
-14.59 
±2.48 
Radial 
Mid 
SAX 
33.88 
±7.87 
28.13 
±14.28 
38.21 
±8.82 
26.66 
±24.25 
30.03 
±7.34 
34.56 
±13.49 
37.79 
±10.01 
30.56 
±8.45 
43.13 
±12.13 
27.94 
±9.70 
32.76 
±8.09 
36.05 
±11.19 
2ch 
LAX 
33.58 
±8.84 
25.28 
±13.76 
33.93 
±10.05 
28.11 
±16.56 
33.82 
±8.32 
23.07 
±11.66 
36.39 
±9.30 
25.89 
±11.27 
36.47 
±9.96 
26.93 
±13.39 
36.42 
±9.11 
25.79 
±10.71 
4ch 
LAX 
35.95 
±7.63 
27.74 
±15.23 
37.09 
±8.74 
33.32 
±18.92 
37.41 
±8.80 
23.15 
±12.93 
36.08 
±9.59 
26.19 
±11.58 
36.58 
±9.66 
30.19 
±17.46 
36.67 
±10.75 
23.53 
±9.36 
Longitudinal 
2ch 
LAX 
-18.12 
±2.38 
-15.48 
±3.00 
-18.17 
±2.44 
-16.35 
±3.35 
-18.38 
±2.44 
-14.55 
±3.02 
-19.03 
±2.59 
-14.09 
±2.17 
-18.95 
±2.78 
-15.17 
±2.60 
-19.16 
±2.56 
-12.81 
±2.15 
4ch 
LAX 
-18.55 
±2.22 
-15.96 
±2.24 
-18.74 
±2.34 
-16.08 
±2.64 
-19.23 
±2.54 
-15.70 
±2.18 
-18.42 
±2.62 
-14.92 
±2.03 
-18.57 
±2.65 
-15.19 
±2.53 
-18.53 
±2.81 
-14.08 
±2.06 
Endo = Endocardial, Epi = Epicardial, SAX = short axis, LAX= long axis, ch = chamber, FT = CVI42, Tag = CIMTag2D.  
  
Table 6.4: Maximum and minimum values for the different strain parameters (%) calculated using CVI42 and CIMTag2D in healthy subjects and hypertensive 
patients. 
 Healthy Subjects Hypertensive patients 
 CVI42 CIMTag2D CVI42 CIMTag2D 
Strain (%) Global Endo Epi Global Endo Epi Global Endo Epi Global Endo Epi 
Circumferential 
Mid 
SAX 
-23.78 
-13.92 
-25.39 
-14.48 
-23.62 
-12.54 
-23.90 
-14.53 
-30.22 
-19.04 
-18.67 
-9.68 
-29.47 
-14.37 
-31.17 
-15.01 
-26.56 
-13.52 
-25.76 
-14.13 
-31.88 
-18.09 
-21.33 
-9.20 
Radial 
Mid 
SAX 
20.27 
51.79 
21.46 
57.73 
17.99 
51.16 
10.04 
74.42 
2.92 
106.08 
14.85 
75.54 
20.86 
73.31 
21.58 
83.59 
19.26 
57.22 
15.15 
58.44 
6.99 
50.62 
16.59 
80.08 
2ch 
LAX 
19.93 
61.35 
20.47 
67.84 
18.66 
59.36 
10.42 
59.91 
13.58 
69.39 
9.34 
50.07 
21.89 
68.23 
20.19 
70.43 
22.64 
71.77 
14.47 
80.14 
16.98 
81.33 
12.67 
79.32 
4ch 
LAX 
20.17 
50.48 
21.26 
57.91 
19.87 
55.75 
9.81 
72.01 
10.28 
80.56 
10.82 
64.53 
17.75 
68.26 
18.74 
71.89 
18.09 
70.89 
12.09 
75.14 
11.67 
93.95 
9.99 
58.38 
Longitudinal 
2ch 
LAX 
-24.36 
-11.62 
-24.74 
-11.57 
-23.44 
-11.24 
-23.36 
-5.98 
-24.76 
-7.89 
-21.84 
-3.94 
-25.71 
-13.57 
-26.12 
-13.12 
-25.23 
-13.61 
-19.55 
-7.96 
-19.56 
-7.05 
-19.41 
-7.44 
4ch 
LAX 
-22.65 
-13.75 
-23.17 
-13.51 
-24.48 
-13.91 
-20.01 
-11.64 
-21.94 
-10.89 
-19.59 
-11.05 
-24.75 
-10.78 
-26.02 
-11.26 
-25.74 
-10.77 
-10.71 
-10.03 
-21.80 
-8.42 
-18.12 
-8.97 
Endo = endocardial, Epi = epicardial, SAX = short axis, LAX= long axis, ch = chamber. 
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6.3 Results 
6.3.1 Healthy subjects 
The radial, circumferential, and longitudinal strain means for global, endocardial, and 
epicardial regional measurements derived from mid ventricle short axis, 2-chamber and 
4-chamber long axis views are given in Table 6.3.  
Comparison between strain results derived from CVI42 and CIMTag2D in healthy 
subjects using paired t-test showed that there were significant differences between FT 
(CVI42) and tagging (CIMTag2D) software packages in 8 out of 18 parameters in 
healthy subjects, one global (longitudinal from 2-chamber long axis) and 7 regionals. 
For epicardial measurements only one was in agreement; radial strain from the mid-
short axis slice. 
Maximum and minimum values for global and regional circumferential, radial, 
longitudinal strain results between CVI42 and CIMTag2D in healthy subjects are shown 
in Table 6.4. The maximum and minimum value for global circumferential strain for 
mid ventricle short axis between CIMTag2D and CVI42 were comparable. However, 
the minimum values for global, endocardial and epicardial longitudinal strain for 2-
chamber and 4-chamber were lower in CIMTag2D compared to CVI42. Likewise, the 
maximum values for global, endocardial and epicardial radial strain for mid ventricle 
short axis and 4-chamber were higher in CIMTag2D than CVI42. 
Inter-observer variability for CIMTag2D results showed no significant difference 
between the two observers' measurements, except for global and endocardial 
circumferential strain calculated from the mid-ventricle short axis. The global 
circumferential strain for basal short axis showed the lowest bias between two 
measurements (0.26 ± 2.32%) and is displayed in Figure 6.1 (left-hand side). However, 
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wide limits of agreement were observed in most radial parameters (Table 6.5). 
The Bland-Altman statistics for intra-observer variability from the CIMTag2D software 
measurements are shown in Table 6.5. There were no significant differences between 
two measurements in all global and regional strain parameters. Additionally, the lowest 
bias was shown for endocardial longitudinal strain for 2-chamber (0.05 ± 4.23%) as 
shown in Figure 6.1 (right-hand side), then for endocardial radial strain for apical short 
axis (-0.09%) with higher SD (±10.14). The widest limits of agreement were observed 
for epicardial radial strain for basal short axis. 
 
 
Figure 6.1: Bland-Altman graphs for the best inter-observer (left-hand side), and the 
best intra-observer (right-hand side) for CIMTag2D in healthy subjects. 
 
The mean and standard deviation for all deformation parameters were calculated for 
healthy male and female subjects as measured by CVI42 and CIMTag2D (Table 6.6). 
There was significant difference for the body surface area (BSA) between male and 
female subjects but other parameters were in agreement. Given that the demographics 
were similar between both genders, this reduces the chance of confounding the 
comparison of strain parameters between male and female subjects.  
 Table 6.5: Bland-Altman statistics for CIMTag2D of ten healthy subjects for the intra-observer variability across all the measured parameters. Red cell = statistical 
significant difference  
Strain (%) 
Intra-observer variability Inter-observer variability 
Bias SD Limits of agreement p-value Bias SD Limits of agreement p-value 
C
ir
cu
m
fe
re
nt
ia
l 
Apical 
SAX 
Global 0.78 2.50 -4.09 5.66 0.35 1.49 3.01 -4.39 7.36 0.15 
Endo 0.82 3.89 -6.77 8.41 0.52 2.33 5.05 -7.52 12.19 0.18 
Epi 0.45 1.66 -2.78 3.68 0.42 0.61 2.63 -4.51 5.73 0.48 
Mid 
SAX 
Global 1.45 2.63 -3.69 6.59 0.12 1.85 1.34 -0.77 4.47 0.002 
Endo 1.31 3.43 -5.37 7.99 0.26 3.05 1.55 0.03 6.07 0.000 
Epi 1.48 2.33 -3.06 6.02 0.08 0.81 1.82 -2.74 4.37 0.19 
Basal 
SAX 
Global 1.02 1.29 -1.51 3.54 0.04 0.26 2.32 -4.25 4.78 0.73 
Endo 0.73 1.98 -3.13 4.58 0.27 1.59 2.92 -4.11 7.28 0.12 
Epi 1.10 1.52 -1.87 4.07 0.05 -0.74 2.12 -4.87 3.39 0.29 
R
ad
ia
l 
Apical 
SAX 
Global -1.84 4.42 -10.47 6.79 0.22 0.59 9.99 -18.91 20.09 0.86 
Endo -0.09 10.14 -19.86 19.69 0.98 6.08 12.81 -18.89 31.06 0.19 
Epi -3.78 8.86 -21.06 13.51 0.21 -3.51 13.56 -29.95 22.92 0.43 
Mid 
SAX 
Global -2.0 9.17 -19.89 15.89 0.51 2.39 8.34 -13.87 18.66 0.39 
Endo -2.99 15.58 -33.37 27.38 0.46 3.07 8.24 -13.01 19.14 0.27 
Epi -3.51 8.91 -20.89 13.87 0.25 1.59 9.72 -17.36 20.54 0.62 
Basal 
SAX 
Global -8.42 14.43 -36.55 19.72 0.09 -1.51 12.97 -26.79 23.77 0.72 
Endo -8.00 18.65 -44.38 28.37 0.21 1.66 16.04 -29.61 32.93 0.75 
Epi -11.92 32.35 -75.00 51.17 0.27 -2.91 13.09 -28.44 22.62 0.50 
2ch 
LAX 
Global 1.08 14.02 -26.25 28.42 0.81      
Endo 1.63 17.26 -32.03 35.28 0.77      
Epi 1.90 12.87 -23.19 26.99 0.65      
4ch 
LAX 
Global 9.10 13.39 -17.01 35.21 0.06      
Endo 10.97 17.02 -22.22 44.16 0.07      
Epi 6.83 10.04 -12.74 26.40 0.06      
L
on
gi
tu
di
na
l 2ch 
LAX 
Global 0.63 3.81 -6.81 8.06 0.62      
Endo 0.05 4.23 -8.19 8.30 0.97      
Epi 1.37 3.63 -5.72 8.45 0.26      
4ch 
LAX 
Global 1.09 2.00 -2.81 4.99 0.12      
Endo 1.49 2.84 -4.05 7.03 0.13      
Epi 0.99 1.85 -2.61 4.60 0.12      
Endo = endocardial, Epi = epicardial, SAX = short axis, LAX= long axis, ch = chamber, SD = standard deviation. 
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The absolute global circumferential, radial and longitudinal strain means parameters 
measured by CVI42 were consistently higher in females than in males. However, 
CIMTag2D results showed that all radial strain mean parameters were higher in males 
than females, whereas the absolute circumferential and longitudinal strain means 
parameters were higher in females than males as shown in Table 6.6. 
 
Figure 6.2: Box plots for male and female strain parameters derived by CVI42 and 
CIMTag2D. The blue p-value (P<0.05 considered as significant) shows any significant 
difference between healthy male and female subjects for CVI42 and CIMTag2D software 
packages. The significance level is unadjusted for multiple comparison. 
There were significant differences between males and females for the measured global, 
endocardial, epicardial circumferential strain for mid ventricle short axis by CVI42 
software. Epicardial radial strain for 2-chamber as well as global, endocardial and 
epicardial longitudinal strain for 2-chamber derived by CVI42 showed significant 
differences. Global, endocardial and epicardial longitudinal strain for 4-chamber 
generated from CVI42 showed significant difference between males and females. While, 
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in CIMTag2D results, epicardial radial strain for mid ventricle short axis and for 2-
chamber showed significant differences. Global, endocardial and epicardial longitudinal 
strain for 4-chamber derived from CIMTag2D showed significant differences between 
males and females results. 
Table 6.6: Summary of CVI42 and CIMTag2D strain parameters, for males (20) and females (8) 
in healthy subjects. Data is presented as mean ± standard deviation (SD). Red cell = significant 
difference (p<0.05). 
Strain (%) 
CVI42 CIMTag2D 
Male Female Male Female 
Circumferential  Mid SAX 
Global -18.64 
±2.41 
-21.29 
±2.29 
-19.47 
±2.65 
-20.49 
±1.74 
Endo -20.05 
±2.47 
-22.74 
±2.46 
-24.49 
±3.49 
-25.16 
±2.25 
Epi -17.37 
±2.68 
-19.66 
±1.90 
-14.55 
±2.25 
-15.82 
±1.62 
Radial 
Mid 
SAX 
G 32.11 
±7.67 
38.32 
±6.93 
30.07 
±15.41 
23.52 
±10.59 
Endo 36.24 
±8.49 
43.15 
±8.09 
26.82 
±25.17 
26.27 
±23.56 
Epi 28.72 
±7.87 
33.32 
±4.75 
37.89 
±13.77 
26.63 
±9.35 
2ch 
LAX 
G 31.63 
±8.37 
38.47 
±8.54 
27.89 
±15.01 
19.07 
±7.84 
Endo 31.93 
±9.67 
38.93 
±9.80 
30.77 
±18.11 
21.81 
±10.53 
Epi 31.72 
±8.09 
39.06 
±6.71 
25.62 
±12.43 
17.00 
±6.90 
4ch 
LAX 
G 35.08 
±7.56 
38.15 
±7.86 
29.59 
±14.90 
23.12 
±16.04 
Endo 36.11 
±8.16 
39.54 
±10.22 
35.36 
±18.82 
28.22 
±19.41 
Epi 36.18 
±8.55 
40.49 
±9.24 
24.78 
±12.84 
19.08 
±13.08 
Longitudinal  
2ch 
LAX 
G -17.38 
±1.99 
-19.98 
±2.35 
-14.42 
±4.84 
-15.90 
±1.96 
Endo -17.47 
±2.11 
-19.94 
±2.42 
-16.28 
±3.56 
-16.53 
±3.03 
Epi -17.59 
±2.17 
-20.32 
±2.04 
-14.28 
±3.54 
-15.21 
±0.93 
4ch 
LAX 
G -17.99 
±2.23 
-19.93 
±1.59 
-15.26 
±2.07 
-17.70 
±1.68 
Endo -18.18 
±2.31 
-20.14 
±1.89 
-15.35 
±2.49 
-17.92 
±2.15 
Epi -18.65 
±2.51 
-20.69 
±2.08 
-15.03 
±2.02 
-17.38 
±1.64 
Endo = Endocardial, Epi = Epicardial, SAX = short axis, LAX= long axis, ch = chamber. 
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Global circumferential strain, global longitudinal strain from 2-chamber and global 
longitudinal strain from 4-chamber, female results were consistently higher in female for 
both CVI42 and CIMTag2D as can be seen in Figure 6.2. For CVI42, female results were 
significantly higher than male for all three parameters. For CIMTag2D, only the global 
longitudinal strain for 4-chamber result was significant.” 
6.3.2 Hypertensive patients 
The global, endocardial and epicardial circumferential, radial, and longitudinal strain 
means and standard deviations for mid ventricle short axis, 2-chamber and 4-chamber 
long axis were measured by CVI42 and CIMTag2D software packages in hypertensive 
patients as shown in Table 6.3. There were significant differences between CVI42 and 
CIMTag2D in 13/18 parameters in hypertensive patients, including 4/6 global parameters. 
For epicardial regional parameters only one (radial strain from mid short axis) was in 
agreement. The other parameters in agreement were global circumferential strain from 
mid-ventricle short axis as well as epicardial radial strain from mid-ventricle short axis, 
endocardial radial strain and endocardial longitudinal strain from 4-chamber and global 
longitudinal strain from 2-chamber.  
The maximum and minimum strain values for global, endocardial, epicardial 
circumferential strain for mid ventricle short axis were comparable between CVI42 and 
CIMTag2D as shown in Table 6.4. However, the maximum and minimum strain values 
for global, endocardial, epicardial longitudinal strain for 2-chamber and 4-chamber were 
consistently lower in CIMTag2D than CVI42. Likewise, the minimum strain values for 
global, endocardial, epicardial for radial strain parameters were consistently lower in 
CIMTag2D than CVI42. 
Comparison between healthy subjects and hypertensive patients strain results derived by 
CVI42 and CIMTag2D are shown in Table 6.7. For CVI42, there was no statistical 
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differences between the two population groups; hypertensive patients exhibiting slightly 
higher absolute strain values for 13/18 parameters. For CIMTag2D, the hypertensive 
group had statistically lower absolute global and epicardial longitudinal strain from both 
2 and 4-chamber views. The value was lower (but not statistically significant) for a 
further 8 parameters. Figure 6.3 shows the box plots comparing the two populations for 
the global parameters and comparing between CVI42 and CIMTag2D strain results in 
both groups. 
 
Figure 6.3: Box plots for healthy subjects and hypertensive patients global strain 
parameters derived by CVI42 and CIMTag2D. The blue p-value (P<0.05 considered as 
significant) shows any significant difference between healthy subjects and hypertensive 
patients for CVI42 and CIMTag2D software packages. The black p-value (P<0.05 
considered as significant) shows any significant difference between CVI42 and 
CIMTag2D software packages for healthy subjects. The red p-value (P<0.05 considered 
as significant) shows any significant difference between CVI42 and CIMTag2D software 
packages for hypertensive patients. The significance level is unadjusted for multiple 
comparison. 
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Principal components analysis (PCA) was performed on the entire 90 subjects from the 
HAPPY London Study to reduce the number of variables, from the 72 original, generated 
by CVI42 software.  
PCA was performed to reduce the number of variables to dimensions or components, so 
that the data can be more easily interpreted, and these components were treated as 
ordinary variables. PCA showed 9 variables loaded on four principal components called 
PC1, PC2, PC3, and PC4. The mid ventricle short axis radial strain and radial strain rate, 
the 2-chamber radial strain and radial strain rate, and the 4-chamber radial strain and 
radial strain rate and 4-chamber longitudinal strain rate explain 71.9 % of the total CVI42 
software derived variables variance; the first component, PC1, explains 21.2 %, the 
second, PC2, explains 18.2 %, the third, PC3, explains 17.2 %, and the forth, PC4, 
explains 15.3 %.  
Each component has a score which is the sum of its variables. Those variables plot 
against the component score to show the correlation coefficient for each variable for 
example the first component, the variable reverse peak for global radial strain rate for 4-
chamber which showed highest correlation coefficient (-0.807) which has a negative 
correlation as shown in Table 6.8.   
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Table 6.7: Summary of CVI42 and CIMTag2D strain parameters. Data is presented as mean ± 
standard deviation (SD), red cells = significant difference (p<0.05). 
Strain (%) CVI42 CIMTag2D 
Healthy Hypertensive Healthy Hypertensive 
Circumferential  Mid SAX  
Global -19.40 ±2.63 
-20.22 
±2.94 
-19.77 
±2.43 
-19.25 
±2.67 
Endo -20.82 ±2.72 
-21.78 
±3.15 
-24.69 
±3.15 
-24.04 
±3.16 
Epi -18.03 ±2.67 
-18.6 
4±2.69 
-14.92 
±2.13 
-14.59 
±2.48 
Radial  
Mid 
SAX 
Global 33.88 ±7.87 
37.79 
±10.01 
28.13 
±14.28 
30.56 
±8.45 
Endo 38.21 ±8.82 
43.13 
±12.13 
26.66 
±24.25 
27.94 
±9.70 
Epi 30.03 ±7.34 
32.76 
±8.09 
34.56 
±13.49 
36.05 
±11.19 
2ch 
LAX 
Global 33.58 ±8.84 
36.39 
±9.30 
25.28 
±13.76 
25.89 
±11.27 
Endo 33.93 ±10.05 
36.47 
±9.96 
28.11 
±16.56 
26.93 
±13.39 
Epi 33.82 ±8.32 
36.42 
±9.11 
23.07 
±11.66 
25.79 
±10.71 
4ch 
LAX 
Global 35.96 ±7.63 
36.08 
±9.59 
27.74 
±15.23 
26.19 
±11.58 
Endo 37.09 ±8.74 
36.58 
±9.66 
33.32 
±18.92 
30.19 
±17.46 
Epi 37.41 ±8.80 
36.67 
±10.75 
23.15 
±12.93 
23.53 
±9.36 
Longitudinal  
2ch 
LAX 
Global -18.12 ±2.38 
-19.03 
±2.59 
-15.48 
±3.00 
-14.09 
±2.17 
Endo -18.17 ±2.44 
-18.95 
±2.78 
-16.35 
±3.35 
-15.17 
±2.60 
Epi -18.38 ±2.44 
-19.16 
±2.56 
-14.55 
±3.01 
-12.81 
±2.15 
4ch 
LAX 
Global -18.55 ±2.22 
-18.42 
±2.62 
-15.96 
±2.24 
-14.92 
±2.03 
Endo -18.74 ±2.34 
-18.57 
±2.65 
-16.08 
±2.64 
-15.19 
±2.53 
Epi -19.23 ±2.54 
-18.53 
±2.81 
-15.70 
±2.18 
-14.08 
±2.06 
Endo = Endocardial, Epi = Epicardial, SAX = short axis, LAX= long axis, ch = chamber. 
There was no significant difference between systolic blood pressure and diastolic blood 
pressure with the components PC1, PC2, PC3 and PC4 as shown in Table 6.9. The 
relationships between the components PC1, PC2, PC3 and PC4 and categorical variables 
were examined by using independent samples t-tests, as shown in Table 6.10. PC2 score 
was significantly higher in hypertensive and those on hypertensive treatment than healthy 
or untreated subjects. 
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Table 6.8: Rotated component matrix including four components: each component has variables 
associated with each another. 
Components variables 
Component 
PC1 PC2 PC3 PC4 
SAM-Radial strain-peak-global  0.796   
SAM-Radial strain rate-reverse peak-global  -0.784   
2ch-Radial strain-peak-global   0.840  
2ch-Radial strain rate-peak-global   0.794  
4ch-Radial strain-peak-global 0.776    
4ch-Radial strain rate-peak-global 0.728    
4ch-Radial strain rate-reverse-peak-global -0.807    
4ch-Longitudinal strain rate-peak-global    -0.901 
4ch-Longitudinal strain rate-reverse peak-global  -0.441  0.652 
SAM = mid short axis, 2ch = 2-chamber long axis and 4ch = 4-chamber long axis 
 
Figure 6.4: Example of a strain measurement (global, endocardial or epicardial) with one 
peak and reverse peak. 
Figure 6.4 illustrates the negative strain curve for longitudinal strain parameters; the 
reverse peak represents the length of the left ventricle at the end-systolic phase compared 
to the length of left ventricle at the end-diastole phase. Negative strain (reverse peak) is 
caused by the shortening of the left ventricle. Strain (%) can be calculated as the 
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difference between the length at the end-systole and to the length at end-diastole. 
Epicardial longitudinal strain shows shortening in the end-systole (negative value) 
compared to the end-diastole. 
Figure 6.5 showed the four variables that exhibited significant discrimination between 
hypertensive and healthy subjects in CIMTag2D, i.e. with a lower confidence interval 
being above 0.5 (an area of 0.5 would indicate no discrimination). The areas under the 
ROC curve ranged from 0.66 (95% (confidence Interval (CI)) CI: 0.53-0.80) to 0.75 (95% 
CI: 0.63-0.86) for these four variables indicating moderate discrimination. Figure 6.6 
showed that no variables exhibited significant discrimination in CVI42 with the highest 
ROC areas ranged from 0.61 (95% CI: 0.49-0.74) to 0.62 (95% CI: 0.49-0.74) for both 
global and epicardial longitudinal strain for 2-chamber as well as for global and 
endocardial radial strain for mid ventricle short axis. 
The lowest ROC area is 0.66 for CIMTag2D and the highest is 0.62 for CVI42 so all the 
CIMTag2D results are higher. The lower confidence intervals are all above 0.5 for 
CIMTag2D indicating significant discrimination. The lower confidence intervals are 0.49 
for the CVI412 results, which are therefore not significant, as results with a confidence 
interval which includes 0.5 do not differ significantly from the diagonal line (black line, 
ROC area =0.5) where there is no discrimination between the two groups. 
 
             Table 6.9: Spearman’s correlation between principle component analysis (PCA). 
Parameters PC1 PC2 PC3 PC4 
Systolic-BP 
Correlation coefficient 0.06 0.04 -0.01 -0.09 
p-value 0.56 0.72 0.93 0.39 
Diastolic-BP 
Correlation coefficient 0.01 -0.02 -0.17 -0.08 
p-value 0.96 0.84 0.12 0.49 
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Table 6.10: The results for independent samples tests between demographic categorical variables 
with principal component analysis: PC1, PC2, PC3, and PC4 for 90 healthy subjects and 
hypertensive patients. Red cell = statistical difference, SD = standard deviation. 
Parameters 
Gender Hypertension Hypertension treatment Diabetes 
Groups Mean ±SD Groups 
Mean 
±SD Groups 
Mean 
±SD Groups 
Mean 
±SD 
PC1 
Male -0.08 ±0.84 Hypertensive 
-0.004 
±1.06 Yes 
0.13 
±1.08 Diabetic 
0.004 
±1.13 
Female 0.22 ±1.33 Healthy 
0.01 
±0.87 No 
-0.16 
±0.88 
Non-
Diabetic 
-0.001 
±0.98 
PC2 
Male -0.11 ±0.91 Hypertensive 
0.1 
±0.99 Yes 
0.19 
±0.97 Diabetic 
0.29 
±0.92 
Female 0.30 ±1.18 Healthy 
-0.39 
±0.90 No 
-0.23 
±1.00 
Non-
Diabetic 
-0.72 
±1.01 
PC3 
Male 0.08 ±1.05 Hypertensive 
0.09 
±1.06 Yes 
0.17 
±1.12 Diabetic 
0.17 
±0.99 
Female -0.22 ±0.82 Healthy 
-0.19 
±0.86 No 
-0.19 
±0.79 
Non-
Diabetic 
-0.04 
±1.01 
PC4 
Male -0.07 ±0.95 Hypertensive 
-0.12 
±0.98 Yes 
-0.10 
±1.03 Diabetic 
0.17 
±1.15 
Female 0.19 ±1.12 Healthy 
0.26 
±1.01 No 
0.12 
±0.96 
Non-
Diabetic 
-0.04 
±0.97 
 
Figure 6.5: Area under curve for CIMTag2D deformation parameters to discriminate 
between hypertensive and healthy cardiac state.  
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Figure 6.6: Area under curve for CVI42 deformation parameters to discriminate between 
hypertension and healthy cardiac state. 
6.4 Discussion 
This chapter compared FT to tagging, regarded as gold standard method (8), in both 
healthy subjects and large cohort of hypertensive patients. This chapter included the 
circumferential strain derived only from mid ventricle short axis level and longitudinal 
strain from 2-chamber and 4-chamber as those variables had a good agreement across all 
the three FT software packages in chapter 5. Chapter 5 showed that CVI42 had the 
highest reproducibility of the 3 FT software packages and consequently was the only one 
used for the FT analysis.  
6.4.1 Reproducibility 
Reproducibility for CIMTag2D showed better intra-observer compared to inter-observer 
agreement. The reproducibility for CVI42 for inter- and intra-observer showed to be 
better compared to CIMTag2D. In previous studies, FT and tagging technique results 
found that strain in radial direction showed wide limits of agreement with high variability 
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irrespective of the software technique used as shown in published articles (30)(45). 
Within this limit, circumferential and longitudinal strain showed the narrowest limit of 
agreement. So it is evident that circumferential strain results derived by FT and tagging 
showed low variability, and can thus be considered as a reliable parameter to consider in 
future research studies, as observed in previous studies (87)(30).  
6.4.2 Comparison between techniques 
There were significant differences between CVI42 and CIMTag2D in both groups, 
however, overall healthy subjects showed a better agreement. A number of factors might 
have influenced the observed differences including image quality, temporal and spatial 
resolution and other factors such as population size, age and gender (91)(92). It might be 
worth highlighting that slice positions of the SSFP and tagged images were similar but 
not identical. 
A few parameters did not significantly vary between CIMTag2D and CVI42 in both 
groups in particular global circumferential strain and epicardial radial strain from the 
mid-ventricle short axis, and endocardial radial strain from the 4-chamber view. 
Circumferential strain for mid ventricle is considered to be the most reproducible 
parameters compared to apical and basal level in FT studies and tagging studies 
(8)(60)(62). Most published studies agreed that circumferential strain parameters are the 
most reliable irrespective of technique or software (8)(30)(67). A study comparing FT to 
CIMTag2D in 145 healthy subjects of which only 20 subjects with tagging images, noted 
a good agreement between techniques for circumferential strain while, FT overestimated 
radial and longitudinal strains, the subjects size was different between FT and tagging in 
this study (30). Another study in 35 healthy subjects, reported a good agreement for 
circumferential and longitudinal strain (45). In agreement with a previous study (8), 
global circumferential strain for mid ventricle short axis had a good correlation in healthy 
subjects. In this chapter, FT overestimated most parameters in both groups, which is in 
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line with previous study which noted that the radial strain results was overestimated by 
FT (30). 
6.4.3 Normal Ranges 
Normal range for strain parameters have been published in 2 meta-analysis. In the first 
one, based on echocardiography data, normal ranges were: global circumferential strain 
(GCS) [-20.9, -27.80]% (mean=-23.3%), global longitudinal strain (GLS) [-15.9, -22.1]% 
(mean=-19.7%), global radial strain (GRS) [35.10, 59] (mean=47.3%) (93). In the second, 
based on FT analysis, the minimum and maximum strain means for GCS  were -17 to -
25%, GLS -19 to -24%, GRS 15 to 51% (72). However, in this chapter the range values 
for GCS (-13.92 to -23.78%), GLS (-11.62 to -24.36%) and GRS (19.93 to 61.35%) by 
FT. However, the range values generated in this chapter for GCS (-14.53 to -23.90%) 
CLS (-5.98 to -23.36%) and GRS (9.81 to 74.42%) by tagging technique. Our healthy 
strain ranges showed that the maximum values for GRS were higher than the published 
ranges by echocardiography and FT, and published normal range vary also from 
echocardiography and published normal for FT derived from different articles (93)(72). 
The minimum value for GCS and GLS is much lower than the previous articles, whereas 
the maximum values of GCS and GLS were within the published range (93)(72). 
Considering those variations in normal values, researchers should be encouraged to 
include control subjects in their studies. 
6.4.4 Gender comparison 
Regarding gender, both software could differentiate between healthy male and female; 
epicardial radial strain for 2-chamber and global, endocardial and epicardial longitudinal 
strain for 4-chamber were significantly higher for female than male. This result could 
have been affected by the smaller female sample size. A previous study showed that 
radial velocity and radial displacement measured by CMR-FT were higher in males than 
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females, the study involved a larger population size (males=54, females=62) (30). 
Another study found that males showed a higher radial strain than female whereas the 
circumferential and longitudinal strains were lower in males (males=75, females=75) 
(91). 
6.4.5 Differences between groups 
In this chapter, FT did not show any significant difference between healthy subjects and 
hypertensive patients, but longitudinal strain measured using tagging could discriminate 
between groups. This is consistent with previous studies that reported reduction in 
longitudinal and circumferential strain (80), and reduction in longitudinal, circumferential 
and radial strain (81). Dysfunction of longitudinal contractility in hypertensive patients 
has also been previously reported (82).  Several studies found that decreased longitudinal 
strain is a sensitive predictor for early detection of sub-clinical LV dysfunction than left 
ventricle ejection fraction (94)(95)(96). Longitudinal strain is considered to be a strong 
and independent predicator for heart failure admission and increased mortality (96). 
Longitudinal fibers are mainly subendocardial and subepicardial, hence the GLS was 
considered to be a useful strain parameter in echocardiography strain quantification (85). 
With regards to systolic and diastolic blood pressures, results in this chapter showed a 
weak reverse correlation with radial strain and strain rate from mid-ventricle and 2-
chamber and longitudinal strain rate for 4-chamber. A previous study in 272 patients also 
reported an inverse correlation of systolic blood pressure with global longitudinal strain 
demonstrated the reduction in strain with increased afterload (97). The inverse correlation 
noted in our study may be because hypertensive conditions induce a compensatory 
thickening of the ventricular wall in an attempt to normalize wall stress which result in 
decreases of the contractility of longitudinal fibers (21). 
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6.5 Conclusion 
This chapter compared FT (CVI42) and tagging (CIMTag2D) analyses to calculate 
myocardial deformation parameters from CMR images in a large cohort of healthy 
subjects and hypertensive patients. In this chapter only the CVI42 FT software was used 
since it showed the best reproducibility among the three software (Tomtec, CVI42 and 
CIM-FT) in chapter 5. Most of the limitations of chapter 5 were removed (cohort size, 
imaging protocol, age match), however, the two populations were not matched in term of 
size and gender. 
 A number of important conclusions can be drawn from this chapter. Firstly, tagging 
analysis with CIMTag2D software (version 8.1.5) showed good inter- and intra- observer 
reproducibility with the best intra reader agreement for two-chamber endocardial 
longitudinal strain and the best inter-reader agreement for global circumferential strain for 
the basal short axis. However, FT, CVI42 software (release 5.1.1) showed the lowest bias 
and standard deviation for circumferential, radial and longitudinal strain parameters in 
comparison to CIMTag2D for intra-agreement. CVI42 had the best inter-agreement for 
circumferential and radial strain parameters for short axes in comparison to CIMTag2D. 
Secondly, there were significant differences for most measured parameters obtained 
between healthy subjects and hypertensive patients for both FT (CVI42) and tagging 
(CIMTag2D). The only parameters not to exhibit statistically significant differences in 
both groups were global circumferential strain for mid ventricle short axis, epicardial 
radial strain for mid ventricle short axis and endocardial radial strain for 4-chamber. 
Thirdly, both FT (CVI42) and tagging (CIMTag2D) could differentiate between healthy 
male and female subjects; 2-chamber epicardial radial strain and 4-chamber global, 
endocardial and epicardial longitudinal strain were significantly higher in females for 
both techniques apart from epicardial radial strain for 2-chamber by CIMTag2D which 
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was significantly higher in male than female. 
Finally, there were significant differences in longitudinal strain calculated from tagged 
images; it was lower in hypertensive patients. No significant differences could be found 
for individual parameters calculated with FT (CVI42), however when FT parameters 
were analysed using PCA. A component combining mid ventricle short axis radial strain 
parameters and 4-chamber longitudinal strain rate parameters showed a significant 
difference between hypertensive and non-hypertensive patients. Giving the low 
agreement between both software packages noted in this study, determining a 
reproducible reference cut off for a single or group of parameters remains challenging at 
this stage. At present, in the absence of standardisation, it might be recommendable for 
each group to obtain healthy reference values for their set-up (specific combination of 
imaging protocol and analysis method).  
Alternatively, a numerical phantom, as explored in the next chapter, could be used to 
compare values between software packages to facilitate comparison between sites/studies. 
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Chapter 7: Development of Numerical 
Phantoms for FT Validation 
7.1 Introduction 
Feature tracking was evaluated by comparing three software packages in chapter 5. 
Furthermore, in chapter 6, the most reproducible software was compared to MR-tagging, 
an established method to assess cardiac deformation (87), and applied to a larger cohort. 
The results showed great variability, and significant differences, in most strain parameters 
derived from the three FT software packages, as well as between FT and tagging. 
However, in chapter 5, there were a good agreement for mid-ventricle short axis 
circumferential strain and to a lesser extend for longitudinal strain. In chapter 6, the best 
agreement between FT and tagging was for mid-ventricle global circumferential strain 
followed by 2-chamber global longitudinal strain. 
As discussed in chapter (review), other research studies have demonstrated the potential 
usefulness of FT tracking parameters to differentiate between healthy subjects and CVD 
patients (50)(98)(51). However, there are no publications reporting the clinical 
implementation and reliability of measured deformation parameters obtained from the FT. 
The variability observed in the previous chapters clearly highlights the difficulties of 
using those parameters in the clinic. The only reliable way to establish why observed 
parameters vary between software would be to use a gold standard numerical model 
(3)(99). This need is further compelled by the fact that FT commercial software packages 
algorithms are not readily available to understand the sources of potential differences.  
The aim of this chapter was to design simplified numerical simulation where all motion 
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and deformation parameters are known and can be calculated analytically; this will serve 
as a gold standard for FT techniques validation. The gold standard validation is to use a 
numerical model to verify accuracy of the deformation measurements derived by FT 
software against the known motion of that numerical simulation calculated from 
mathematical equations. 
The theoretical motion and strain values of the numerical phantom were compared to the 
experimental results measured using the FT software packages. In order to achieve this 
goal, several numerical simulations of left ventricle short axis and long axis simulation 
models of gradual complexity were implemented.  
7.2 Method  
All numerical simulation images were carried out with the Matlab programming language 
(MathWorks, Natick, MA, USA). Series of synthetic DICOM images mimicking a 
simplified left-ventricular (LV) motion model were generated and saved for subsequent 
FT analysis. A radial movement in the short axis view, and radial and longitudinal 
movements in the long axis model view were modelled. The numerical simulations 
consisted of short axis and long axis cine frames generated using different myocardial 
intensity patterns, i.e. uniform, radial, and circular checkerboard.  
 The short axis endocardial and epicardial borders were generated by plotting two 
concentric circles, resulting in an annulus representing the myocardium. The endocardial 
border is represented by a circle C"#$%  (equation 1) where its radius &'($)(*"#$% (t)	varies 
through the cardiac cycle following a cosine function (equation 2). The epicardial border 
is represented by a circle /"0) (equation 3) where its radius &'($)(*"0) (t)	varies through the 
cardiac cycle following a cosine function (equation 4). Radii (mm) are expressed as a 
function of time t (ms), where t takes the values 1, 2…T, with T the heartbeat period. T 
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was set to 1000 ms (heartrate of 60 bpm) in the simulations. 
C"#$%: x − x4 5+ y − y4 5 = &'($)(*"#$% t   (1) 
&'($)(*"#$% (t) 	= − (&9(:"#$% + &9)#"#$%)2 + (&9(:"#$% − &9)#"#$%)2 × cos 2@AB  (2) /"0):	 x − x4 5+ y − C4 5 = &'($)(*"0) (t) (3) 
&'($)(*"0) (t) 	= − (&9(:"0) 	+ 	&9)#"0)2 + (&9(:"0) 	− 	&9)#"0)2 × cos 2@AB  (4) 
 
Figure 7.1: The short axis simulation model with endocardial border with &'($)(*"#$%  radius 
and epicardial border with &'($)(*"0)  radius inside a matrix of (Nx ×	Ny). Ibg, Imyo and Ibp 
represent the image signal intensities of background, myocardium and blood pool regions 
respectively. 
Circles are concentric with centre image coordinates of x0 and y0. The x and y coordinate 
can vary from 1 to Nx,y with Nx and Ny equals to the image matrix size (Figure 7.1). The 
maximum and minimum values represent the endocardial and epicardial radial and 
longitudinal radii expansion and contraction at end-diastole and end-systole respectively. 
The endocardial and epicardial radial and longitudinal motions are controlled by a set of 
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parameters given in Table 7.1 while the other image parameters are given in Table 7.2. 
Equations 2 and 4 give &'($)(*"#$% (t) and &'($)(*"0) (t) as a function of time, expressed as a 
cosine function. There is a continuous variation in the radii of both circles and by using 
the parameters in Table 7.1, the displacement for &'($)(*"#$% (t)  and &'($)(*"0) (t)  can be 
expressed as:  
D'($)(*"#$% (A) 	= − (&9(:"#$% + &9)#"#$%)2 + (&9(:"#$% − &9)#"#$%)2 × cos 2@AB − (&9(:"#$% + &9)#"#$%)2 + (&9(:"#$% − &9)#"#$%)2 × cos 2@0B  (5) 
D'($)(*"0) (t) 	= − (&9(:"0) 	+ 	&9)#"0)2 + (&9(:"0) 	− 	&9)#"0)2 × cos 2@AB − (&9(:"0) 	+ 	&9)#"0)2 + (&9(:"0) 	− 	&9)#"0)2 × cos 2@0B  (6) 
The analytical radial displacement values from equations 5 and 6 are negative and the 
positive direction of motion was selected as shown in Figure 7.1 and 7.2, in order to 
match the direction of motion used by the FT software packages (100).  
 
Figure 7.2: Long axis simulation model endocardial border with &'($)(*"#$% and &*%#F)GH$)#(*"#$%  
radii and epicardial border with &'($)(*"0) and &*%#F)GH$)#(*"0)   radii inside a matrix of (Nx 
×	Ny). Ibg, Imyo and Ibp represent the image signal intensities of background, myocardium 
and blood pool regions respectively. 
 137 
Table 7.1: Parameters used to define the simulation short and long axis; the maximum 
and minimum values for endocardial and epicardial, radial and longitudinal radii 
represents the radii at end-diastole and end-systole. The parameters values measured 
from images of a healthy patient. 
Parameters Short axis model Long axis model 
Time (ms) 
Max 950 950 
Min 0 0 &'($)(*"#$% (t) (mm) Max 25 55 Min 15 48 &'($)(*"0) (t) (mm) Max 30 68 Min 27 60 &*%#F)GH$)#(*"#$% (A) (mm) Max NA 100 Min NA 84 &*%#F)GH$)#(*"0) (A) (mm) Max NA 105 Min NA 90 
 
The endocardial and epicardial borders of long axis model were generated by plotting two 
concentric semi-ellipses; LAX1 and LAX2 (Figure 7.2). The variations of those two 
semi-ellipses through the cardiac cycles are given by the following set of equations: 
LAX1 ∶ 	 NON4 P'QRSTRUVWSX (G)P + (YOY4)P'UXWZT[\STWRUVWSX (G)P =           (7) 
		&'($)(*"#$% t = − (&]^_`aDb + &]ca`aDb)2 + (&]^_`aDb − &]ca`aDb)2 × cos 2@AB 	  (8) 
&*%#F)GH$)#(*"#$% A = (&]^_`aDb + &]ca`aDb)2 + (&]^_`aDb − &]ca`aDb)2 × cos 2@AB  (9) 
LAX2 ∶ 	 x − x0 5&'($)(*"0) (A)5 + (y − y0)5&*%#F)GH$)#(*"0) (A)5 = 1 (10) &'($)(*"0) t = − (&]^_`dc 	+ 	 &]ca`dc2 + (&]^_`dc 	− 	&]ca`dc2 × cos 2@AB 	  (11) 
&*%#F)GH$)#(*"0) A = (&]^_`dc 	+ 	 &]ca`dc2 + (&]^_`dc 	− 	&]ca`dc2 × cos 2@AB 	 	 (12) 
The endocardial and epicardial radial and longitudinal motions for the long axis model 
are controlled by a set of parameters given in Table 7.1.  
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Table 7.2: Image parameters for the short and long axis simulations. 
Parameters Short axis and long axis images 
Nx 360 
Ny 360 
Spatial resolution (mm) 1 
Temporal resolution (ms) 50 
Number of cardiac phases 20 
 
The endocardial and epicardial radial and longitudinal displacements follow the form of 
equations 5 and 6. 
In the short axis model, the derived endocardial and epicardial radial motion parameters 
are the displacement and velocity, while the radial deformation parameters, strain and 
strain rate, are derived from the endocardial and epicardial radial radii &'($)(*"#$% (t) and &'($)(*"0) (t)  in equations 2 and 4 shown as analytical values in Table 7.3. The results 
include endocardial and epicardial displacement measured in mm, velocity measured in 
mm/s, strain in % and strain rate in %/s. The endocardial and epicardial radial velocities e'($)(*"#$% A  and e'($)(*"0) A  in equations 13 and 14, are the derivatives of &'($)(*"#$% (t) and &'($)(*"0) t , respectively, with respect to time measured in (mm/s) (3). 
e'($)(*"#$% A = $'QRSTRUVWSX (g)$G = 10@	 sin(5jGk )  (13) e'($)(*"0) A 	= D&'($)(*"0) (t)DA = 3@	 sin(2@AB ) (14) 
The endocardial and epicardial radial strain are calculated from equations 15 and 16 and 
expressed in %. 
S'($)(*"#$% (t) = 100×	 &'($)(*"#$% (t) − &'($)(*"#$% (0)	&'($)(*"#$% (0)  (15) S'($)(*"0) (t) = 100×	 (&'($)(*"0) (t) − &'($)(*"0) (0)&'($)(*"0) (0)  (16) 
The endocardial and epicardial radial strain rate equations, n&'($)(*"#$% A  and n&'($)(*"0) A , 
respectively, are measured in %/s as follow (3): 
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n&'($)(*"#$% A = 	100× e'($)(*"#$% A&'($)(*"#$% (t)  (17) n&'($)(*"0) A = 100×	oQRSTRUVpT G'QRSTRUVpT (g)  (18) 
In the long axis model, the endocardial and epicardial radial and longitudinal motion and 
deformation parameters are derived from &'($)(*"#$% (t) , &*%#F)GH$)#(*"#$% A ,  &'($)(*"0) (t) , &*%#F)GH$)#(*"0) (A). The endocardial and epicardial radial velocities e'($)(*"#$% A  and e'($)(*"0) A  
(equations 19 and 20) are the derivatives of &'($)(*"#$% (t) and &'($)(*"0) (t) with respect to time 
and measured in mm/s (3), the endocardial and epicardial radial strain are shown in 
equations 21 and 22. 
e'($)(*"#$% (t) = D&'($)(*"#$% (t)DA = 	7@ sin 2@AB  (19) e'($)(*"0) (t) = D&'($)(*"0) (t)DA = 8@	 sin 2@AB  (20) n&'($)(*"#$% t = 100×	e'($)(*"#$% t&'($)(*"#$% t  (21) n&'($)(*"0) (t) = 100×	e'($)(*"0) (t)&'($)(*"0) (t)  (22) 
The endocardial longitudinal velocity is calculated from equation 23, while the epicardial 
longitudinal velocity is calculated from equation 24 and measured in mm/s: 
e*%#F)GH$)#(*"#$% (A) = D&*%#F)GH$)#(*"#$% (A)DA = −16	@ sin(2@AB )	 (23) e*%#F)GH$)#(*"0) (A) = D&*%#F)GH$)#(*"0) (A)DA = −15	@sin(2@AB )	 (24) 
The endocardial and epicardial longitudinal strain are calculated from equations 25 and 
26 and measured in %. 
S'($)(*	*%#F)GH$)#(*"#$% (t) = 100×	 'UXWZT[\STWRUVWSX (G)O'UXWZT[\STWRUVWSX (4)'UXWZT[\STWRUVWSX (4)   (25) 
S*%#F)GH$)#(*"0) (t) = 100×	 &*%#F)GH$)#(*"0) (A) − &*%#F)GH$)#(*"0) (0)&*%#F)GH$)#(*"0) (0) 	 (26) 
Finally, the endocardial and epicardial longitudinal strain rates are calculated from 
equations 31 and 32, respectively, and measured in %/s. 
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n&*%#F)GH$)#(*"#$% (A) = 100×	oUXWZT[\STWRUVWSX (G)'UXWZT[\STWRUVWSX (G)  (31) n&*%#F)GH$)#(*"0) A = 100× e*%#F)GH$)#(*"0) (A)&*%#F)GH$)#(*"0) (A)  (32) 
For all models, analytical values, calculated from the motion equations, were compared to the 
experimental results from the FT software packages. Errors (%) were calculated as the root mean 
square of the difference between the analytical and the experimental values: 
u = 100× n A − n4(A) 5nA4(A) 5 v5 (33) 
Where n4(t) is the analytical value of a variable of interest (such as displacement, strain, or strain 
rate), and n A  is the corresponding measured value (101)(102).  
However, the analytical circumferential parameters were zero and consequently, the errors for 
circumferential parameters were calculated from equation 34. 
uw)'wH9x"'"#G)(*	 = n A − n4(A) 5 yP  (34) 
 
The first major contribution is I have extended the simulation model to include a long 
axis model to validate feature tracking which has not been done before to the best of our 
knowledge. The difference between the equations for short axis model used to validate 
the Tomtec software (3), and the modified equations are the inclusion of a new long-axis 
phantom model and the use of more realistic radii parameters to represent the real 
dimensions of the human heart in both the short-axis and long axis views. These real 
dimensions of the human heart are essential for development of software in short axis and 
long axis models. The introduction of endocardial and epicardial radii from real images as 
shown in Table 7.1, is to give the FT software a more human-like model to import into 
the FT software and analyse. The second major contribution is the introduction of 
different complex patterns of myocardial tissue which has not been explored previously 
(3)(99). These patterns were used to assess the accuracy of the derived results from FT 
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software packages with increasing levels of patterns complexity, and compare them to the 
uniform models in section 7.3. 
7.3 Uniform Model 
 
Figure 7.3: Example images from the uniform short axis model, the end-diastole on (left-
hand side), and the end-systole on (right-hand side). 
The first model was created with uniform intensity and no pattern in the myocardium. For 
this model, both short and long axis images were generated and analysed with two FT 
packages, Tomtec and CVI42. 
7.3.1 Method 
The images were created following the methodology developed in section 7.2. 
 
Figure 7.4: Example images from the uniform long axis model, the end-diastole on (left-
hand side), and the end-systole on (right-hand side). 
The images for both, short axis and long axis models were composed of three intensity 
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defining three regions. First, the background intensity Ibg was set to zero. Second, the 
intensity in the annulus, representing the myocardial tissue was Imyo >0. The intensity 
appears as grey on the images. Finally, the blood pools were set to Ibp> Imyo and appears 
bright to mimic in vivo bSSFP images (Figure 7.1 and 7.2). The images were loaded in 
the software and analysed following the method described in Chapter 4. Example images 
of the with CVI42 analysis are displayed in Figure 7.5. Statistical analysis is described in 
Chapter 4 section. 
7.3.2 Results and Discussion 
The uniform short axis and long axis models results, derived from Tomtec and CVI42, as 
well as the errors between the peak values and overall curves are shown in Table 7.3 and 
Table 7.4; an error <10% can be considered to be acceptable (3). Example plots of the 
global parameters throughout the cardiac cycle for the short and long axis models are 
given in Figure 7.6. 
  
Figure 7.5: CVI42 FT tracking of the uniform short-axis (left-hand side) and long axis model 
(right-hand side) at frame 11 (systole). The green points show the tracking trajectory for the 
epicardial contour, whereas the red points show the tracking trajectory for the endocardial 
contour. A non-modelled circumferential motion (rotation) can be observed in the sort axis view.  
The parameters to consider predominantly for comparison are displacement and strain. As 
velocity and strain rate are the derivatives of those two measurements, their errors will be 
amplified and higher than the errors for displacement and strain (3).  
Overall, both software performed poorly when analysing the uniform models and were 
 143 
ever hardly in agreement between them for global measurements; the only time was for 
circumferential strain but they were both incorrect. 
Displacement: 
Tomtec was the most accurate for radial displacement and was within 10% of the 
expected peak value for both models. The overall error was also within 10% for the short 
axis model and the curves were closely matched throughout the cardiac cycle (see Figure 
7. 6A). Thanks to this good performance in measuring radial displacement, Tomtec was 
also accurate in assessing radial velocity in the short axis model. Although, CVI42 
produced radial displacement curves with a more accurate overall appearance, especially 
on the long axis model, this software overestimated displacement by 16.9% for the short 
axis model and 24% for the long axis. 
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Table 7.3: Experimental and analytical values for global, endocardial and epicardial parameters 
using the uniform short axis model. Errors expressed in percentage (%) except for the 
circumferential parameters were the errors have corresponding units. Green cells = FT in 
agreement with analytical value (less than or equal to10% difference in peak value or less than or 
equal to 10% in error), yellow cells = 10% or less in difference in peak value between software. 
Parameters 
Experimental 
results Analytical 
values 
Difference in 
peak value (%) Errors 
Tomtec CVI42 Tomtec CVI42 Tomtec CVI42 
Radial  
displacement 
(mm) 
Endo P 6.8 7.9 10.0 -32.0 -21.0 31.3 21.3 
Epi P 5.8 7.1 3.0 93.3 136.7 99.4 137.2 
G P 6.3 7.6 6.5 -3.1 16.9 2.4 16.4 
Radial velocity 
(mm/s) 
Endo 
P 
RP 
23.1 31.2 31.0 -25.5 0.6 
30.3 26.2 
-20.9 -31.2 -31.0 32.6 -0.6 
Epi 
P 
RP 
19.3 28.1 9.0 114.4 212.2 
104.0 150.6 
-20.2 -28.1 -9.0 -124.4 -212.2 
G 
P 
RP 
21.2 29.8 20.0 6.0 49.0 
8.3 166.2 
-20.5 -29.8 -20.0 -2.5 -49.0 
Radial strain 
(%) 
Endo P NA 51.9 40.0 NA 29.8 NA 22.8 
Epi P NA 38.4 10.0 NA 284.0 NA 259.5 
G P 20.4 45.5 25.0 -18.4 82.0 33.3 69.1 
Radial strain 
rate  
(%/s) 
Endo 
P 
RP 
NA 
NA 
195.7 127.0 NA 
NA 
54.1 
NA 53.8 
-195.7 -127.0 -54.1 
Epi 
P 
RP 
NA 
NA 
139.0 31.5 NA 
NA 
341.3 
NA 308.5 
-139.0 -31.5 -341.3 
G 
P 
RP 
65.1 170.5 79.0 -17.6 115.8 
58.6 102.4 
-77.0 -170.5 -79.0 2.5 -115.8 
Circumferential  
displacement 
(deg) 
Endo RP -0.1 -0.5 0 ND ND 7.2 1.3 
Epi RP -0.1 -0.5 0 ND ND 26.6 1.2 
G RP -0.1 -0.5 0 ND ND 15.9 1.2 
Circumferential  
velocity  
(deg/s) 
Endo 
P 
RP 
26.1 
-20.9 
4.2 
-10.5 
0 
0 
ND 
ND 
ND 
ND 
61.6 12.5 
Epi 
P 
RP 
38.5 
-57.4 
4.1 
-10.1 
0 
0 
ND 
ND 
ND 
ND 
112.9 11.9 
G 
P 
RP 
23.1 
-31.6 
4.1 
-10.2 
0 
0 
ND 
ND 
ND 
ND 
65.7 12.1 
Circumferential  
strain  
(%) 
Endo RP -26.0 -25.4 0 ND ND 72.0 71.2 
Epi RP -18.3 -21.7 0 ND ND 52.1 60.8 
G RP -22.2 -23.7 0 ND ND 62.0 66.3 
Endo = endocardial, Epi = epicardial, G = global, P = peak, RP = reverse peak, NA = not 
available, ND = not defined. 
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Table 7.4: Experimental and analytical values for global, endocardial and epicardial parameters 
using the uniform long axis model. Errors expressed in percentage (%). Green cells = FT in 
agreement with analytical value (less than or equal to10% difference in peak value or less than or 
equal to 10% in error), yellow cells = 10% or less in difference in peak value between software. 
Parameters 
Experimental 
results Analytical  
values 
Difference in 
peak value (%) Error (%) 
Tomtec CVI42 Tomtec CVI42 Tomtec CVI42 
Radial  
displacement 
(mm) 
Endo P 6.3 9.5 7.0 -10.0 35.7 15.1 34.2 
Epi P 9.3 9.1 8.0 16.3 13.8 23.9 12.6 
G P 7.8 9.3 7.5 4.0 24.0 17.0 23.1 
Radial  
velocity 
(mm/s) 
Endo P RP 
33.7 29.2 22.0 53.2 32.7 
60.7 39.9 
-31.4 -29.2 -22.0 -42.7 -32.7 
Epi P RP 
37.5 28.5 25.0 50.0 14.0 
41.7 21.8 
-36.3 -28.5 -25.0 -45.2 -14.0 
G P RP 
35.6 28.9 24.0 48.3 20.4 
47.4 30.0 
-32.7 -28.9 -24.0 -36.3 -20.4 
Radial  
strain 
(%) 
Endo P NA 11.9 12.7 NA -6.3 NA 17.2 
Epi P NA 10.1 11.8 NA -14.4 NA 19.8 
G P -19.9 11.0 12.2 -263.1 -9.8 219.3 16.9 
Radial  
strain rate 
(%/s) 
Endo P RP 
NA 47.3 43.0 NA 10.0 
NA 30.2 
NA -47.3 -43.0 NA -10.0 
Epi P RP 
NA 43.1 39.0 NA 10.5 
NA 24.7 
NA -43.1 -39.0 NA -10.5 
G P RP 
138.0 45.5 41.0 236.6 11.0 
314.0 26.6 
-144.0 -45.5 -41.0 -251.2 -11.0 
Longitudinal  
displacement  
(mm) 
Endo RP -9.8 -1.6 -16.0 38.8 90.0 66.6 90.8 
Epi RP -6.6 -1.8 -15.0 56.0 88.0 72.1 92.0 
G RP -8.2 -1.7 -15.5 47.1 89.0 68.9 91.4 
Longitudinal  
velocity 
(mm/s) 
Endo P RP 
81.9 7.9 50.0 63.8 -84.2 
102.5 91.5 
-80.2 -7.0 -50.0 -60.4 86.0 
Epi P RP 
55.0 7.2 47.0 17.0 -84.7 
90.1 92.6 
-59.9 -7.2 -47.0 -27.4 84.7 
G P RP 
66.4 7.5 49.0 35.5 -84.7 
95.0 92.1 
-69.9 -7.5 -49.0 -42.7 84.7 
Longitudinal  
strain  
(%) 
Endo RP -11.4 -9.4 -16.0 28.8 41.3 103.1 45.7 
Epi RP -15.0 -8.3 -14.3 -4.9 42.0 11.5 101.6 
G RP -12.2 -9.0 -15.1 19.2 40.4 52.1 44.4 
Longitudinal  
strain rate  
(%/s) 
Endo P RP 
201.0 32.0 55.0 265.5 -41.8 
190.4 47.1 
-164.0 -32.0 -55.0 -198.2 41.8 
Epi P RP 
263.0 29.7 48.0 447.9 -38.1 
246.5 45.0 
-217.0 -29.7 -48.0 -352.1 38.1 
G P RP 
158.0 30.8 51.0 209.8 -39.6 
133.2 45.4 -162.0 -30.8 -51.0 -217.6 39.6 
Endo = endocardial, Epi = epicardial, G = global, P = peak, RP = reverse peak, NA = not available.  
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Both software introduced a small circumferential displacement in the short axis model, 
although the overall error was still acceptable for CVI42. 
Finally, the two software were inadequate in estimating longitudinal displacement, CVI42 
could hardly pick any changes while Tomtec computed both positive and negative 
displacement when only the latter existed (Figure 7.6C). 
Strain: 
Both software packages were particularly poor at computing strain values from the 
simulated images. Only the global radial peak strain calculated by CVI 42 from the long 
axis model was within the 10% acceptable range. However, its overall error was nearing 
17%. Although the values were incorrect, the overall shapes of the strain curves produced 
by CVI42 were realistic. This was not the case for Tomtec especially for the long axis 
model (Figure 7.6  E-F). 
Both FT software packages measured non-zero circumferential parameters even though 
no circumferential motion was simulated, i.e. there was no in-plane rotation. These errors 
could be related to; i) intrinsic algorithm errors (small scale errors) or ii) model factors 
(larger scale errors).  For instance, the modelled uniform myocardium signal intensity 
might have lacked sufficient features for FT software packages to correctly track the 
moving contours. This could also explain why a circumferential motion was measured by 
both software as a uniform disk area (the myocardium) has an infinite rotational 
symmetry.  In order to add features to the myocardium a radial pattern was simulated; this 
is discussed in the next section. 
7.4 Radial model 
FT techniques rely on variation in signal intensities, changes in texture and patterns, as 
well as the endocardial and epicardial edges to compute displacement and strain. 
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Therefore, in this section, to improve on some of the limitations of the previous uniform 
numerical phantom, a textured pattern was used in the myocardial tissue for both the short 
axis and long axis models. In this case, a radial pattern of varying signal intensities was 
created. Simulated images were then analysed with both FT software packages and the 
results compared to the analytical motion parameters. 
 
Figure 7.6: Experimental and analytical plots for global parameters for the short and 
long axis uniform models. (A-C) displacement, (D-F) strain, (G-I) velocity radial and (J-
L) strain rate. 
7.4.1 Method 
The main aim of using a simple radial pattern as the myocardial tissue signal intensity 
was to investigate whether these features were able to better constrain and reduce the 
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measured circumferential motion (rotation), which was modelled as zero. Additionally, 
could the pattern improve the overall tracking in both radial and longitudinal directions. 
As an initial step, the radial patterns were modelled to contract without any 
circumferential motion (rotation).  
 
Figure 7.7: Example images from the radial short-axis model for s = 1 and Nspokes = 40. 
The end-diastole (left-hand side), and end-systole (right-hand side) images are shown. 
 
Figure 7.8: Example images from the radial long axis model for s = 1 and Nspokes = 60. 
The end-diastole (left-hand side), and the end-systole (right-hand side) images are shown. 
The radial patterns were modelled to deform radially with the endocardial and epicardial 
contours during one complete motion cycle representing one RR interval. Mathematically 
speaking, the patterns can be generated as a multiplication of two sine functions 
(equations 35 and 36). The first function depends on the radius (r) and the number of 
selected radial rings (z), while the second equation is a function of the angle ({) and the 
number of radial spokes (Nspokes) or lines. 
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|v(r) = sin(& ∗ z) (35) |5({) = sin({ ∗ Ä0%Å"Ä) (36) Bhe variables z and Nspokes control the pattern appearance as shown in Figures 7.7  and 
7.8 for the short and long axes models, respectively. For the short axis (Figure 7.7), both 
variables were set to s =1, and Nspokes = 40 spokes to cover the entire myocardium. While 
for the long axis (Figure 7.10), contained s =1, and Nspokes = 60 radial spokes to cover the 
entire semi-ellipse. In both models, the signal intensity of myocardium tissue (ÇÇÉÑÖÉÜáàÑâ ä <Ç å < ÇÇÉÑÖÉÜáçÖ ä ) Imyo varied circumferentially, whereas the intensity is the same radially. 
The same background (Ibg) and blood pool signal (Ibp) signal intensities as the uniform 
model were used and the radial short-axis is still modelled to contract radially only, while 
the radial long axis is modelled to contract radially and longitudinally.  
 
7.4.2 Results and discussion 
The radial short axis and long axis models results derived from FT software packages as 
well the errors between the peak values and overall curves are given in Table 7.5 for the 
short axis and Table 7.6 for the long axis model. Example frames from the analysis of the 
short and long axis using CVI42 is shown in Figure 7.9  while plots for global 
displacements and global strains throughout the cardiac cycle are displayed in Figure 
7.10.  
Overall, both software performed poorly especially for the long axis model with no 
agreement with the analytical values. In terms of global measurements, both software 
only agreed on three parameters all calculated from the short axis model: radial 
displacement, radial reverse peak velocity and radial strain. However, out of those three 
parameters only CVI42 agreed with the analytical peak value for displacement but none 
had an acceptable overall error. As in the uniform model, both software computed non-
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zero circumferential parameters when no rotation was simulated. 
 
  
Figure 7.9: CVI42 FT tracking of the radial short-axis (left-hand side) and long axis model 
(right-hand side) at frame 11 (systole). The green points show the tracking trajectory for the 
epicardial contour, whereas the red points show the tracking trajectory for the endocardial 
contour. A small non-modelled circumferential motion (rotation) can still be observed in the sort 
axis view. 
 
 
 
Figure 7.10: Experimental and analytical plots for global displacement (A-C) and global 
strain (D-F) for the short and long axis radial models. 
 
Displacement: 
Both software produced realistic radial displacement curves for the two models (Figures 
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7.10A and 7.10B). However, the peak values were overestimated in the short axis and 
underestimated in the long axis. In both cases, CVI42 performed better for both short and 
long axis models and the error in peak value (10.8%) and the overall error (12%) were 
just outside the acceptable rage. Similarly to the uniform model, both software struggled 
with longitudinal displacement; CVI42 grossly underestimated it, and once more 
calculated near zero displacement throughout the cardiac cycle while Tomtec produced 
unrealistic tracking plots (Figure 7.10C). Finally, both software introduced a 
circumferential displacement, although this was once again acceptable for CVI42 (2.5%). 
Strain: 
The introduction of the radial pattern did not lead to a better agreement when measuring 
radial strain with the short axis model with both software generating unacceptable errors. 
However, for the long axis model errors improved and for CVI42 the difference in peak 
value was acceptable (-1.6%) and the overall error slightly above the acceptable range 
(11.7%).  
Overall, the addition of the radial pattern did little to improve the performance of the 
software. Once more both software performed best for radial displacement with CVI42 
outperforming Tomtec and also producing acceptable values for long axis radial strain. 
All the other strain measurements were inadequate and once more, both software 
introduced a rotational component to the movement and the value associated with it did 
not improved compared to the uniform model. In the next section, the complexity of the 
simulations was further increased by introducing two sets of perpendicular lines forming 
a checkerboard pattern in the myocardium. 
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Table 7.5: Experimental and analytical values for global, endocardial and epicardial parameters 
using the radial short axis model. Errors expressed in percentage (%) circumferential parameters 
were the errors have corresponding units. Green cells = FT in agreement with analytical value 
(less than or equal to10% difference in peak value or less than or equal to 10% in error), yellow 
cells = 10% or less in difference in peak value between software. 
Parameters 
Experimental 
results Analytical 
values 
Difference in peak 
value (%) 
Error  
(%) 
Tomtec CVI42 Tomtec CVI42 Tomtec CVI42 
Radial 
displacement 
(mm) 
Endo P 8.5 7.6 10.0 -15.0 -24.0 15.5 24.4 
Epi P 7.0 6.8 3.0 133.3 126.7 169.8 128.3 
G P 7.7 7.2 6.5 18.5 10.8 27.9 12.0 
Radial velocity 
(mm/s) 
 
Endo 
P 
RP 
27.3 32.9 31.0 -11.9 6.1 
14.8 29.9 
-31.8 -32.9 -31.0 -2.6 -6.1 
Epi 
P 
RP 
23.1 29.7 9.0 156.7 230.0 
186.8 144.6 
-34.2 -29.7 -9.0 -280.0 -230.0 
G 
P 
RP 
23.4 31.4 20.0 17.0 57.0 
38.2 31.8 
-31.8 -31.4 -20.0 -59.0 -57.0 
Radial strain 
(%) 
Endo P NA 48.4 40.0 NA 21.0 NA 16.5 
Epi P NA 36.2 10.0 NA 262.0 NA 240.1 
G P 45.3 42.5 25.0 81.2 70.0 123.2 58.8 
Radial strain 
rate 
(%/s) 
Endo 
P 
RP 
NA 180.1 127.0 NA 41.8 
NA 46.3 
NA -180.1 -127.0 NA -41.8 
Epi 
P 
RP 
NA 141.8 31.5 NA 350.2 
NA 285.7 
NA -141.8 -31.5 NA -350.2 
G 
P 
RP 
361.4 162.2 79.0 357.5 105.3 
386.4 89.8 
-482.0 -162.2 -79.0 -510.1 -105.3 
Circumferential 
displacement 
(deg) 
Endo RP -0.9 -0.7 0 ND ND 28.4 2.5 
Epi RP -4.2 -0.7 0 ND ND 17.7 2.5 
G RP -2.1 -0.7 0 ND ND 22.5 2.5 
Circumferential 
velocity 
(deg/s) 
Endo 
P 
RP 
123.9 
-77.1 
7.2 
-7.2 
0 
0 
ND 
ND 
ND 
ND 
220.8 12.9 
Epi 
P 
RP 
62.7 
-48.8 
7.3 
-7.3 
0 
0 
ND 
ND 
ND 
ND 
132.0 13.1 
G 
P 
RP 
93.3 
-62.9 
7.2 
-7.2 
0 
0 
ND 
ND 
ND 
ND 
167.3 12.9 
Circumferential 
strain 
(%) 
Endo RP -33.1 -24.6 0 ND ND 88.1 68.9 
Epi RP -24.5 -20.9 0 ND ND 71.9 58.8 
G RP -27.8 -22.8 0 ND ND 79.7 64.1 
Endo = endocardial, Epi = epicardial, G = global, P = peak, RP = reverse peak, NA = not 
available. ND = not defined. 
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Table 7.6: Experimental and analytical values for global, endocardial and epicardial parameters 
using the radial long axis model. Errors expressed in percentage (%). Green cells = FT in 
agreement with analytical value (less than or equal to10% difference in peak value or less than or 
equal to 10% in error), yellow cells = 10% or less in difference in peak value between software. 
Parameters 
Experimental 
results Analytical 
values 
Difference in 
peak value (%) Error (%) 
Tomtec CVI42 Tomtec CVI42 Tomtec CVI42 
Radial 
displacement 
(mm) 
Endo P 10.6 9.4 7.0 51.4 34.3 54.3 33.8 
Epi P 10.3 8.9 8.0 28.8 11.3 29.9 11.3 
G P 10.5 9.2 7.5 40.0 22.7 41.1 21.8 
Radial 
velocity 
(mm/s) 
Endo P RP 
41.3 29.0 22.0 87.7 31.8 73.1 39.5 -38.2 -29.0 -22.0 -73.6 -31.8 
Epi P RP 
38.4 28.1 25.0 53.6 12.4 43.9 20.8 -32.6 -28.1 -25.0 -30.4 -12.4 
G P RP 
39.8 28.5 24.0 65.8 18.8 56.5 28.8 -35.4 -28.5 -24.0 -47.5 -18.8 
Radial strain 
(%) 
 
Endo P NA 13.1 12.7 NA 3.1 NA 10.9 
Epi P NA 11.0 11.8 NA -6.8 NA 13.3 
G P 9.5 12.1 12.3 -22.8 -1.6 47.8 11.7 
Radial strain 
rate 
(%/s) 
Endo P RP 
NA 49.2 43.0 NA 14.4 NA 27.8 NA -49.2 -43.0 NA -14.4 
Epi P RP 
NA 43.3 39.0 NA 11.0 NA 24.5 NA -43.3 -39.0 NA -11.0 
G P RP 
85.0 46.3 41.0 107.3 12.9 97.9 25. 6 -59.0 -46.3 -41.0 -43.9 -12.9 
Longitudinal 
displacement 
(mm) 
Endo RP -2.8 -2.0 -16.0 82.5 87.5 94.7 87.4 
Epi RP -2.7 -1.8 -15.0 82.0 88.0 108.6 87.9 
G RP -2.8 -1.9 -15.5 81.9 87.7 101.3 87.6 
Longitudinal 
velocity 
(mm/s) 
Endo P RP 
49.9 11.9 50.0 -0.2 -76.2 105.2 88.9 -46.6 -11.9 -50.0 6.8 76.2 
Epi P RP 
50.4 11.6 47.0 7.2 -75.3 126.5 89.5 -43.8 -11.6 -47.0 6.8 75.3 
G P RP 
50.2 11.8 49.0 2.4 -75.9 114.4 89.2 -35.7 -11.8 -49.0 27.1 75.9 
Longitudinal 
strain 
(%) 
Endo RP -15.5 -9.9 -16.0 3.1 38.1 19.1 41.5 
Epi RP -10.9 -8.7 -14.3 23.8 39.2 24.2 43.4 
G RP -13.0 -9.3 -15.1 13.9 38.4 15.9 40.7 
Longitudinal 
strain rate  
(%) 
Endo RP P 
16.7 33.9 55.0 -69.6 -38.4 202.6 41.0 -18.9 -33.9 -55.0 65.6 38.4 
Epi RP P 
93.0 31.0 48.0 93.8 -35.4 69.1 43.7 -67.0 -31.0 -48.0 -39.6 35.4 
G RP P 
87.0 32.4 51.0 70.6 -36.5 
122.2 43.8 -128.0 -32.4 -51.0 150.9 36.5 
Endo = endocardial, Epi = epicardial, G = global, P = peak, RP = reverse peak, and NA = not available. 
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7.5 Checkerboard Short Axis Model 
In the radial pattern model, intensities varied only circumferentially, however, in this 
section the aim was to create a more structured patterns or texture where the intensities 
varied circumferentially as well as radially. As the motion of a checkerboard pattern is 
complex to generate for a long axis only a short axis numerical phantom was created in 
this section. 
7.5.1 Method 
A short axis model using a checkerboard pattern was modelled to contract radially and to 
deform with the endocardial and epicardial contours. A Checkerboard pattern can be 
generated by using the same equations (35 and 36) introduced in the previous model 
(section 7.4.1). Obtaining a checkerboard pattern can easily be done by using a s > 1 
value, i.e. having more than one concentric rings within the myocardial area. The number 
of radial spokes (Nspokes) variable still determines the number of total radial sectors. 
Myocardial signal intensities were varied both radially and circumferentially to create the 
final checkerboard pattern (see Figure 7.12). Two signal intensities were chosen I1myo and 
I2myo, with Ibg < I1myo < I2myo < Ibp. Although the pattern varies circumferentially, there is 
no circumferential movement like in the previous two models. 
 
Figure 7.11: Example images from the checkerboard short-axis model for s = 4 and 
Nspokes = 20. The end-diastolic phase (left-hand side), and the end-systolic phase (right-
hand side) are shown. 
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Figure 7.12: CVI42 FT tracking of the uniform short-axis (left) and long axis model 
(right) at frame 11 (systole). The green points show the tracking trajectory for the 
epicardial contour, whereas the red points show the tracking trajectory for the 
endocardial contour. A small non-modelled circumferential motion (rotation) is observed 
in the sort-axis view. 
7.5.2 Results and discussion 
The checkerboard short axis model results, derived from Tomtec and CVI42, as well as 
the errors between the peak values and the overall curves are displayed in Table 7.7. 
Curves for all four global parameters are displayed in Figure 7.13.  
As for the previous two models, there was little agreement between software. In this case, 
they did not agree on a single global measurement. 
Displacement: 
Both software produced realistic displacement curves, however, CVI42 overestimated 
displacement by approximately 18% while Tomtec underestimated it by approximately 
55%. In the case of CVI42, this was similar to the uniform model (16.9% peak error, 
16.4% overall) but worth than the radial model (10.8% peak error, 12.0% overall). In the 
case of Tomtec, the checkboard pattern gave worth displacement results than the radial 
pattern that in turn was worth than the uniform model (overall errors of 55.7, 27.9 and 
2.4% respectively). 
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Table 7.7: Experimental and analytical values for global, endocardial and epicardial parameters 
using checkerboard short axis model. Errors expressed in percentage (%) except for the 
circumferential parameters were the errors have corresponding units. Green cells = FT in 
agreement with analytical value (less than or equal to10% difference in peak value or less than or 
equal to 10% in error), yellow cells = 10% or less in difference in peak value between software. 
Parameters 
Experimental 
results Analytical 
values 
Difference in 
peak value (%) 
Errors  
(%) 
Tomtec CVI42 Tomtec CVI42 Tomtec CVI42 
Radial 
displacement 
(mm) 
Endo P 2.9 8.0 10.0 -71.0 -20.0 69.1 20.4 
Epi P 2.7 7.2 3.0 -10.0 140.0 12.0 140.2 
G P 2.9 7.7 6.5 -55.4 18.5 55.7 17.5 
Radial velocity 
(mm/s) 
Endo 
P 
RP 
10.3 30.2 31.0 -66.8 -2.6 
69.4 25.3 
-11.1 -30.2 -31.0 64.2 2.6 
Epi 
P 
RP 
8.9 27.5 9.0 -1.1 205.6 
22.5 149.1 
-8.9 -27.5 -9.0 1.1 -205.6 
G 
P 
RP 
9.6 28.9 20.0 -52.0 44.5 
55.7 29.5 
-8.4 -28.9 -20.0 58.0 -44.5 
Radial strain 
(%) 
Endo P NA 52.9 40.0 NA 32.3 NA 24.2 
Epi P NA 39.6 10.0 NA 296.0 NA 268.9 
G P 14.8 46.6 25.0 -40.8 86.4 53.1 72.3 
Radial strain 
rate 
(%/s) 
Endo 
P 
RP 
NA 177.8 127.0 NA 40.0 
NA 54.6 
NA -177.8 -127.0 NA -40.0 
Epi 
P 
RP 
NA 133.8 31.5 NA 324.8 
NA 314.7 
NA -133.8 -31.5 NA -324.8 
G 
P 
RP 
45.4 158.3 79.0 -42.5 100.4 
90.3 104.2 
-77.9 -158.3 -79.0 1.4 -100.4 
Circumferential 
displacement 
(deg) 
Endo P -2.8 -2.0 0 ND ND 6.9 3.9 
Epi P -1.9 -1.9 0 ND ND 5.4 3.9 
G P -2.5 -1.9 0 ND ND 5.9 3.9 
Circumferential 
velocity 
(deg/s) 
Endo 
P 
RP 
38.1 
-40.4 
27. 8 
-40.1 
0 
0 
ND 
ND 
ND 
ND 
92.5 56.7 
Epi 
P 
RP 
20.3 
-21.8 
27.4 
-39.9 
0 
0 
ND 
ND 
ND 
ND 
49.1 56.2 
G 
P 
RP 
27.3 27.6 0 
0 
ND 
ND 
ND 
ND 
66.6 56.4 
-31.1 -39.9 
Circumferential 
strain 
(%) 
Endo RP -12.9 -25.7 0 ND ND 37.4 71.9 
Epi RP -9.3 -22.1 0 ND ND 25.1 61.9 
G RP -11.1 -23.9 0 ND ND 31.2 67.2 
Endo = endocardial, Epi = epicardial, G = global, P = peak, RP = reverse peak, NA = not 
available, ND = not defined. 
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Figure 7.13: Experimental and analytical plots for global parameters for the short axis 
checkerboard model; (A) displacement, (B) strain, (C) velocity radial and (D) strain rate. 
 
As with previous models, both software detected a small circumferential displacement in 
the checkerboard short axis model. However, this time the error was acceptable for both 
software as opposed to only acceptable for CVI42 in the previous two models.  
Strain: 
Both software packages gave inadequate results for circumferential strain. Although the 
curve produced by CVI42 was once more realistic in terms of appearance the peak value 
was grossly overestimated (86.4%) leading to an overall error of 72.3%. Tomtec 
produced an unrealistic curve, underestimated the peak value by 40.8% and had an 
overall error of 53.1%. 
As with the uniform and radial pattern models, both software calculated a non-zero 
circumferential strain when no rotation had been simulated. For CVI42, the calculated 
strain was almost identical to the previous two models, however, the error was halved for 
Tomtec when compared to the uniform model; 31.2% for the checkerboard compared to 
62% for the uniform model (see also figure 7.14C  & D). 
Displacement
Velocity
Strain
Strain	rate
A																																																																							B																																																	
C																																																																							D																																									
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Figure 7.14: Circumferential displacement and circumferential strain computed by both 
software for the different numerical models. For all simulation, rotation was set to zero 
and consequently, displacement and strain should have been equal to zero throughout the 
cardiac cycle (dashed line). 
7.6 General Discussion 
Prior knowledge of the exact motion and deformation parameters acting as a ground truth 
is essential for the development of FT software packages validation to assess precision 
and accuracy. A similar approach was used in the ongoing standardisation efforts and 
validation processes to reduce inter-vendor variability of the measurements across 
software packages for 2D speckle tracking echocardiography based on synthetic 
ultrasound data (99). However, only one study so far, used numerical simulations to 
validate a commercial FT software (Tomtec) (3).In this case, a range of uniform short 
axis models contracting only radially were generated to investigate the effects of varying 
spatial resolution, frame rate and the number of points used to track the endocardium. To 
build on this work, this chapter compared the deformation parameters measured by 
Tomtec and CVI42 software packages (experimental results) to the analytical values 
(gold-standard) of five different numerical motion models; uniform myocardial intensity 
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and radial pattern models for a short and a long axis view and a short-axis checkerboard 
myocardial pattern numerical phantom. Unlike the previous published work (3), my 
primary interest was not to investigate the effect of specific image parameters but to 
gradually work towards a realistic model with fixed image parameters for the different 
simulations.  
Although, the different model results in sections 7.3.2, 7.4.2. and 7.5.2 focussed on global 
displacements and strains for their respective models, this general discussion looks more 
specifically at trends with the increasing model complexity and touches on some of the 
other parameters. 
It is fair to say that both software struggled to analyse the models and the experimental 
values hardly ever agreed with the analytical values (Tables 7.3 to 7.7). This was not only 
the case for the global parameters but also for the epi and endocardial borders. This, at 
first, can look unexpected as those are such well-defined borders in terms of intensity 
transitions, however, it is possible that the tracking algorithms expect more anatomical 
features and not such smooth edges. One could think of making edges more realistic and 
adding papillary muscles to the model to test this hypothesis. 
Although both software packages were inaccurate for most calculations, it is worth 
highlighting that CVI42 always produced realistic parameter curves whereas, except for 
the short axis displacements, Tomtec generated unrealistic curves that often lacked the 
expected symmetry. 
Disagreement between numerical simulations and values calculated from commercial 
software have also been observed for 2D speckle tracking echocardiography (99). In this 
study, comparing global longitudinal strain between 9 vendors, some underestimated it 
compared to the analytical values, while others overestimated it. Like in the results 
observed in this chapter, it can be challenging to know if software packages are purely 
and simply inaccurate or if the models are not realistic enough for the algorithm to 
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function correctly. A clear demonstration of this is the presence of non-zero 
circumferential parameters for all short axis models in the results of both software when 
no rotation was simulated. Interestingly, the circumferential strain curves produced by 
both software models are very similar and physiologically realistic (Figure 7.14 C-D). 
The introduction of geometric patterns to the simulated myocardium has no effect on the 
strain output of CVI42 (Figure 7.14D) while the error reduces greatly with the use of a 
checkerboard pattern for Tomtec (Figure 7.14C). This seem to indicate that both software 
expect a rotational component and in its absence revert to a “physiological” output. One 
can speculate that the starting point of the algorithm is that physiological output that is 
altered to represent the actual displacement and strain. It is hard to estimate the effect of 
the absence of rotational component has on the correct calculation of the other parameters 
as we have no details on the algorithm used. However, it is clear from those results that a 
model should include this motion component in order to correctly assess the current FT 
commercial software packages. 
7.7 Conclusion 
Numerical simulation models with known motion and deformation parameters were 
developed in this chapter in order to create a true gold standard to test and validate FT 
software packages. The models of increasing complexity were analysed with two 
commonly used software packages, CVI42 and Tomtec, and the outputs compared to the 
analytical values. 
Overall, CVI42 generated the most realistic parameter curves but the values were 
inaccurate for the majority of parameters. Increasing the complexity of the model had 
little effect on the errors. 
Undoubtedly, both short and long axes simulations did not represent realistic clinical 
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images: the images were generated with simple non-physiological contraction, and did 
not containe detailed anatomical structures. The lack of rotational motion clearly created 
problems. Based on the results, I would strongly recommend including a rotational 
motion when refining those models and adding more anatomical features.. 
Despite these limitations, simulation models remain useful and essential since they can 
report the exact values for the motion and deformation parameters, however, this chapter 
experimental results coupled with highlighted limitations, clearly indicate that the model 
complexity needs to be further improved and refined, taking into account the varying 
texture across the myocardial tissue, the surrounding cardiac chambers and additional 
imaging factors, such as acquired spatial and temporal resolutions and effects of noise on 
image tracking quality. Additionally, there was lack of complete description of in plane 
myocardial contraction in short-axis models. Thus, the circumferential motion needs to be 
added to short-axis models thus potentially improving the outcomes. Short and long axes 
models at different spatial and temporal resolutions could then be compared for 
optimisation of scanning parameters, then implemented in vivo. 
Finally, only two commercial FT software packages were used in this chapter, however it 
is desirable to include more commercial and research analysis tools in this developmental 
and standardisation process. As with speckle tracking echocardiography, cardiovascular 
imaging societies and related organizations could help bring different vendors to provide 
information on algorithms used within their software (103), so researchers and clinicians 
can interpret their experimental results. FT software packages manufacturers should be 
encouraged to take an active role in the standardisation of FT methodology. This will help 
to reach a consensus on the best method of analysis, similarly to the standardisation 
processes actually carried out in echocardiographic studies. Standardising MRI 
acquisition parameters, in particular taking into account the spatial and temporal 
resolution, is also crucial and should be put into consideration if FT is to be accepted in 
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routine clinical practice.   
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Chapter 8: Conclusions and future work 
The main focus of this thesis was to validate the use of feature tracking to derive global 
and regional deformation parameters to assess myocardial function. The technique has 
already shown promising results as an early predictor of several sub-clinical 
cardiovascular diseases (4)(5)(87).  
The experimental work in this PhD thesis is a direct follow-up of the findings of the 
review chapter (chapter 3). To guide unfamiliar readers, the thesis includes a chapter that 
covers CMR imaging and provides some details on cardiac function and hypertension 
(chapter 2). In order to lighten the experimental chapters (chapter 5, 6 and 7), the 
common methodologies, including detailed information on the different software 
packages and statistics are including in chapter 4. 
The remainder of this chapter resumes the key findings of the literature review and 
experimental chapters, discusses the limitations of this work, makes recommendations 
based on the results and suggest possible further research. 
8.1 Summary of findings 
This section summarises the key findings from the literature review and the three 
experimental chapters and discusses some of the limitations of the work carried out. 
8.1.1 Literature review (Chapter 3) 
The literature review chapter summarised all the studies, published until mid-2017, that 
used FT. Particular attention was paid to validation studies comparing FT to other 
techniques, CMR- tagging and echocardiographic speckle tracking, or models/numerical 
phantoms. 
Previous studies have highlighted the potential effectiveness of FT in a clinical setting by 
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demonstrating the technique can discriminate between healthy heart state and some 
diseases (50)(51)(98). However, other researcher have highlighted the variability of FT 
and the differences in output when compared to echocardiography (67)(68). The main 
variabilities were found in regional deformation parameters compared to global 
measurement (6)(68), and when measuring radial strain parameters (30). Circumferential 
strain was the most reproducible parameter, followed by longitudinal strain (6)(67). This 
reported variability and the lack of absolute agreement between FT and established 
techniques (30)(67) remains an obstacle to its clinical use. 
The chapter highlighted the key findings and limitations of all reviewed articles, however, 
no meta-analysis was carried out. This could have been useful to obtain normal values 
and cut-off points to discriminate between healthy populations and the studied 
pathologies. Nevertheless, the results clearly justified the work carried out in the 
following three experimental chapters. 
8.1.2 Comparison between FT software (Chapter 5) 
This chapter compared three FT software packages (Tomtec, CVI42 and CIM-FT) in a 
hypertensive population and a group of healthy subjects. Significant differences were 
found and few parameters were in agreement. For global measurements, software 
packages were only in agreement for the 2-chamber longitudinal strain.  
ICC analysis demonstrated that global circumferential strain calculated from a mid-
ventricle short axis slice and longitudinal strain were the most consistent parameters 
across software packages. Overall, global measurements displayed higher reproducibility 
than regional measurements for the three software. CVI42 was the software with the 
lowest inter- and intra- observer variability.  
When interpreting the results of this chapter, readers should bear in mind that the analysis 
was carried out on a small sample size (28 size subjects and 26 hypertensive patients). 
Another confounding factor was the imaging protocol that was different for the healthy 
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subjects and the hypertensive patients. This may have accounted for a certain percentage 
of the variability and bias in this study. However, CVI42 was clearly more consistent and 
consequently was chosen to compare FT to CMR tagging. 
8.1.3 Comparison between FT and Tagging (Chapter 6) 
In this chapter, the most reproducible FT software from chapter 5 was compared to the 
established method of CMR tagging (8); CIMTag2D was used for the tagging analysis. 
Once more a group of healthy subjects and hypertensive patients were used but the 
hypertensive cohort was larger (n=62) and the imaging protocol identical for each group.  
Significant differences between software were found in both groups and only a few 
parameters were in agreement. Those were global circumferential, global, endocardial 
and epicardial radial strain calculated from the mid-ventricle short axis slice and the 
endocardial radial strain calculated from the for 4-chamber view. 
Significant differences were found between healthy males and females with both 
techniques; global and endocardial longitudinal strain from 4-chamber were significantly 
higher in female for both techniques, while the epicardial radial strain from 2-chamber 
was significantly higher in males for tagging only. 
When comparing healthy subjects and hypertensive patients, CVI42 could not find any 
differences, however, global radial strain from the mid-ventricle short axis and 4-chamber 
global longitudinal strain rate were significantly higher in hypertensive patients using the 
tagging technique. When interpreting those results, it is worth keeping in mind that the 
two groups were heterogeneous in the term of size, age and gender. 
8.1.4 Numerical simulations (Chapter 7) 
Numerical simulations in the long and short axes, with increasing myocardial pattern 
complexity, were created and analysed with two FT software packages (Tomtec and 
CVI42). Both software struggled to analyse the models correctly, disagreeing between 
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them and with the analytical values for most parameters. Overall, CVI42 did produce 
realistic parameters curves (but with wrong values) while Tomtec mainly generated 
unrealistic asymmetric curves. None of the models used rotational motion and this might 
have strongly influenced the results as both software calculated non-zero circumferential 
parameters. Although, the introduction of more complex pattern helped reducing this 
issue for Tomtec but had no effect on the CVI42 results. 
8.2 Implications of study and recommendations 
8.2.1 Choice of software and strain parameters 
More and more FT software are becoming available commercially or through research 
agreements. High variability between software has been clearly highlighted in this thesis 
and by previous authors, and consequently, until a gold standard is established to test the 
various software packages, it is hard to recommend one software based on accuracy. 
However, based on its better inter and intra-observer-variability and its more reasonable 
analysis of simulations, it might be preferable to use CVI42 if available. 
Radial strain results showed the highest variability in vivo and until this is understood and 
fixed, it is preferable to avoid drawing clinical conclusions from them. The most 
consistent parameters across the three software by ICC agreement were mid-ventricle 
short axis circumferential strain and to a lesser extend longitudinal strain. It would 
therefore be advisable to privilege those parameters for analysis.  
8.2.2 Standardization efforts 
It is clear from the thesis and all published data, that efforts to standardise FT need to be 
undertaken. This process was carried out for 2D speckle tracking echocardiography with 
the European Association of Cardiovascular Imaging (EACVI) and the American Society 
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of Echocardiography (ASE) (70). A standardization task force was established with 
manufacturers to standardize deformation imaging parameters, providing definitions, 
abbreviations, formulas, and procedures for calculation of physical quantities derived 
from speckle tracking technology (70). The process involved the creation of synthetic 
ultrasound images for quality insurance process, and to compare global longitudinal strain 
in nine vendors (99). A related study, looked at global longitudinal strain in healthy 
subject with seven software (69). Following this work, guidelines were published  in 2015 
(85). It is obvious that the CMR community will need to come up with a similar plan for 
FT, involving societies and vendors. A reliable numerical phantom would play an 
essential role in this process. 
8.3 Areas of further study 
In a relatively new field avenues for further research are numerous and the suggestions in 
this section are far from exhaustive. They are however areas that could have been 
explored as the continuation of the work described in this thesis. 
8.3.1 Normal values and cut-offs 
There is an obvious lack of reliable normal range(s) and in the absence of standardization 
it might be interesting to establish them for the different software in healthy volunteers. 
The effect of imaging parameters could also be studied in a sub-set at the same time. This 
work could then be extended to different patient groups, thus leading to the establishment 
of cut-off values that could be used for diagnostic purposes. 
Currently, there is a lack of data on segmental and torsion parameters in particular when 
comparing software. This would be of particular clinical relevance as those particular 
parameters appear to be valuable when looking at the presence of scar tissues (50)(51). 
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8.3.2 Improving numerical simulations 
As demonstrated with speckle tracking (99), numerical phantoms will play a key role in 
the FT standardization process, it is therefore crucial to increase research efforts in this 
area. The results of chapter 7 demonstrate that it is essential to include rotational motion 
for the software to operate correctly. Consequently, this should be the first step in 
improving the models. Introducing more realistic anatomy and feature patterns would be 
the next step. This could be achieved by segmenting the relevant anatomical features 
from high resolution scans to create an initial image. Cine series would then be generated 
by deforming the first image using realistic values. Adding anatomical structure such as 
papillary muscles, right ventricle and the upper and lower insertion points would allow 
for segmental assessment.  
Finally adding controllable parameters, in particular spatial and temporal resolutions, and 
noise level, would then help defining standard acquisition protocols. 
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